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ABSTRACT 
Glucose absorption along the intestine primarily occurs through sodium-dependent 
glucose transporters (SGLTs).  Recently, it has been suggested that glucose transport across the 
brush-border membrane (BBM, or apical side of epithelial cells) can also occur through sodium-
independent/facilitative glucose transporters (GLUTs) in mammals.  Here, the Ussing chamber 
was used to characterize sodium-dependent and sodium-independent glucose transport systems 
across ex-vivo intestinal segments in the mammalian pig, and the aquatic species tilapia and 
trout.   
 In our first study, electrogenic sodium-dependent glucose transport in tilapia 
demonstrated a homogeneous high-affinity, high-capacity (Ha/Hc) transport system across the 
proximal intestine, mid-intestine, and hindgut segments, associated with transporters from the 
solute carrier 5A (SLC5A) family.  In contrast, trout demonstrated a heterogeneous glucose 
transport system with a high-affinity, low-capacity (Ha/Lc) in the pyloric caeca, a super-high-
affinity, low-capacity (sHa/Lc) in the midgut, and a low-affinity, low-capacity (La/Lc) in the 
hindgut, associated with different expressions of SLC5A transporters in each segment.  
Additionally, fish were different from mammals in demonstrating hindgut sodium-dependent 
glucose absorption.  
In our second study, we found that sodium-dependent glucose and galactose transport 
along the porcine jejunum and ileum followed sigmoidal/Hill kinetics.  This strongly suggested 
that each segment had multiple transporter involvement.  The transport systems in the jejunum 
demonstrated a Ha/super-low-capacity (sLc) for glucose and a La/Lc for galactose.  In contrast, 
the ileum demonstrated a Ha/super-high-capacity (sHc) glucose transport system, and a La/Hc 
galactose transport system.  In support of this, different SLC5A transporters were associated with 
the kinetics in each segment.  Finally, the absence of monosaccharide transport in the colon was 
supported with pharmacological data and low expression of all SLC5A genes.   
Our last study characterized total tissue glucose flux in tilapia, trout, and pig.   We 
demonstrated a Ha/Hc system in tilapia, a Ha/Lc system in trout, and a La/Lc system in the pig.  
The overall La system in the pig, with differences in pharmacological inhibition and gene 
expression in comparison to the aquatic species, revealed a different mechanism of glucose 
transport in the pig.  Interestingly, our results revealed the possible involvement of AQPs in 
tilapia and pig to total tissue glucose absorption.     
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 Overall, our results in each study highlighted the fact that aquatic species have 
divergently adapted mechanisms for glucose absorption differing from the mammalian pig, 
which may have evolved to meet their individual needs.  
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Chapter 1 - Introduction 
 
1.1 Rationale 
The digestion and absorption of nutrients in all species are essential to maintaining an 
animal’s homeostasis and development (194).  The gastrointestinal (GI) tract is the primary site 
of digestion and absorption of nutrients (155).  Once the food is ingested and digested, the main 
classes of absorbed nutrients are lipids, amino acids, monosaccharides, as well as other 
compounds like vitamins, minerals, and electrolytes (155).  Specifically, here I focus on 
monosaccharides, the product of complex oligosaccharide and polysaccharide carbohydrate 
digestion, providing the major energy source from the diet (20, 21, 118, 160, 199).  
 A major product of carbohydrate digestion is the monosaccharide glucose (178).  Glucose 
provides energy via its oxidation through glycolysis, the pentose phosphate pathway, and the tri-
carboxylic acid (TCA) cycle (178).  However, for glucose to be utilized by these pathways, it 
must first be transported into intestinal epithelial cells (150, 178).  The transport of glucose can 
either be through sodium-dependent or sodium-independent transporters from different solute 
carrier gene families (53, 75, 95, 179, 191).  This transport has been extensively studied in 
mammals like pigs, cats, humans, and rats, as well as ruminant species like cattle and goats (12, 
16, 87, 101, 112, 113, 147, 201).  It has also been studied in fish species like the Pacific copper 
rockfish, as well as avian species like the chicken (4, 68, 130).  Interestingly, the transport of 
glucose along the intestinal length of these species not only revealed the diversity in expression 
and function of glucose transporters, but it also presented unique patterns of segregation.  More 
specifically, different kinetic sodium-dependent glucose transport systems along the length of the 
small intestine have been discovered in many species, and the reason for this adaptation is still 
unknown (4, 21, 22, 75).  Nevertheless, these significant differences likely evolved to meet the 
needs of these individual species.   
Here, we investigate the similarities and differences between electrogenic sodium-dependent 
glucose transport systems present in the omnivorous Nile tilapia (Oreochromis niloticus) and the 
carnivorous rainbow trout (Oncorhynchus mykiss).  We found that tilapia demonstrated a 
homogeneous sodium-dependent glucose transport system throughout its gastrointestinal (GI) 
tract.  In contrast, trout demonstrated a heterogeneous sodium-dependent glucose transport 
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system segregated into each of its intestinal segments.  These systems in both fish species were 
associated with different transporters from the solute carrier 5A family (SLC5A).  
Comparatively, the electrogenic sodium-dependent transport of glucose and galactose was 
studied in the mammalian pig (Sus scrofa) revealing differences in transport systems between the 
jejunum and ileum.  More importantly, these transport systems followed sigmoidal/Hill kinetic 
fits that suggested the involvement of multiple transporters in each intestinal segment.  
Additionally, different SLC5A transporters were likely associated with the transport systems in 
each segment. 
Finally, the characterization of total tissue glucose flux between tilapia, trout, and pig 
presented major differences in the glucose transport mechanism between all three species.  
Overall, this work presents evolutionary adaptations between these three species in terms of 
differences in glucose transport mechanisms, for the benefit of their individual needs. 
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1.2 Objectives 
1. To characterize electrogenic sodium-dependent glucose transport in the omnivorous Nile 
tilapia and the carnivorous rainbow trout in Ussing chambers, with pharmacological 
inhibition, and genomic and gene expression analysis. 
 
2. To characterize electrogenic sodium-dependent glucose transport along the porcine jejunum, 
ileum, and distal colon in Ussing chambers, with two different substrates, pharmacological 
inhibition, and genomic and gene expression analysis. 
 
3. To characterize total tissue glucose absorption in the proximal small intestine of tilapia, trout, 
and pig in Ussing chambers using 14C 3-O-Methyl D-Glucose, pharmacological inhibition, 
and genomic and gene expression analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
 
1.3 Hypotheses 
1. Omnivorous tilapia has a higher capacity of electrogenic sodium-dependent glucose transport 
than the carnivorous trout, with differences in transport kinetics.   
 
2. The porcine jejunum and ileum have differences in glucose and galactose transport kinetics, 
involving different transporters. 
 
3. The pig, a representative mammalian model, has a different mechanism of total glucose 
absorption along the intestinal brush-border membrane in comparison to aquatic species 
tilapia and trout.   
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Chapter 2 – Literature Review 
 
2.1 General Overview of Carbohydrate Digestion and Absorption  
Carbohydrates are one of the major components present in feed for mammals like pigs, 
dogs, mice, and rats, and it represents the greatest source of energy from the diet (32, 47, 51, 
109, 114).  Additionally, the gastrointestinal (GI) tract of these species has adapted to digest and 
absorb carbohydrates (61).  Carbohydrates can be digested and absorbed by the host, beginning 
in the mouth, and ending in the large intestine (139).  Carbohydrate digestion is primarily 
mediated by enzymes present in the mouth and small intestine (salivary and pancreatic α-
amylase, as well as other hydrolytic enzymes) that break down carbohydrates into mono- and di-
saccharides (74, 114).  In the small intestine, these hydrolytic enzymes are either on the brush-
border membrane (BBM, or apical side of the enterocyte) or secreted as a soluble form (114, 
152).  These monosaccharides that are released from carbohydrate digestion include glucose, 
galactose, and fructose, which are then absorbed by the enterocytes in the small intestine (114).  
The absorption of these monosaccharides across the BBM occur via transcellular transporters  
(114, 152).  Once in the enterocytes, these monosaccharides are either oxidized for energy or 
transported into the blood and used by the animal (139).   
Following carbohydrate digestion, absorption occurs specifically in the villi tips, or 
microvilli (74, 139).  These structures are the sites of nutrient absorption, where most of the 
transporters on the BBM for monosaccharides, amino acids, vitamins, and minerals are located 
(74, 139).  The absorption of carbohydrates across the BBM can be an active process, requiring 
energy (ATP) or passive transport, not requiring ATP (139).  Active absorption occurs using the 
electrochemical gradient of sodium, which is established by the basolateral sodium/potassium 
ATPase (202).  Sodium is pumped out from the basolateral side, which develops a concentration 
gradient favoring sodium entry into the enterocyte (97).  Along with sodium entry, it can co-
transport an amino acid, monosaccharide, or vitamin (114).  Therefore, these transporters are 
called sodium-dependent co-transporters, meaning the transport of the nutrient requires the co-
transport of sodium to enter the enterocytes (97, 204).  Additionally, monosaccharides can be 
absorbed passively through facilitative transporters down its concentration gradient, a process 
that does not require coupling and the use of ATP (106).  Such transport is often referred to as 
sodium-independent glucose transport (44, 106, 203, 213).  Thus, glucose, fructose, and 
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galactose can be absorbed using either type of transport (13, 18, 75, 106, 112, 115, 171, 204).  
These transporters can also use other ions, like potassium or hydrogen, for co-transport as well 
(13, 22, 204).  After the transport of these monosaccharides into the enterocyte, they can be 
oxidized for energy, or exit the enterocyte via the basolateral membrane through passive 
transporters, and into the circulatory system (127).  Once in the bloodstream, the resulting 
average blood glucose levels in the pig is around 6mM, in tilapia it is around 5mM, and in 
rainbow trout it is around 3mM, all fed on a commercial diet (85, 158, 208). 
The digestion and absorption process of carbohydrates can differ between species, 
depending on many factors including the gastrointestinal tract anatomy.  However, I focus on the 
transport mechanism of glucose specifically, which can vary between species.  Understanding 
the functional GI anatomy in its contribution to glucose absorption is essential, and this is 
presented below.   
 
2.2 Gastrointestinal Tract Functional Anatomy of Porcine, Nile Tilapia, and Rainbow 
Trout 
Adequate nutrition is essential for all mammals and vertebrates, with the digestive system 
playing a crucial role in attaining this need (155).  The GI tract has the same general function 
throughout all species, which is to digest and absorb ingested nutrients (74, 98, 139, 194).  Its 
specific functions include the mechanical and chemical breakdown of the food components, 
followed by absorption mediated by transporters (74, 194).  Additionally, specific anatomic 
functions of the GI tract can depend on many factors including the type of species (omnivore, 
carnivore, herbivore, etc.), the diet, the amount of food intake, and the natural environment (98, 
194).  Thus, the anatomy and specific functions of the GI tract can vary among different types of 
species (98, 194).  The description of these species differences in GI tract anatomy allows for a 
better understanding of glucose absorption.  The gastrointestinal tract functional anatomy for 
porcine, Nile tilapia and rainbow trout are presented below.   
 
2.2.1 Porcine Gastrointestinal Tract Anatomy 
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Swine are omnivorous species with similar nutrient requirements and GI tract anatomy to 
humans (74, 98).   Digestion of oligosaccharides and polysaccharides to monosaccharides 
(glucose, galactose, and fructose) and absorption of these components in pigs is essential for 
providing energy for various bodily functions (3, 114).  The entirety of the GI tract is composed 
of four predominant tissue layers that are similar in humans and other mammals (194).  The four 
layers moving from the innermost layer to the outermost layer consists of the mucosa, 
submucosa, muscularis, and serosa (139, 194).  The mucosa surrounds the lumen of the intestine 
and is mainly composed of polarized epithelial cells (34).  The submucosal layer supports the 
mucosa and contains the majority of blood vessels and nerves (34).  The submucosa is followed 
by the muscularis layer, which is then covered by the serosal layer (34, 194).  These four layers 
continue throughout the GI tract, being present in the stomach, small intestine, and large intestine 
(34, 194).   
The porcine GI tract starts with the mouth, where absorption is negligible, but the saliva 
containing water, mucus, and salivary α-amylase begins digestion of the oligo- and 
polysaccharides (56).  Following the mouth and esophagus is the stomach, which is the organ 
that allows for the mechanical breakdown of food components (Figure 1) (98, 194).  Mechanical 
digestion is defined as the physical contraction and churning of the stomach contents to 
breakdown the food (194).  Little carbohydrate digestion occurs in the stomach, which is 
primarily involved in protein and lipid digestion (56, 194).  However, the stomach does serve to 
release the carbohydrates from complex food, allowing for carbohydrate digestion in the 
intestine (194).  Once the food components have been digested to smaller particles, they pass 
through the pyloric sphincter situated at the end of the stomach, and into the small intestine 
(167). 
The porcine small intestine is the longest organ of the GI tract (Figure 1) (98).  The small 
intestine is the major site of digestion and absorption of carbohydrates (especially glucose), in 
addition to other nutrients (98, 139).  This function is present in most mammals, vertebrates, and 
avian species (98, 139).  The small intestine as a whole has a very large surface area that is 
coated with plicae (circular folds from the mucosal and submucosal layers), villi, and microvilli 
on the luminal side of the intestine (98, 139).  The presence of the villi and microvilli increase 
the surface area of the small intestine from 30-60 fold (139).  The villi are around 300-500 µm in 
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length and contain blood and lymphatic vessels, which transport the absorbed nutrients to other 
places in the body (194).   
Additionally, the villi are covered by enterocytes/absorptive cells, which represent about 
90% of the villi surface (98).  The enterocytes have fine extensions called microvilli, which are 
around  1 µm in length (139).  These microvilli are coated with a glycoprotein complex called 
the glycocalyx, and together, they further increase the absorptive capacity of the small intestine 
(139).  The microvilli and glycocalyx complex are called the brush-border membrane (BBM) 
(139).  The BBM has a variety of digestive enzymes and nutrient transporters that assist in the 
digestion and absorption of food components present in the chyme (139).  This architecture of 
plicae, villi, and microvilli continues throughout the different sections of the small intestine (98, 
139, 194). 
The small intestine is further separated into the duodenum, jejunum, and ileum, where the 
duodenum is the first portion encountered after the stomach (Figure 1) (194).  The pancreatic 
duct and common bile duct both secrete digestive enzymes and bile, respectively, into the 
duodenum, which makes the duodenum the main hub for degradation of food products 
(especially carbohydrates) from the stomach (194).  The secretory juices from the pancreas and 
gallbladder contribute to a pH environment of around 6.1-6.7 for the entire pig small intestine 
(134).  The duodenum is composed of four major cell types: the absorptive cells/enterocytes, the 
goblet cells, the granular cells, and the endocrine cells (194).  The absorptive/enterocytic cells 
are mainly involved in nutrient uptake (194).  The goblet cells assist in mucus secretion and 
protection, thus providing lubrication for the luminal mucosa (139).  The granular cells, also 
called Paneth’s cells, protect the lumen by secreting digestive enzymes like lysozymes, to break 
down invasive bacterial species (194).  Finally, the endocrine cells are involved in providing 
regulatory hormones for various functions in the duodenum (194).   
Although absorption occurs in the duodenum, the majority of nutrient absorption occurs 
in the following segments, the jejunum and ileum (194).  The jejunum and ileum both differ from 
the duodenum by being smaller in diameter and having a reduced number of villi and plicae 
(194).  Additionally, the ileum contains a small number of microbes which assist in initial 
fermentation of undigested feed (98, 194).  Altogether, the duodenum, jejunum, and ileum of the 
porcine GI small intestine possess the molecular machinery for the digestion and absorption of 
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nutrients, including oligo- and polysaccharides to monosaccharides such as glucose, galactose, 
and fructose. (98, 194). 
The porcine small intestine is followed by a pouch-like structure called the cecum (Figure 
1) (98).  The cecum size varies amongst mammals, with the pig’s cecum being generally larger 
than humans (98).  Additionally, the cecum pH environment is more acidic than the pH of the 
small intestine, because of the microbial environment fermenting undigested feed matter into 
short-chain fatty acids (SCFA) (134).   
The cecum is followed by the large intestine/colon, and the small intestine is attached to 
the large intestine via the ileocecal junction (Figure 1) (194).  The large intestine is not as long as 
the small intestine, and its absorptive properties are different as well (194).  The digesta transit 
time through the large intestine is much longer than the small intestine (compare 2-16 hours for 
small intestine versus 20-40 hours for large intestine) (139).  In contrast to the small intestine, the 
large intestine does not contain villi, and the microvilli along the colonic enterocytes are less 
packed together (98).  Additionally, the large intestine in the pig contains a unique spiral colon, 
with digesta moving similarly to the rest of the large intestine (78).  Finally, the lumen of the 
large intestine has a larger diameter than the small intestine (194).   
The porcine large intestine is primarily involved in the absorption of water, minerals, 
electrolytes, and sodium, with little to no absorption of carbohydrate digestive products like 
glucose (98, 139, 194).  By absorbing the majority of the water, it helps concentrate the 
undigested food particles traveling from the small intestine (194).  The sodium/potassium 
ATPase is the main molecular machinery that creates the gradient for re-absorption of sodium 
and water into the cells (194).  Additionally, the colon houses a diverse population of microbial 
organisms that ferment indigestible food components passed on from the small intestine (98, 
139).  Similar to the cecum, the undigestible matter in the colon is broken down by these 
microbes into volatile fatty acids (VFA), which are passively and actively absorbed across the 
intestinal epithelium (98, 139).  The colon represents the last portion of the digestive tract that 
can digest and absorb indigestible material, before food and waste components are excreted 
through the rectum (139, 194).    
 
 
 10 
 
 
 
Figure 2.1 Schematic diagram of porcine gastrointestinal tract anatomy.  
Schematic diagram representing the stomach, duodenum, jejunum, ileum, cecum, and large 
intestine and spiral colon. 
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2.2.2 Overview of Carbohydrate Digestion and Absorption in Fish 
Carbohydrate digestion and absorption in fish has become a popular area of study as the 
inclusion of dietary carbohydrates in fish feed increases (26).  Carbohydrates represent the 
cheapest energy source in fish feed (199).  Similar to mammals, carbohydrate digestion and 
absorption primarily occurs in the small intestine of fish (38).  However, the digestion and 
absorption of carbohydrates can vary between fish species, especially between omnivorous, 
carnivorous, and herbivorous species (74, 199).  Nevertheless, all fish species can use 
carbohydrates as an essential source of energy, in addition to lipids and protein (199).  However, 
a diet low in carbohydrates would result in more protein and lipids catabolized for energy use 
(199).  Therefore, an appropriate amount of carbohydrates are incorporated into fish feed to 
reduce the catabolism of expensive protein for energy for farmed fish like rainbow trout and Nile 
tilapia (9, 59, 199).   
The general trend of carbohydrate digestion in fish is that warm water, omnivorous fish 
tend to consume and digest carbohydrates more efficiently than cold-water, carnivorous fish 
(199).  These differences can be attributed to a greater amount of α-amylase activity in warm 
water and freshwater fish in comparison to cold water and marine fish species (110, 151, 160).  It 
was shown that in the omnivorous carp, the amylase activity was about 10-30 times greater than 
rainbow trout (88).  Therefore, differences in carbohydrate digestion can exist between fish 
species. 
Similar to mammals, after carbohydrate digestion, the carbohydrate products which are 
monosaccharides (glucose, galactose, and fructose) are transported through sodium-dependent 
and sodium-independent transporters (118, 162, 190).  These transporters are present on the 
BBM or apical side of enterocytes along the intestine (4, 79, 130, 161).  Depending on the fish 
species, the amount and locations of these transporters can vary along the intestine (38, 161).  
This includes some segments of the intestine containing a higher number of monosaccharide 
transporters than other segments (4, 18, 130).  Studies of glucose absorption have been 
investigated in a limited number of fish species.  Of these studies, one investigated the uptake of 
3H-D-glucose in brush-border membrane vesicles (BBMVs) of the Pacific copper rockfish (4). 
This study demonstrated that the kinetics of glucose transport differed between the intestinal 
segments, pyloric caeca and upper intestine (4).  Additionally, another study investigating 
glucose uptake in herbivorous and carnivorous fish species in the Amazon found glucose 
 12 
 
absorption occurred throughout the gastrointestinal tract (156).  Nevertheless, the overview of 
glucose absorption in fish is similar to mammals (presented above).  Overall, glucose uptake in 
the fish GI tract is currently an active area of study, as glucose transport kinetics and identities 
are discovered and characterized.   
 
2.2.3 Nile Tilapia Gastrointestinal Tract Anatomy  
Nile tilapia (Oreochromis niloticus) is an omnivorous fish from the Cichlid family of 
teleosts, and is one of the most popular fish farmed worldwide (38, 67).  In the aquaculture 
industry, the use of carbohydrates in tilapia feed has become more popular since it provides a 
cheap energy source and tilapia can tolerate the carbohydrates better than their carnivorous 
counterparts (157).   
Little is known about carbohydrate digestion in the mouth of tilapia species.  Therefore, 
we will start with the stomach, which represents a small, sac-like structure that initially received 
speculation from many researchers on whether it was a functional stomach (Figure 2) (136, 138).  
However, once its histological characteristics were studied, this structure was confirmed as the 
stomach (31, 67, 138).  Earlier studies of the stomach described it as a single functioning unit 
containing proteases and a low pH environment (138).  Later research, especially by Caceci et al. 
1997, found that the stomach contained three separate regions, the initial, middle and terminal 
regions, and they were structurally similar to the cardiac, fundic, and pyloric regions of 
mammalian stomachs (30, 138).  The stomach as a whole has four tissue layers, the tunica 
mucosa, tunica submucosa, tunica muscularis, and tunica serosa, which is very similar to 
mammals (30).  The tilapia stomach is shaped like a “Y,” where the body of the “Y” represents 
the middle region, and the arms represent the initial and terminal regions of the stomach (30).  
 The start of the stomach directly after the oesophagus contains gastric glands and 
columnar epithelial cells (30).  It has a smooth mucosal surface with no gastric pits, and merges 
with the middle region, which is defined by fibers of skeletal muscle and invaginations that 
contain secretory epithelium (30).  The middle region is the largest of the two sections, and its 
secretory epithelium contains gastric pits and acinar glands (30).  These secretory regions 
provide the distinction between the initial and middle regions of the tilapia stomach (30).  This 
region is primarily responsible for secretion of enzymes and gastric acid (30).  The middle region 
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is lined with simple columnar epithelial cells, and contains large blood capillaries (30).  The 
terminal region continues from the middle region and joins with the small intestine (30).  Its 
epithelial lining is similar to the middle region, containing columnar epithelial cells, but with less 
secretory function (30).  Similar to mammals, the glands present in the terminal region, as well 
as in the initial region, are thought to secrete mucopolysaccharides that prevent erosion of the 
stomach epithelium from the gastric acid (31, 138).   
The middle region is the most extensively studied by earlier researchers because it is the 
largest section (30).  Therefore, the initial and terminal regions were missed because of their 
smaller architecture (30).  The middle region is thought to represent the site of acid production 
since low pH values around 3-5 have been reported here (30).  A study looking at the pH 
fluctuation in tilapia stomach fed blue-green algae (a natural part of their diet) found the pH to be 
the lowest in the middle region (1-4) compared to the initial (2.5) and terminal (2.0) regions (30, 
136).  Interestingly, the middle stomach is also called a blind diverticulum in tilapia (30).  Food 
components have the ability to bypass the middle region of the stomach, since there is a 
diverticulum connecting the initial and terminal regions of the stomach (30).  Some food 
components like plant material or resistant starches need a longer time to be digested by the 
gastric juices, so they reside in the middle region of the stomach, whereas components that are 
digested easily can bypass the middle region, and enter into the intestine (30).  This was 
discovered when studying the digestibility of blue-green algae in Nile tilapia, where some algae 
in the stomach were brown due to the acidic conditions, but some of the algae remained green, as 
it passed along the anterior surface of the stomach, further supporting this bypass mechanism 
(136, 138).  It was hypothesized that this mechanism evolved as tilapia switched from an 
omnivorous to herbivorous feeding strategy, as plant material incorporated into their diet needed 
longer time to digest (138).   
Once the food components are digested in the stomach, it passes into the intestine where 
the pancreatic and bile secretions assist with further digestion (141).  In Nile tilapia, the pancreas 
is dispersed along the neighboring blood vessels in the messentery to join the liver and form a 
hepatopancreas (137).  The pancreatic duct, as well as the bile duct extends from the liver and 
empties into the intestine of tilapia (137). 
Information on the intestinal anatomy of tilapia is more limited, with a few studies 
identifying tilapia intestine as macroscopically indistinguishable from post-stomach to the anus 
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(Figure 2) (138).  However, microscopically, the differences observed distinguish the anterior 
portion of the intestine (stomach to ¾ length of the intestine) to be in the shape of a U-loop and 
is more thicker than the posterior portion of the intestine  (rest of the intestine to the anus) (138).  
The posterior portion also has less-folded mucosa and many clear vacuoles in columnar 
epithelial cells (138).  In a related species, O.mossambicus, the posterior part of the intestine is 
considered to be the rectum because it has shallow mucosal folds (153).  Additionally, the entire 
intestine in the tilapia species, O.mossambicus, is in the form of a cork screw, and is about eight 
times longer than the fish itself, similarly in Nile tilapia (153).   
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Figure 2.2 Image of Nile tilapia gastrointestinal tract anatomy. 
Image of Nile tilapia gastrointestinal tract anatomy, representing the stomach, proximal intestine, 
mid-intestine, and hindgut. 
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2.2.4 Rainbow Trout Gastrointestinal Tract Anatomy 
Rainbow trout is a strict carnivorous fish with a natural diet that consists of mainly 
protein and minimal carbohydrates (19, 45, 59, 102, 168).  However, with carbohydrates 
providing a cheaper energy source than protein in fish feed, higher inclusions of carbohydrates 
are becoming more prominent in trout feed (66, 121, 160, 175).   However, trout is a strict 
carnivore, and this carnivorous nature has influenced the development of its GI tract to present 
major differences with omnivorous species like the pig and tilapia.   
The trout GI tract begins with a short esophagus that opens into a cardiac stomach 
consisting of inner circular and outer longitudinal smooth muscle (Figure 3) (27).  There are 
valves present at the duct of the oesophagus and the stomach to prevent regurgitation of food 
material (27).  The last portion of the stomach called the pyloric stomach is dominated by 
circular muscle (27).  Finally, the pyloric sphincter at the distal end of the stomach opens up to 
the intestine (27).   
The intestine can be distinguished from the stomach because it is histologically distinct, 
and contains no submucosa or muscularis mucosa layer (Figure 3) (27).  Carnivorous fish, 
especially trout, have a region in the proximal portion of their intestine called the pyloric caeca 
(27). The pyloric caeca region occurs directly after the pyloric sphincter of the stomach and 
extends to the upper regions of the small intestine (214).  They are blind projections that come 
off the upper portions of the small intestine to increase the surface area for absorption, similar to 
the function of villi in mammalian small intestine (27, 214).  In brown trout, it was found that 
about 45 pyloric caeca come off the intestine, and it is thought that in carnivorous fish species, 
the number of pyloric caeca can increase as the fish length increases (27, 149, 214).   
Pyloric caeca are thought to be the major site for amino acid, monosaccharide, and lipid 
absorption (168).  It has been proposed that the pyloric caeca has the largest amount of 
monosaccharide uptake in trout and cod fish, compared to the rest of the intestine (52).  
However, the digesta transit time through the pyloric caeca is similar to the rate of passage in the 
rest of the intestine (52).  These functions of the pyloric caeca continue to be studied, including a 
study that found trypsin in the pyloric caeca, suggesting this organ as a site for protein 
degradation (117).  The pyloric caeca is not present in omnivorous mammals, like the pig, as 
well as herbivorous and omnivorous fish, like Nile tilapia (27).  It is postulated that the major 
importance of the pyloric caeca for carnivorous fish is to increase the absorptive capacity to 
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compensate for the shorter GI tract present in these species (2, 27, 52).  Additionally, the luminal 
epithelium of the pyloric caeca were found to contain large microvilli, where monosaccharide, 
amino acid, fat, water and sodium absorption occur (214).  In contrast, the longer GI tract in 
herbivores and omnivores increases the transit time for chyme, allowing for a longer absorption 
period (5).  This function of increasing absorptive capacity is supported by the pyloric caeca’s 
contribution to total absorptive surface area of the GI (5).  The pyloric caeca’s contribution to the 
total surface area of the intestine is: about 70% in trout, 69% in cod, 42% in largemouth bass, 
and about 12% in striped bass to the total surface area (52).  Finally, the pyloric caeca lacks  
microflora, thus suggesting no bacterial fermentation occurs in this region (214). 
The pancreas in rainbow trout is a diffusive gland, which lies between the pyloric caeca 
(197).  Therefore, the pancreas in trout does not connect with the liver, as it does in tilapia 
(described above) (197).  However, the bile duct that emerges from the liver does penetrate the 
pancreas and merges with the pancreatic duct, emptying into the proximal portions of the 
intestine (midgut) (197).   
In addition to the pyloric caeca, the small intestine that follows continues the absorptive 
process already occurring in the pyloric caeca (Figure 3) (27).  No histological differences were 
observed between the small intestinal portion that followed (called midgut, or the duodenal-ileal 
sections in brown trout) the pyloric caeca (27).   However in the northern pike, the small 
intestine was found to contain columnar and goblet cells, possibly involved in mucous secretions 
(23).  The small intestine joins with the rectum/hindgut of trout, which is visibly and 
histologically distinct from the rest of the intestine (27).  The hindgut/rectum is thicker and larger 
in diameter, and consists of a darker pigment with circular surrounding blood vessels (Figure 3) 
(27).  The rectum is also known to absorb nutrients in carnivorous fish (2).  Comparison between 
the gut of the carnivorous trout and cats show that they are the only species (as well as a few 
other carnivorous species) that have the stratum compactum layer throughout their intestine (27).  
This layer is a dense collagen layer that helps strengthen and preserve the gut from any violent 
extensions from the eaten prey (27).  These carnivorous species have a habit of swallowing large 
pieces of food that may be whole or active animals, which can violently stretch and damage the 
intestine (27).  Therefore, the stratum compactum layer evolved to adapt to this feeding strategy 
(27).  Similarly to the pig and tilapia, trout’s GI tract ends with the rectum, which is involved in 
the excretion of undigested food material and waste products (27). 
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This description of the functional anatomy of the gastrointestinal tract of pig, Nile tilapia, 
and rainbow trout give context and background to the absorptive process described and studied 
in the following text and chapters.    
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Figure 2.3 Image of Rainbow trout gastrointestinal tract anatomy. 
Image of rainbow trout gastrointestinal tract anatomy, representing the stomach, pyloric caeca, 
midgut, and hindgut. 
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2.4 Glucose Transporters 
2.4.1 Overall Function in Intestinal Epithelium 
 Glucose is the major constituent derived from carbohydrate digestion and is absorbed 
across glucose transporters present on the BBM (5, 66, 86, 133, 161).  Glucose transporters are 
present in all mammals, avian, and fish species (4, 5, 7, 68, 75, 130, 170, 196, 202).  Sodium-
dependent glucose transporters function using the sodium/potassium (Na+/K+) ATPase present 
on the basal side of these cells to provide a concentration gradient for Na+ to enter into these 
cells from the luminal side (Figure 4) (4, 55, 75, 170, 202).  The presence of sodium-dependent 
glucose transporters is generally on the BBM/apical side of enterocytes, as well as other cells 
dispersed throughout the body, and they primarily belong to the solute carrier family member 5A 
(SLC5A) (75, 84, 112).  Comparatively, the sodium-independent glucose transporters are present 
on both the BBM/apical side and the basal side of enterocytes, as well as other cells throughout 
the body, and are mainly part of the solute carrier family member 2A (SLC2A) (18, 70, 95, 106, 
133, 179).  These two families represent the majority of transporters involved in glucose uptake 
in the entire body of all species.  Finally, these families are the most extensively studied and 
characterized.   
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Figure 2.4 Overview of glucose absorption across mammalian enterocyte. 
Schematic diagram of sodium-dependent and sodium-independent glucose transport across a 
mammalian enterocyte. 
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2.4.2 SLC5A family 
 The SLC5A family is represented by 12 members of sodium-dependent transporters for 
glucose (57, 131, 169, 187).  Apart from the small intestine, their expression and function exist 
throughout the mammalian system, including the kidney, thyroid gland, and central nervous 
system (204).  The identities and functions of these 12 members have been characterized using 
heterologous expression systems like oocytes, or studied using brush-border membrane vesicles 
and Ussing chambers (51, 64, 191, 204, 212).  Most of the genes in this family consist of 14-15 
exons, except for SLC5A8 and SLC5A3 (57, 131, 169, 187).  Additionally, differences of 
functions for the same transporter were found between species (13, 53, 204).  This includes 
SLC5A4 in the human characterized as a glucose sensor in neuronal and muscle cells, however 
in pigs, it was found to function as a sodium-dependent glucose transporter (13, 53, 129).  
Collectively, all of the SLC5A members have the ability to transport more than one type of 
substrate, and they all share the common function of transporting substrates using the 
electrochemical gradient of sodium (204).   
Finally, these SLC5A transporters are characterized using Michaelis-Menten fits (4, 22, 
55, 75, 132, 147, 148).  These fits characterize protein transporters that saturate at certain 
concentrations of substrate, thus yielding Vmax and Km values (4, 22, 55, 75, 132, 148).  A 
Vmax value characterizes the maximum rate of the transporter, and it is expressed in units based 
on the technique used (39, 202).  In the literature, the Vmax value represents the capacity, where 
a transporter exhibits either low-capacity (saturation at low concentrations of glucose) or high-
capacity (saturation at high concentrations of glucose) transport of glucose (4, 55, 75, 177, 202).  
A Km value represents the substrate concentration at half of the Vmax value (or half maximum 
saturation), and it is also used to represent the affinity of the substrate to the transporter’s active 
site (39, 97).  The affinity can be represented as either low-affinity (sensitivity to transport at 
high glucose concentrations) or high-affinity (sensitivity to transport at low glucose 
concentrations) (4, 55, 75, 177, 202).  A summary of the major characteristics for each of these 
transporters are presented in Table 2.1.  Additionally, the identities and functions of these 
transporters present in mammals and fish are explained in more detail below.   
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Table 2.1 SLC5A Family members. 
 
SLC5A member Tissue Expression 
Major Substrate 
Transported 
Co-Transporter Ion 
SLC5A1/SGLT1 Small Intestine, kidney, 
brain, prostate, trachea 
Glucose, Galactose 
Na+ 
SLC5A2/SGLT2 Kidney, brain, liver, 
heart muscle 
Glucose 
Na+ 
SLC5A3/SMIT1 Brain, heart, kidney, 
lung 
Myo-inositol, glucose 
Na+ 
SLC5A4/SGLT3 Cholinergic neurons, 
skeletal muscle, kidney, 
uterus, testis 
Glucose (some 
species) 
Na+ (some species) 
SLC5A5/NIS Thyroid, lactating breast, 
stomach 
Iodide 
Na+ 
SLC5A6/SMVT Brain, heart, kidney, 
placenta 
Biotin, lipoate, 
panthothenate 
Na+ 
SLC5A7/CHT 
Spinal cord, medulla Choline 
Na+/Cl- 
SLC5A8/SMCT1 Small intestine, kidney, 
brain, retina, muscle 
Monocarboxylates 
Na+ 
SLC5A9/SGLT4 Kidney, small intestine, 
brain, liver, heart 
Mannose, fructose, 
glucose 
Na+ 
SLC5A10/SGLT5 
Kidney cortex 
Mannose, fructose, 
glucose 
Na+ 
SLC5A11/SMIT2 Thyroid, brain, heart, 
muscle, spleen, liver 
Myoinositol, D-
chiro-inositol 
Na+ 
SLC5A12/SMCT2 Intestine, brain, retina, 
muscle 
Monocarboxylates 
Na+ 
 
Summary of the characteristics of the SLC5A members.  Adapted from Wright 2013. 
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2.4.2.1 SLC5A1/SGLT1 
SLC5A1 represents the founding member of this family because it was the first 
transporter cloned and characterized (24, 97, 191, 204).  The common name for SLC5A1 is 
SGLT1 or sodium-glucose co-transporter type 1 (53, 75, 187, 191, 204).  The identity of this 
transporter was first proposed in 1956 as one of the apical/brush-border components of glucose 
absorption in the intestine (105).  It was also found in the brush-border kidney of mammals, 
where it was involved in glucose reabsorption (13, 204).  Following this discovery, the rabbit 
SGLT1 was cloned in 1987 (105).  It revealed a high-affinity, low-capacity transporter for 
glucose, meaning it had high sensitivity to glucose, and saturated at low concentrations (55, 203).  
Additionally, SGLT1 was found to transport glucose and sodium at a ratio of 1:2, respectively 
(204).   
The versatility of SGLT1/SLC5A1 in transporting other substrates along with sodium 
includes the monosaccharide galactose, which is another major monosaccharide generated from 
carbohydrate digestion (43, 165, 204).  However, SGLT1/SLC5A1 transports galactose at a 
much lower affinity than glucose, and mutations in the SLC5A1 gene lead to glucose-galactose 
malabsorption in humans (43, 165, 204).  Finally, inhibitors against SGLT1/SLC5A1 were used 
to further its characterization, and it includes the SGLT1 inhibitor, phloridzin dihydrate (4, 130, 
177, 184, 200).  Phloridzin dihydrate is a phenyl-β-glucoside, and was first isolated in the 1800s 
where it was used in diabetes and renal physiology research to inhibit against the high-affinity, 
low-capacity (Ha/Lc) SGLT1 transporter (64, 96, 116, 128).  This inhibitor has been used in 
many studies ranging from mammals to fish, to inhibit SGLT1 (75, 77, 84, 86, 96, 116, 206).   
The SGLT1/SLC5A1 transporter has been studied in many different species.  In humans, 
SGLT1/SLC5A1 was identified as the major sodium-dependent glucose transporter on the brush-
border membrane of the small intestine and proximal tubules of the kidney (97).  Additionally, it 
was confirmed as a high-affinity, low-capacity transporter for glucose that was inhibited by 
phloridzin dihydrate (97).  Similarly, in a human colon epithelial cell line called HT-29-D4 cell 
line, the expression of SGLT1/SLC5A1 confirmed a high-affinity, low-capacity transporter, 
reporting a Km value of 1.2 ± 0.12mM and a Vmax value of 3.24 ± 0.25 nmol/mg protein/min 
(147).  Additionally, identification of the protein in this study confirmed the presence of 
SGLT1/SLC5A1 transporters on the apical membrane, using rabbit SGLT1/SLC5A1 antibodies 
(147).  In another mammalian species the rat, glucose transport in perfused rat jejunal 
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membranes demonstrated sodium-dependent glucose transport mediated by SGLT1/SLC5A1, as 
the replacement of sodium with choline eliminated transport of glucose through SGLT1/SLC5A1 
(107).  Finally, in the pig, SGLT1/SLC5A1 expression was greater in the jejunal segment of the 
small intestine, in comparison to the duodenum and ileal sections, suggesting most of the high-
affinity, low-capacity sodium-dependent transport of glucose occurred in the jejunum (84, 112).   
In fish, the mRNA expression of SGLT1/SLC5A1 has been shown including in salmon 
and rainbow trout (163).  Additionally, SGLT1/SLC5A1 was found to be upregulated when a 
high glucose load is administered in fish, and these effects were seen in the carnivorous rainbow 
trout, and the omnivorous black bullhead fish (121, 163, 177).  Finally, studies on sodium-
dependent glucose transport along the intestine of carnivorous fish found higher 
SGLT1/SLC5A1 expression along the pyloric caeca and upper intestine, especially in the 
gilthead sea bream (172).  It was found that the SGLT1/SLC5A1 transporter was inhibited with 
phloridzin dihydrate, with kinetic parameters that were similar to mammalian SGLT1/SLC5A1 
characteristics (172).  Overall, SGLT1/SLC5A1 seems to be involved in sodium-coupled Ha/Lc 
transport in the intestine and kidney of many species.   
 
2.4.2.2 SLC5A2/SGLT2 
 SLC5A2, also known as sodium-glucose cotransporter 2 (SGLT2) was the second 
transporter identified in this family (203, 204).  This transporter was identified in earlier studies 
using BBMVs from rodent proximal tubule sections of the kidney cortex (204).  It was first 
found to be responsible for the majority of glucose reabsorption in the kidney, and represented a 
low-affinity, high-capacity (La/Hc) system for glucose in comparison to SGLT1/SLC5A1 (128, 
203, 204).  Specifically, the Km and Vmax values for SGLT2/SLC5A2 was found to be higher 
for glucose than SGLT1/SLC5A1 (128).  SGLT2/SLC5A2 transport stoichiometry also differed 
from SGLT1/SLC5A1 in that it co-transported glucose at a 1:1 ratio with sodium (128).  
Additionally, it was found to be a poor transporter of galactose (128).  Nonetheless, the 
transporter seems to play a significant role in glucose absorption, particularly in the kidney 
(128).   
 Since its discovery, SGLT2/SLC5A2 has been identified in the mammalian kidney and 
intestine of multiple species, including pigs, humans, and rabbits (97, 128).  Its identification and 
importance in kidney glucose reabsorption made it a potential target for novel therapeutic drugs 
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against diabetes mellitus (93, 97, 116, 143, 154).  Therefore, specific glycosides were created to 
specifically target SGLT2/SLC5A2 (93, 116, 143, 154).  These inhibitors included dapagliflozin 
and canagliflozin, which had more sensitivity towards SGLT2/SLC5A2 than SGLT1/SLC5A1 
(93, 116, 143, 154). 
However, in contrast to mammals, its identity and importance in fish species is minimal.  
Specifically, SGLT2-like transporters were identified in the shark (Squalus acanthias) kidney 
(7).  However, a SGLT transporter identified in rainbow trout kidney shared similar amino acid 
identity with both mammalian SGLT1/SLC5A1 and SGLT2/SLC5A2 transporters, suggesting 
fish have an SGLT2-like transporter with similar function to those in mammals (7).   
 
2.4.2.3 SLC5A3/SMIT1 
 SLC5A3, or sodium-myoinositol cotransporter 1 (SMIT1) differs from the other 
members of the SLC5A family because it primarily transports myo-inositol (11).  Myo-inositol is 
important in the signal transduction pathways, and it is a precursor for compounds like 
phosphoinositides and inositol phosphates (11).  SMIT1/SLC5A3 was the first myo-inositol 
transporter identified, and it is primarily present in the brain and renal medulla (11, 42, 111).  
Apart from myo-inositol being a preferred substrate, it does transport glucose but at a lower 
affinity than inositols (11, 204).  Physiologic concentrations for myo-inositols in the plasma are 
around 30 µM, which is lower than plasma glucose concentrations (around 3-5mM in mammals), 
thus suggesting SMIT1/SLC5A3 is very sensitive for myo-inositols (11, 158).  Overall, the 
primary function of SMIT1/SLC5A3, apart from being a low-affinity glucose transporter, was its 
involvement with osmoregulation, by maintaining osmotic balances for neural and renal cells in 
hypertonic environments (111, 185).     
 
2.4.2.4 SLC5A4/SGLT3 
SLC5A4, or sodium-glucose cotransporter 3 (SGLT3) was found to have different 
functions depending on the type of species (53).  Specifically, in humans it was found to function 
as a glucose sensor in neuronal and muscle cells, whereas in the pig, it was characterized as a 
low-affinity, sodium-dependent glucose transporter (53, 129, 171, 204).  Additionally, the pig 
SGLT3/SLC5A4 was initially called a neutral amino acid transporter (SAAT1), and then later 
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identified as pig SGLT2, and finally confirmed to be pig SGLT3/SLC5A4 (53).  In pigs, 
SGLT3/SLC5A4 demonstrated intermediate functions between SGLT1/SLC5A1 and 
SGLT2/SLC5A2, where it exhibited similarities to SGLT1/SLC5A1 by transporting sodium and 
glucose at a ratio of 2:1 respectively, and it showed similarities to SGLT2/SLC5A2 for its low 
affinity for both glucose and sodium (53).  Finally, SGLT3/SLC5A4 was found to be sensitive to 
phloridzin dihydrate, but not as sensitive as SGLT1/SLC5A1 (204).   
As mentioned above, one of the more interesting finds for SGLT3/SLC5A4 was the 
difference in its function between humans and pigs (53, 171).  These differences in function were 
found to be due to a single amino acid (17, 53, 171).  In human SGLT1/SLC5A1, the amino acid 
at position 457 (glutamate) was found to play a critical role in glucose binding and transport 
(17).  In fact, a mutation of this amino acid to another residue causes glucose-galactose 
malabsorption in humans, thus emphasizing the important role of this residue (17).  In human 
SGLT3/SLC5A4, the residue at position 457 is a glutamine, and substituting this glutamine with 
a glutamate found an increase in glucose uptake by about 100 fold compared to native human 
SGLT3/SLC5A3 expressed in ooctyes (17).  Thus, SGLT3/SLC5A4 illustrates the diversity in 
function of specific SLC5A members between different species.  
 
2.4.2.5 SLC5A5/NIS 
 SLC5A5, or sodium-iodide cotransporter (NIS) is a sodium/iodide symporter that 
transports iodide using the downhill gradient of sodium (48, 62).  It is dominantly expressed in 
the thyroid gland of mammalian species, and transports iodide necessary for the production of 
thyroid hormones, T3 and T4 (48, 62).  NIS/SLC5A5 was first cloned in 1996 from rats, and 
later found to transport sodium and iodide at a ratio of 2:1 respectively, similar to the ratio of 
sodium to glucose in SGLT1/SLC5A1 (62).  Even though NIS/SLC5A5 does not transport 
glucose, its function of transport by coupling iodide transport to the downhill gradient of sodium, 
justifies its inclusion with the SLC5A family members (62). 
 
2.4.2.6 SLC5A6/SMVT 
 SLC5A6, or sodium-multivitamin transporter (SMVT) was identified as a sodium-
dependent vitamin transporter, for substrates like panthothenic acid, biotin, and alpha-lipoic acid 
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(195).  Similarly to SMIT1, it is widely distributed throughout the mammalian body, and it 
shares a high sequence similarity with NIS (204).  Additionally, it transports sodium and 
vitamins at a 2:1 ratio respectively, similar to SGLT1/SLC5A1 and NIS/SLC5A5 (195).  The 
SMVT/SLC5A6 transporter has been studied in human placental BBMVs, as well as BBMVs 
from rat, rabbit, and human kidney and intestine (195).  Similarly to NIS/SLC5A5, 
SMVT/SLC5A6 is not a transporter of glucose, but it does utilize the electrochemical gradient of 
sodium to cotransport vitamin molecules, which allows it to be a part of the SLC5A family 
members (195).  
 
2.4.2.7 SLC5A7/CHT1 
 SLC5A7, or chloride-dependent sodium-choline transporter (CHT1) was characterized as 
a member of this family due to its co-transport with sodium (146).  However, it differs from the 
other members of the SLC5A family because it is dependent on the chloride electrochemical 
gradient, in addition to the sodium electrochemical gradient (204).  Similarly to NIS/SLC5A5 
and SMVT/SLC5A6, its main substrate is choline and not glucose (146).  It is mainly expressed 
in the central nervous system, and its absorption of choline contributes to the acetylcholine (type 
of neurotransmitter) synthesis pathway (146).  Despite its dependence on the chloride gradient 
and transporting choline as its preferred substrate, its function is more homologous to the SLC5A 
members than the neurotransmitter transporters (146).  Finally, this transporter is sensitive to 
changes in pH, which can affect the concentration gradient of chloride, thus impeding choline 
uptake by CHT1/SLC5A7 (204). 
 
2.4.2.8 SLC5A8/SMCT1 
 SLC5A8, or sodium-coupled monocarboxylate transporter 1 (SMCT1) primarily 
transports monocarboxylate substrates that include lactate, pyruvate, and nicotinate (72).  The 
stoichiometry of transport for sodium to substrate was found to be 2:1, similar to the ratio of 
sodium to glucose in SGLT1/SLC5A1 (41).  SMCT1/SLC5A8 was characterized as a high-
affinity transporter for lactate in the mouse kidney cortex (72).  Its function in the kidney of mice 
was found to be similar to the function of SGLT1/SLC5A1 in mammalian kidneys, where both 
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functions were to re-absorb any left over substrate (glucose or lactate) in the distal proximal 
tubules (72).  
 
2.4.2.9 SLC5A9/SGLT4 
 SLC5A9, or sodium-glucose co-transporter 4 (SGLT4) is primarily known as a mannose 
transporter (73, 183).  This transporter is mainly expressed in the liver, intestine, and kidneys of 
mammals (204).  Studies in COS-7 cells found that it was able to transport α-methyl-D-
glycopyranoside along with sodium, resulting in a Km of 2.6mM, which defined it a very low-
affinity transporter (183).  However, the transport of mannose was at a much higher affinity, and 
was found to exhibit transport into COS-7 cells (183).  In fact, the uptake of α-methyl-D-
glycopyranoside was impeded more by D-mannose than D-glucose, further confirming mannose 
as a preferred substrate for this transporter (183).  Finally, in comparison to SGLT1/SLC5A1, its 
sensitivity to phloridzin was found to be much less (204). 
 
2.4.2.10 SLC5A10/SGLT5 
 SLC5A10, or sodium-glucose cotransporter 5 (SGLT5) is similar in function to 
SGLT4/SLC5A9, where it has a much higher affinity for mannose than glucose (73).  It is 
mainly expressed in the kidney cortex of humans (73).  Apart from its high-capacity transport for 
mannose, it was also found to transport fructose at a high-capacity (73).  However, its transport 
of glucose, galactose, and α-methyl-D-glycopyranoside were at a much lower capacity in 
comparison (73).  Finally, the inhibition of α-methyl-D-glycopyranoside transport in 
SGLT5/SLC5A10 with SGLT2/SLC5A2 inhibitors canagliflozin, dapagliflozin, empagliflozin, 
phlorizin, remogliflozin, and T-1095A had a low potency, revealing poor inhibition of 
SGLT5/SLC5A10 with SGLT2/SLC5A2 inhibitors (73).   
 
2.4.2.11 SLC5A11/SMIT2 
 SLC5A11 was formally identified as sodium-glucose cotransporter 6 (SGLT6), but is 
currently identified as a sodium-myoinositol co-transporter 2 (SMIT2), because of its higher 
affinity to transport inositols than glucose (124).  It is the second isoform of SMIT, exhibiting 
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similar functions to SMIT1 (124).  In contrast to SMIT1, it is a low-affinity myo-inositol 
transporter and a very-low affinity glucose transporter (124).  SMIT2/SLC5A11 transports both 
myo-inositol and D-chiro-inositol, which is mostly involved in the bioactivity of insulin (124).  
Similar to the function of SGLT2/SLC5A2 in kidneys, SMIT2/SLC5A11 is involved in the bulk 
reabsorption of myoinositol, demonstrating a low-affinity and high-capacity for myo-inositol 
(124).  Finally, this transporter has the lowest amino acid sequence similarity with 
SGLT1/SLC5A1 (204). 
 
2.4.2.12 SLC5A12/SMCT2 
 SLC5A12, or sodium-coupled monocarboxylate transporter 2 (SMCT2) is similar in 
function to SMCT1/SLC5A8, in primarily transporting monocarboxylates like lactate and 
pyruvate (72).  It is widely expressed throughout the mammalian body, but is predominant in the 
kidney cortex (72, 204).  Both SMCT1/SLC5A8 and SMCT2/SLC5A12 share about 75% amino 
acid sequence similarity (72).  However, in comparison to SMCT1/SLC5A8, SMCT2/SLC5A12 
is a low affinity monocarboxylate transporter with a Km for lactate around 35mM (compare Km 
around 0.25mM for lactate by SMCT1/SLC5A8) (72).  Finally, both transporters exhibit sodium-
dependency of substrate transport, but SMCT1/SLC5A8 demonstrates stronger electrogenic 
signals than SMCT2/SLC5A12 (72).     
 
2.4.3 SLC2A Family 
SLC2A is the second dominant family of glucose transporters that do not require energy, 
nor the co-transport of glucose with sodium (97, 203).  They are facilitative glucose transporters, 
transporting glucose down its concentration gradient (108).  These transporters either passively 
diffuse glucose across the BBM or via the basolateral membrane to exit the cell (80).  The first 
member of this family, GLUT1 (SLC2A1) was first identified in 1985, and since then, 13 
members of this family have been identified and most have been functionally characterized (91, 
108, 203).  The major characteristics of these transporters are presented in Table 2.  Their 
general structure represents a 12-membrane spanning domain, with the N- and C- termini buried 
intracellularly (203).  The GLUTs range between 28-65% identity in nucleotides with each other, 
but they all carry two common amino acids, glycine and tryptophan (203).  Similar to the SLC5A 
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members, GLUT members vary in the type of substrates they transport (108, 203).  The GLUTs 
are further classified into three families, which are explained in more detail below.   
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Table 2.2 SLC2A Family members. 
 
SLC2A member Tissue Expression 
Major Substrate 
Transported 
GLUT1 Erythrocytes, brain, kidneys, muscle, liver, 
adipose tissues 
Glucose 
GLUT2 Liver, pancreatic beta cells, small intestine, 
kidneys 
Glucose, fructose 
GLUT3 
Brain, adipose tissue, liver, adult skeletal muscle Glucose 
GLUT4 Heart, skeletal muscle, white and brown adipose 
tissue, brain 
Glucose  
GLUT5 
Small intestine, testes, kidneys Fructose, glucose 
GLUT6 
Brain, spleen, leucocytes Glucose 
GLUT7 
Small intestine, colon, testis, prostate Glucose, fructose 
GLUT8 
Liver, heart, testes, adipose tissue, brain Glucose 
GLUT9 
Liver, kidneys Glucose, fructose, urate 
GLUT10 Skeletal, heart, pancreas, liver, brain, placenta, 
kidney 
Glucose 
GLUT11 Short variant – heart, skeletal muscle 
Long variant – lungs, trachea, brain 
Short variant – glucose 
Long variant – fructose  
GLUT12 
Heart, skeletal muscles Glucose 
HMIT 
Brain Glucose, inositols 
 
Summary of the major characteristics of the SLC2A family members. 
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2.4.3.1 Class 1: GLUTs 1- 4 
 Class 1 represents the GLUT1-4 transporters, all involved in the facilitative transport of 
glucose (108).  GLUT1 (SLC2A1) is mostly expressed in the brain and erythrocytes, with some 
expression in the muscle, liver, and adipose tissues (140).  GLUT2/SLC2A2 demonstrates low-
affinity for glucose, with its expression dominating in the liver, pancreatic beta cells, the small 
intestine, and kidney (80, 108).  GLUT2/SLC2A2 has been extensively studied in the literature, 
and its characterization is described in more detail below (see section 2.4.3.1.1 GLUT2).  
GLUT3 (SLC2A3) is a high-affinity glucose transporter primarily expressed in the brain (103).  
GLUT3/SLC2A3 is mostly found in tissues where there are high levels of glucose (103).  
GLUT4, coded by the gene SLC2A4 is another glucose transporter that has been extensively 
studied because it is the only one sensitive to insulin (181).  It is present in the heart, skeletal 
muscle, adipose, and brain tissues, and it transports glucose from the blood plasma into the tissue 
(181).  When blood glucose levels rise, insulin binds to insulin receptors on skeletal muscle 
tissues, which initiates a cascade resulting in GLUT4/SLC2A4 translocation to the membrane, 
thus increasing glucose uptake into cells (181, 203).   
 The identification and characterization of GLUTs 1-4 in fish species is more limited (18).  
One study attempting to identify GLUT1 and GLUT4 in the white muscle of eel, rainbow trout 
and catfish, using northern blots of mammalian GLUT1 and GLUT4 probes, and found no 
hybridization in any of the tissues (121).  However, this does not conclude the lack of GLUT1 or 
GLUT4 in these fish species, but it provides evidence that GLUT1 and GLUT4 transporters in 
the eel, rainbow trout, and catfish may be drastically different in sequence similarities to their 
mammalian counterparts (121).  Apart from the intestine, GLUTs have been identified in other 
tissues in fish, specifically in the Atlantic cod where GLUT3 was found expressed in the kidney 
(76).  Comparatively, GLUT2 was expressed in the liver, intestine, and kidney of rainbow trout, 
and it shared 58% and 52% nucleotide sequence similarity with chicken and mammalian GLUT2 
sequences, respectively (6).  Additionally, this GLUT2 called OmnyGLUT2 in rainbow trout had 
an extracellular loop that connected the first and 12th transmembrane segments of this transporter 
(6).  This was associated with an additional 14 amino acids in trout compared to humans (6).  In 
contrast in Nile tilapia, GLUT1 was cloned from the cDNA library and exhibited 74% homology 
with mammalian GLUT1 (91).  It was called tGLUT1 and present in the white muscle, where it 
was further characterized to increase its expression in the white muscle after a high glucose load 
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or carbohydrate-rich meal (91).  Finally, tGLUT1 was similar to mammalian GLUT1 based on 
amino acid and mRNA levels, as well as its function as a constitutive glucose transporter at basal 
conditions (91).  Comparisons and differences between fish and mammalian GLUTs exist and 
become more prominent as more GLUTs are identified and characterized in fish species. 
 
2.4.3.1.1 GLUT2 
It would appear that GLUT2 is the major or only GLUT involved in glucose absorption 
in the small intestine (80).  In 1960, two components of glucose absorption in the small intestine 
were identified (80).  The first was SGLT/SLC5A1, which represented active uptake of glucose 
into intestinal epithelial cells (80).  The second transporter was a diffusive component that did 
not appear to saturate, even when glucose concentrations were higher than 100mM (80).   
It has been proposed with supporting studies that GLUT2/SLC2A2 traffics to the apical 
membrane of enterocytes when luminal glucose concentrations reached levels higher than 30-
50mM (80).  However, the trafficking of GLUT2 to the apical membrane was highly reliant on 
SGLT1/SLC5A1 activation (80).  When glucose is present in the lumen of the small intestine, 
SGLT1 is first activated in transporting glucose into the enterocytes (80, 97).  Its active transport 
initiates the function of another enzyme called protein kinase C βII  (PKC βII) (80).  PKC βII 
initiates downstream processes to activate GLUT2’s translocation to the brush-border membrane, 
which then assists in the absorption of higher amounts of glucose (80).  GLUT2/SLC2A2 
trafficking to the apical side is very rapid, usually within a couple of minutes, to start 
transporting the glucose at the high concentrations (80).  Further confirming this mechanistic link 
between PKC βII and GLUT2/SLC2A2, it was found when PKC βII levels were high, GLUT2 
levels were high as well, indicating a correlation between the two (80).  To understand the 
commensal behaviour between SGLT1/SLC5A1 and GLUT2/SLC2A2, it was demonstrated that 
when sodium was replaced with choline or potassium, GLUT2/SLC2A2 levels on the apical side 
would decrease as SGLT1/SLC5A1 would not function (80).  Comparatively, phloridzin 
dihydrate inhibition of SGLT1/SLC5A1 also decreased levels of GLUT2/SLC2A2 on the apical 
membrane of enterocytes (80).   
However, other studies found GLUT2/SLC2A2 to have more of a permanent position on 
the BBM of diabetic and insulin-resistant rats (106).  This study demonstrated that in diabetic 
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rats,  GLUT2/SLC2A2 traffics to the apical side, where  its apical membrane presence was 
further confirmed using western blots and biotinylation (106).  The western blots performed on 
apical membrane vesicles perfused with 0-20mM glucose found GLUT2/SLC2A2 levels 
remained constant on the basal membrane (106).  However, around 30mM glucose, 
GLUT2/SLC2A2 was detected on the apical side, and around 100mM glucose, GLUT2/SLC2A2 
levels on the apical side were double that on the basal side (106).  This suggested that 
GLUT2/SLC2A2 was a high-capacity transporter for glucose when SGLT1/SLC5A1 transport 
reached saturation (106).   Therefore, the proposal of GLUT2/SLC2A2 as the diffusive 
component responsible for absorbing glucose when luminal glucose concentrations are high is a 
possibility, and a current area of active study (80).  Other endocrine hormones, like insulin, 
growth factors, and cytokines, have shown to be involved in GLUT2/SLC2A2 trafficking as 
well, but further investigation in this area is needed (80) .   
 
2.4.3.2 Class 2: GLUTs 5, 7, 9, and 11 
 Class 2 of GLUT transporters are represented by GLUT 5, 7, 9, and 11 members (203).  
Class 2 of GLUTs was created because of the sequence similarity between these GLUT members 
(70).  GLUT5 (SLC2A5) mainly transports fructose, and is present in the small intestine, testes, 
and kidneys of mammals (13, 70).  GLUT7 (SLC2A7) has shown to be expressed in the small 
intestine and colon, as well as exhibited expression in the testis and prostate (37).  It represents a 
high-affinity transporter for glucose and fructose, with a Km less than 0.5mM (37).  GLUT9 
(SLC2A9) is mostly expressed in the liver and kidneys, and known to transport glucose, fructose, 
and urate (166).  GLUT9/SLC2A9 has two splice variants, with the longer variant predominantly 
present on the basal membrane of epithelial cells, and the shorter variant present on the apical 
side (166).  Finally, GLUT11 (SLC2A11) is mainly expressed in the heart and skeletal muscle, 
with high amino acid identity to GLUT5 (41.7%) (54).  Similarly to GLUT9/SLC2A9, 
GLUT11/SLC2A11 has two splice variants, each with different functions (203).  The shorter 
variant is characterized as a low-affinity glucose transporter and is expressed in the heart and 
skeletal muscle tissues (203).  In contrast, the longer splice variant is expressed in the liver, 
lungs, trachea, and brain, and involved in the transport of fructose (203). 
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2.4.3.3 Class 3: GLUTs 6, 8, 10, 12, and HMIT 
 The main difference between members of class 3 with classes 1 and 2 is the presence of a 
glycosylation site on loop 9 of the 12 membrane-spanning transporter, whereas this glycosylation 
site is present in loop 1 on members in classes 1 and 2 (203).  Additionally, all of the members in 
this class have a targeting motif, but the importance of this motif in their function is still not 
known (203).  GLUT6 (SLC2A6) has been shown to transport glucose, but its affinity for 
glucose, as well as its ability to transport other substrates is unknown (28).  It is mainly 
expressed in the brain, spleen, and leucocytes of humans (28).   Additionally, it shares high 
amino acid sequence similarity to GLUT8/SLC2A8 (44.8%) (28).  GLUT8 (SLC2A8) is 
dominantly expressed in the liver, heart, testes, adipose, and brain tissues, and it mainly 
functions in the transport of glucose and fructose (49).  It was found that in female mice lacking 
the GLUT8/SLC2A8 transporter impeded fructose uptake in the liver, demonstrating its essential 
function as a fructose transporter in the liver (49).  GLUT10, encoded by the gene SLC2A10, is 
present in the skeletal muscles, heart, pancreas, liver, brain, placenta, and kidney (46).  It has the 
longest amino acid sequence than other GLUT members, and it is present on the chromosome 
containing the Type 2 diabetes-linked region, suggesting its possible involvement with Type 2 
diabetes (46).  Additionally, in a Xenopus laevis oocyte expression system, GLUT10/SLC2A10 
was found to transport 2-deoxy-D-glucose, with a resulting Km of about 0.3mM (46).  GLUT12 
(SLC2A12) is a glucose transporter suggested to be insulin-sensitive, similarly to 
GLUT4/SLC2A4 because of its abundancy in the skeletal muscle and heart (193).  Finally, 
HMIT (myo-inositol glucose transporter) is a glucose transporter that primarily transports 
inositols and is mostly present in the brain (203). 
 
2.4.4 Alternative Pathways of Glucose Absorption 
Many pathways have been suggested to contribute to the diffusive component of glucose 
absorption along the BBM of the small intestine, including the involvement of aquaporins.  
Aquaporins are a large family currently consisting of 13 members, all primarily involved in 
water absorption and secretion contributing to the maintenance of osmotic balances (50).  Each 
porin differs in its tissue specificity as well as its sensitivity to transport certain substrates (50).  
The possibility of aquaporins transporting other substrates apart from water has been suggested 
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(50).  A study carried out by Tsukaguchi et al. 1999, re-evaluated the function of human AQP9, 
after discovering that rat AQP9 could transport both water and other small, neutral solutes (186).  
They expressed hAQP9 in Xenopus oocytes and found it to transport neutral solutes like 
carbamides, purines, and even mannitol (186).  If AQP9 was found to transport solutes other than 
water, then other isoforms of aquaporins have the possibility of transporting substrates like 
glucose.  However, more study is needed in this area.  
Additionally, paracellular transport of glucose has been proposed when luminal glucose 
concentrations are very high, and it was termed the “solvent drag theory” (213).  This theory 
follows as SGLT1 reaches its maximum capacity, downstream processes lead to the tightening of 
the cytoskeleton, which in turn increase the paracellular space (213).  Tight junctions also open 
up, creating space that drags large amounts of solvent and solutes (like glucose) across the 
intestinal epithelium (213).  This theory represents a possible alternative pathway for glucose 
absorption, only when luminal glucose concentrations are very high. 
 
2.5 Heterogeneous and Homogeneous Intestinal Segregation of Sodium-Dependent Glucose 
Transport 
The heterogeneous system defined below for some species represents the kinetic 
transport systems of glucose, segregated according to the intestinal segment.  One example 
follows in the pig that found two kinetic glucose transport systems high-affinity, low-capacity 
(Ha/Lc) and high-affinity, high-capacity (Ha/Hc) in the jejunum and ileum respectively, 
representing a heterogeneous system (112).  A homogeneous system means one kinetic glucose 
transport system that dominates throughout the intestine.  One example follows in tilapia 
(presented below), where a Ha/Hc system exists in all three segments of the intestine, 
representing a homogeneous system (180).  Finally, these heterogeneous and homogeneous 
systems can contain one or multiple transporters that contribute to each transport system.  For 
example: the homogeneous system in tilapia (Ha/Hc throughout the intestine) is likely associated 
with two transporters in all three intestinal segments (180).  Overall, these definitions for 
homogeneous and heterogeneous sodium-dependent glucose transport systems are used to 
characterize the transport systems in the species presented below.   
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Generally, sodium-dependent glucose transport along the small intestine of mammals is 
defined as a heterogeneous system.  The need for this heterogeneous system is not understood, 
but it dominates sodium-dependent glucose transport across the apical membrane of the small 
intestine of many species (4, 68, 75, 101, 202).   
In mammals, a heterogeneous system of glucose transport exists in the kidneys, where a 
La/Hc SGLT2/SLC5A2 transporter dominates the proximal tubules, and a Ha/Lc 
SGLT1/SLC5A1 transporter is present in the distal tubules (148, 171, 188, 191).  The purpose of 
the segregation of this transport activity in the mammalian kidney is better understood than the 
segregation present in the small intestine.  The SGLT2/SLC5A2 present in the kidney proximal 
tubules is responsible for the majority of glucose re-absorption, thus exhibiting high-capacity 
transport, whereas the high-affinity characteristic of SGLT1/SLC5A1 is beneficial in the distal 
tubule where glucose concentrations are low (148, 171, 188, 191).  However, in contrast to the 
kidney, the segregation of sodium-dependent glucose transport along the mammalian small 
intestine is often found to be opposite, where a Ha/Lc sodium-dependent glucose transporter is 
present in the proximal sections of the intestine, and the distal sections are dominated by a La/Hc 
sodium-dependent glucose transporter (21, 22, 75, 101, 112, 202).   
Comparatively, this does not hold true for all mammalian and avian species, where some 
present a homogeneous system of sodium-dependent glucose transport along the small intestine 
(68, 94, 99).  This system of sodium-dependent glucose transport that exists in these different 
species is presented in more detail below.           
 
2.5.1 Porcine Heterogeneous System 
 The heterogeneous system of sodium-dependent glucose transport has been extensively 
studied in the mammalian model, the pig (75).  In the pig, a Ha/Lc and La/Hc sodium-dependent 
glucose transport system was found using jejunal and ileal BBMVs (75).  Both transport systems 
demonstrated Michaelis-Menten kinetics, where the first component (Ha/Lc) was confirmed to 
be SGLT1/SLC5A1 in the jejunum (75).  SGLT1/SLC5A1 exhibited sodium-dependent glucose 
absorption at lower concentrations of glucose (75).  In contrast, the identity of the second system 
in the ileum has not been confirmed yet, but its function demonstrates a La/Hc sodium-
dependent transport for glucose, transporting glucose at the higher concentrations (75).  
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Additionally, the second La/Hc system had no preference for sodium or potassium in 
transporting glucose, and D-mannose was also transported by this system (75).  It was concluded 
from this study that more work needed to be done to identify this second system (75). 
 Following this study, Herrmann et al. 2012 further confirmed the first system to be 
carried out by SGLT1/SLC5A1 using quantitative polymerase chain reaction (qPCR) and 
western blots (84).  They also discovered that the segregation of sodium-dependent glucose 
absorption was only present in mature pigs, and not in suckling pigs (84).  It was suggested that 
in suckling pigs, the intestine was not completely developed, therefore intestinal glucose 
segregation would not be present (84).  Thus, their research focused on mature pigs, and found 
SGLT1/SLC5A1 was more abundant in the jejunum than the ileum (84).  Using Ussing 
chambers to measure basal short-circuit current (Isc), they found that the ileum produced higher 
electrogenic current in response to glucose transport compared to the jejunum (84).  
Additionally, using jejunal and ileal BBMVs, they found that both the jejunum and ileum 
followed Michaelis-Menten kinetics, and resulted in a 2-fold higher Vmax value in the ileum 
compared to the jejunum (84).  However, both segments resulted in similar Km values (84).  The 
influence of different breeds of pigs and different diets were also conducted to see changes in 
Vmax and Km values between both segments, and again it was found that the ileum had higher 
sodium-dependent glucose transport than the jejunum and it was unaffected by pig breed or diet 
(84).  Finally, the use of phloridzin dihydrate resulted in a greater decrease in the Isc in the ileum 
in comparison to the jejunum (84).   
 Herrmann et al. 2012 discovered that SGLT1/SLC5A1 was glycosylated in the jejunum 
of pigs, and its protein expression was higher in the jejunum than ileum, but with no significant 
difference between the two (84).  Therefore, they suggested that glycosylated SGLT1/SLC5A1 
was responsible for the lower electrogenic Isc in the jejunum, and responsible for the Ha/Lc 
sodium-dependent glucose transport (84).  Additionally, they proposed that the glycosylated 
SGLT1/SLC5A1 may be responsible for the segregation of glucose transport between the 
jejunum and ileum (84).  However, the importance of this glycosylated SGLT1/SLC5A1 was not 
confirmed (84).  Additionally, they suggested two more reasons for this heterogeneous system 
along the pig GI tract (84).  One involves the higher expression of CFTR (cystic fibrosis 
transmembrane conductance regulator) in the jejunum than the ileum, which contributes to the 
higher secretion of chloride into the lumen (84).  They suggested that the higher concentration of 
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luminal chloride impedes with sodium binding to SGLT1/SLC5A1, thus resulting in lower 
electrogenic currents for the jejunum (84).  Comparatively, the porcine ileum expresses more 
apical potassium channels than the jejunum, which increases the driving force of sodium into 
enterocytes, thus resulting in higher electrogenic currents in this segment (84).   
 Recently, in response to the study by Herrmann et al. 2012, the possibility of a 
glycosylated SGLT1/SLC5A1 contributing to the heterogeneity of sodium-dependent glucose 
transport along porcine small intestine was rejected (112).  This study found that even though 
SGLT1/SLC5A1 expression was similar in both the jejunum and ileum, and a modified 
SGLT1/SLC5A1 (phosphorylated SGLT1/SLC5A1, or glycosylated SGLT1/SLC5A1) may 
compensate for the decreased glucose transport in the jejunum, these observations were not 
responsible for the heterogeneous differences between both segments (112).  Additionally, they 
confirmed through western blots that SGLT1/SLC5A1 protein was similar between the jejunum 
and ileum, even though the ileum demonstrated higher Isc for sodium-dependent glucose 
transport (112).  From this study, it was concluded that regardless of glycosylated or 
phosphorylated SGLT1/SLC5A1 in the jejunum, it did not determine the heterogeneity present 
along the porcine GI tract (112).  In fact, the identification of this second La/Hc system in the 
ileum of the porcine GI has yet to be identified, along with no answers to understand the purpose 
of the intestinal segregation of glucose transport.  
 
2.5.2 Feline Heterogeneous System 
 Using intestinal BBMV of the cat, D-glucose transport was measured to find two glucose 
systems that exhibited Michaelis-Menten kinetics (202).  The two systems demonstrated 
different Vmax and Km values, representing a Ha/Lc system in the jejunum and a La/Hc system 
in the ileum for sodium-dependent glucose transport (202).  These findings were shown to be 
similar to those found in the pig, rabbit, and bovine species (202).  Interestingly, sodium-
dependent glucose uptake in the cat BBMV exhibited higher transport capacity in comparison to 
the cattle and rabbit, suggesting an adaptation to compensate for the shorter GI tract and low 
levels of carbohydrates present in its natural, carnivorous diet (202).  However, the identities of 
these two transport systems were not found, due to the technical limitations present at the time.   
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2.5.3 Guinea Pig Heterogeneous System 
 Similar heterogeneity was found along the intestinal segment of guinea pigs, which were 
designated systems 1 and 2 (21).  Using BBMVs of guinea pig, they identified that system 1 was 
a Ha/Lc sodium-dependent glucose transporter identical to the functions of SGLT1/SLC5A1 in 
the jejunum (21).  However, the identity of the transporter of system 2, a La/Hc system in the 
ileum, was not determined (21).  Their study of system 1 and 2 in response to control, fasted, and 
semistarved guinea pigs revealed that semistarved animals demonstrated an increase in glucose 
uptake via system 2 (increases in both Vmax and Km values), whereas no changes were present 
in system 1 (21).  Additionally, guinea pigs exposed to lactation or cold-temperature were found 
to increase their system 2 transport, whereas system 1 did not change (21).  They suggested that 
system 2 may be an adaptable system of glucose uptake, whereas system 1 may represent a 
constitutive system of glucose uptake, mediated by SGLT1/SLC5A1 (21).  Overall, this study 
demonstrated the existence of two sodium-dependent glucose uptake systems in guinea pig small 
intestine, but the identity of the second system remains to be elucidated (21).     
 
2.5.4 Rabbit Heterogeneous System 
 In contrast to the above mammals, a study using rabbit jejunal BBMVs found the 
presence of  two sodium-dependent glucose transport systems in the jejunum itself (55).  These 
two systems revealed a Ha/Lc system and a La/Hc system (55, 101).  The first system was 
confirmed to be SGLT1/SLC5A1, similar to other mammals (55, 86, 209).  Both systems were 
found to be inhibited by phloridzin dihydrate (55).  Overall, it was concluded that two glucose 
transport systems exist along the rabbit intestine (55).  However, the identification of the second 
system (La/Hc) has not been confirmed.   
 
2.5.5 Bovine Heterogeneous System 
 Similar to the  monogastric species mentioned above, heterogenous sodium-dependent 
glucose absorption has also been observed in ruminant species, specifically bovine (101).  Using 
BBMV of steers, it was demonstrated that at glucose concentrations over 20mM, a high-capacity 
sodium-dependent transporter was present (101).  This transporter exhibited a sodium to glucose 
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coupling ratio of 1:1 (101).  Comparatively, at glucose concentrations lower than 0.05mM, a 
minor, high-affinity sodium-dependent glucose transporter dominated (101).  Altogether, the 
presence of two sodium-dependent glucose transport systems, a Ha/Lc and a La/Hc , was 
discovered in steer small intestine (101).  However, intestinal segments were not specified.    
 
2.5.6 Equine Heterogeneous System 
 Horses represent a nonruminant, herbivorous species that generally consume pasture 
forage (grass) (58).  However, to increase their energy and work performance, they are fed diets 
containing hydrolyzable carbohydrates, usually in the form of grain (58, 94).  Very few studies 
exist studying glucose uptake in equine species.  One of the preliminary studies that investigated 
D-glucose uptake along the BBM of the equine small intestine discovered the presence of a 
Ha/Lc SGLT1 transporter (94).  It was demonstrated that the highest transport of glucose (in 
pmol/s/mg protein) in BBMVs was in the duodenum, followed by the jejunum, and then the 
ileum (94).  Additionally, it was concluded that D-glucose uptake along the BBM of equine 
small intestine was mediated by only SGLT1/SLC5A1 (94).   
The pattern of glucose uptake along the equine small intestine is different in comparison 
to most of the mammalian models studied (presented above) (94).  However, all three intestinal 
segments in the horse followed Michaelis-Menten saturation kinetics, and the Km values 
between jejunal and ileal BBMVs were not significantly different from each other, similarly to 
the results found in pigs (94).  In contrast to the pigs and other mammals, the Vmax values were 
reported to be higher in the jejunum BBMV than the ileum BBMV, which were 918 ± 73.3 
pmol/s/mg protein and 698 ±61 pmol/s/mg protein, respectively (94).  It was suggested that the 
higher Vmax value in the jejunum was due to an increase in protein expression of 
SGLT1/SLC5A1, rather than a different sodium-dependent glucose transporter (94).  Therefore, 
the characterization of sodium-dependent glucose transport along the equine small intestine does 
represent a heterogeneous system of glucose absorption, dominated by one transporter, 
SGLT1/SLC5A1 (94).   
  
2.5.7 Aquatic Heterogeneous and Homogeneous Systems 
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 Many studies in aquatic species revealed the presence of an SGLT1/SLC5A transporter 
present on the BBM of the intestine, but very few studies identified a heterogeneous system of 
sodium-dependent glucose transport along the GI tract (110).  One of the few studies that 
discovered a heterogeneous system of glucose uptake was in the carnivorous seawater fish, the 
pacific copper rockfish (4).  The BBMVs from the pyloric caeca and upper intestine were 
prepared and the transport of 3H-D-glucose was  found to exhibit sodium-dependent Michaelis-
Menten kinetics in both intestinal segments (4).  The pyloric caeca demonstrated a lower affinity 
binding of 3H-D-glucose compared to the upper intestine, revealing a higher affinity of glucose 
uptake in the upper intestine (4).  Interestingly, the mucosal to serosal flux, or the Vmax values, 
between the two segments were similar, revealing no differences in glucose transport capacities 
(4).  It was concluded that in the pacific copper rockfish, the upper intestine adapted to transport 
glucose at a higher affinity than the pyloric caeca possibly because of the lower nutrient content 
that reaches the upper intestine, after passing through the pyloric caeca (4).  Additionally, it 
represented a heterogeneous system where the upper intestine represented a Ha/Lc and the 
pyloric caeca represented a La/Lc glucose transport system (4). 
 A homogeneous system has been defined in tilapia, which is presented in Chapter 1.  This 
homogeneous system is represented as a Ha/Hc glucose transport system that is present 
throughout the proximal, mid-intestine, and hindgut segments of the tilapia GI tract (180).  This 
is the only reported homogeneous sodium-dependent glucose transport system reported in any 
fish species.  As more glucose transport studies are conducted in fish species, more 
heterogeneous and homogeneous glucose transport systems will be characterized.   
  
2.5.8 Invertebrate Sodium-Dependent Glucose Transport System  
 The few studies that have investigated glucose uptake along the intestine include the 
American lobster (144).  This study demonstrated that mucosal-to-serosal glucose uptake along 
the BBM of lobster intestine exhibited hyperbolic saturation with a Km around 15.2 µM (144).  
Additionally, it was suggested that an SGLT1-like transporter was responsible because of its 
inhibition with phloridzin dihydrate (144).  Similarly in another invertebrate, the parasitic wasp, 
a detailed study of glucose and fructose uptake was performed on intestinal epithelial cells, and 
found a sodium-dependent glucose transporter on the BBM (29).  Immunohistochemical studies 
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that were performed further confirmed the presence of a SGLT1-like transporter present on the 
apical membrane of the intestine, that was sensitive to inhibition by phloridzin dihydrate (29).  
Nevertheless, sodium-dependent glucose transport similar to mammals is present along the 
intestine of invertebrates studied, but the presence of glucose transporter segregation has not 
been confirmed or studied as of yet.  
 
2.5.9 Avian Homogeneous and Heterogeneous Transport Systems 
 D-glucose transport has been measured along the small intestine of different avian 
species.  One study investigated D-glucose transporter expression in jejunal, ileal, and rectum 
BBMVs of the chicken (68).  It has been characterized previously that enterocytes in the small 
and large intestine of chickens express a BBM sodium-dependent glucose transporter that is 
electrogenic and sensitive to inhibition by phloridzin dihydrate (68).  In fact, this transporter 
exists along the length of the intestine, including the proximal cecum and rectum of chickens 
(68).  It was demonstrated in this study that SGLT1/SLC5A1 was responsible for the sodium-
dependent glucose absorption along the small intestine and large intestine of chickens, with no 
heterogeneous transport of glucose present (68).  Therefore, chicken sodium-dependent glucose 
transport represents a homogeneous system along the entire GI tract (68).   
 In another avian species, the Rufous hummingbird, active glucose transport decreased 
moving distally along the intestine, which is different from mammals (99).  Additionally, it was 
concluded that all intestinal glucose absorption was mediated by an active process, thus 
suggesting sodium-dependent transport for all glucose absorption in the hummingbird (99).  
Finally, this study demonstrated a single, Michaelis-Menten saturation kinetics of glucose 
transport along the intestine of hummingbirds (99).  With decreasing glucose uptake moving 
distally along the intestine possibly defines glucose transport kinetics as a heterogeneous system 
in the hummingbird.   
 
2.5.10 Conclusion 
 Most of the mammalian small intestine, as well as the avian species, presents a 
heterogeneous system of sodium-dependent glucose transport (55, 75, 101, 202).  The few fish 
and avian studies that were studied, demonstrate heterogeneous and homogeneous systems of 
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glucose transport along their intestine (4).  Overall, this intestinal glucose transport segregation 
that has been discovered in many species presents itself with a confusing paradigm: why the 
need for this heterogeneous system in the intestine?  Some studies speculate heterogeneous 
systems have evolved to meet the needs of individual species, but no assumptions have been 
confirmed (21).  As more studies are conducted and newer techniques are developed, possible 
answers may arise to this question.  Additionally, it will help us to understand the importance of 
this segregation.   
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3.1 Abstract 
Electrogenic sodium dependent glucose transport along the length of the intestine was compared 
between the omnivorous Nile tilapia (Oreochromis niloticus) and the carnivorous rainbow trout 
(Oncorhynchus mykiss) in Ussing chambers.  In tilapia, a high-affinity, high-capacity (Ha/Hc) 
kinetic system accounted for the transport throughout the proximal intestine, mid-intestine, and 
hindgut segments. Similar dapagliflozin and phloridzin dihydrate inhibition across all segments 
support this homogenous Ha/Hc system throughout the tilapia intestine.  Genomic and gene 
expression analysis supported findings by identifying 10 of the known 12 SLC5A family 
members, with homogeneous expression throughout the segments with dominant expression of 
SGLT1 (SLC5A1) and SMIT2 (SLC5A11).  In contrast, trout’s electrogenic sodium-dependent 
glucose absorption was 20-35 times lower and segregated into three significantly different 
kinetic systems found in different anatomical segments.  A high-affinity, low-capacity (Ha/Lc) 
system in the pyloric caeca, a super-high-affinity, low-capacity (sHa/Lc) system in the midgut, 
and a low-affinity, low-capacity (La/Lc) system in the hindgut.  Genomic and gene expression 
analysis found 5 of the known 12 SLC5A family members with dominant expression of SGLT1 
(SLC5A1), SGLT2 (SLC5A2), and SMIT2 (SLC5A11) in the pyloric caeca, and only SGLT1 
(SLC5A1) in the midgut, accounting for differences in kinetics between the two.  The hindgut 
presented a La/Lc system partially attributed to a decrease in SGLT1 (SLC5A1).  Overall, the 
omnivorous tilapia had a higher electrogenic glucose absorption than the carnivorous trout, 
represented with different kinetic systems and a greater expression and number of SLC5A 
orthologs.  Fish differ from mammals having hindgut electrogenic glucose absorption and 
segment specific transport kinetics.   
 
3.2 Introduction 
 Glucose is the major molecular constituent of carbohydrate digestion entering the 
intestinal enterocytes via the apically located sodium-dependent glucose transporters (SGLTs) 
(4, 12, 18, 20, 75).  These transporters are members of the SLC5A (solute carrier family member 
5A) family, simultaneously transporting glucose and sodium, creating a measurable current 
during absorption (13, 16).  The transporters exist in both omnivorous and carnivorous species 
and represent the first ports of entry for glucose into the enterocytes (53, 105, 115, 161).   
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 Since their initial discovery, a total of 12 SLC5A isoforms have been identified in the 
omnivorous human genome and are expressed in various tissues (60, 191).  Ten of these genes 
are sodium-coupled substrate transporters for solutes like glucose, myoinositol, and anions, while 
the other two genes have different coupling ions and functions (124, 191).  The stoichiometry of 
this transport is dependent on the family member (124, 132).  Generally, the SGLTs are 
characterized kinetically in two categories.  First is a high-affinity (Ha) transporter, with 
sensitivity to low concentrations of glucose and low-capacity (Lc), saturating at low 
concentrations of glucose (35, 75, 86, 124, 132, 147).  Second is a low-affinity (La) transporter 
with sensitivity to glucose at higher concentrations and high-capacity (Hc), saturating at high 
concentrations of glucose (35, 75, 86, 124, 132, 147).  This classification developed due to the 
initial difference in kinetics between the first SGLTs discovered (4, 35, 75, 84, 101, 188, 201).  
The SGLT isoform 1 (SLC5A1) transporter demonstrated a Ha/Lc transport and SGLT2 
(SLC5A2) exhibited La/Hc transport (4, 13, 75, 97, 116).  Physiological studies identifying two 
transport systems supported the existence of both a Ha/Lc and La/Hc for glucose in the intestine 
of both omnivorous and carnivorous mammals including: cat,  rat, pig, human, and cattle (12, 16, 
87, 101, 112, 147, 201).  Only a few of these studies have segregated the Ha/Lc to the proximal 
small intestine in omnivores and carnivores, but gene association is minimal or lacking (75, 84, 
132).  However, defining specific physiological attributes to members of the SLC5A family has 
been challenging due to a previous lack of genomic information, substrate promiscuity, species 
differences, and tissue specific regulation (84, 129).  In fish, this is particularly true, with the 
identification of SGLTs being minimal and their functions mostly presumed from sequence 
identity with mammalian SGLTs despite sequence differences (4, 95, 130).   
 Studies comparing intestinal glucose absorption kinetics and association with SLC5A 
gene family between omnivores and carnivores are lacking in mammalian literature and 
unknown in fish, despite the generally accepted notion that omnivores can absorb larger amounts 
of glucose than carnivores (15, 25, 32, 36, 47, 86, 157).  This gap in the literature is particularly 
salient in fish, which have a lower importance for carbohydrates in their natural diet, but have 
known differences between omnivorous and carnivorous utilization of glucose (162).  Here, 
using ex-vivo intestinal segments mounted in Ussing chambers, we measured the sodium-
coupled electrogenic absorption of glucose along the gastrointestinal tract of omnivorous Nile 
tilapia (Oreochromis niloticus) and carnivorous rainbow trout (Oncorhynchus mykiss).  
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Differences and absences of intestinal segmental kinetic segregation and pharmacological 
inhibition were successfully compared to expression of specific SLC5A family members with 
previously described functions, some supporting known glucose absorption.  Tilapia 
demonstrated similar kinetics throughout all of its intestinal segments, which was defined as a 
one-kinetic homogeneous system.  Specifically, tilapia has a single Ha/Hc sodium-dependent 
glucose transport system along the entirety of its intestinal tract.  In contrast, trout demonstrated 
different transport kinetics in the pyloric caeca, midgut, and hindgut intestinal segments.  This 
was defined as a three-kinetic heterogeneous system, with a Ha/Lc, sHa/Lc, and La/Lc transport 
occurring in the pyloric caeca, midgut, and hindgut, respectively.  Overall the data presented here 
define a high-capacity, one-kinetic homogenous system in tilapia and a low-capacity, three-
kinetic heterogeneous system of sodium-dependent glucose transport in trout, supported by 
SLC5A gene expression.     
 
3.3 Materials and Methods 
3.3.1 Maintenance of Animals 
All fish were maintained in accordance with the guidelines of the Canadian Council on 
Animal Care (CCAC, 2005) (33). All animal protocols were approved by the Animal Care 
Committee at the University of Saskatchewan (AUP#: 19980142).    
 
3.3.1.1 Nile Tilapia.  Nile tilapia were obtained from AmeriCulture Inc. (New Mexico, USA) as 
fingerlings.  They were housed in 360L tanks filtered via a biological filtration system.  
Photoperiod was kept constant at 14h light/10h dark, and the water temperature maintained at 27 
± 2oC.  Fish were fed a standard ration of commercial feed by hand twice per day to visual 
satiety.  The contents of the feed contained: crude protein (54%), crude fat (16%), crude fibre 
(1%), vitamin A (15000 IU/kg), vitamin D3 (5000 IU/kg), vitamin E (400 IU/kg), calcium 
(2.3%), phosphorous (1.5%), and sodium (0.2%) (EWOS).  The average weight of fish at the 
time of study was 500 grams.   
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3.3.1.2 Rainbow Trout.  Female rainbow trout were obtained as wild-type, fertilized eggs from 
Trout Lodge Inc (Sumner, Washington State, USA).  After hatching, the fish were reared in 
standard 1000-4000L density tanks, provided with biologically-filtered recirculation systems 
until two years of age when used for this study. They were housed in municipal, dechlorinated 
water at temperatures between 11 ± 2oC, with a photoperiod at 12h light/12h dark.  They were 
fed a standard ration of commercial feed at 2-5% of their body weight.  The contents of the feed 
contained: crude protein (53%), crude fat (20%), crude fibre (1%), vitamin A (15000 IU/kg), 
vitamin D3 (5000 IU/kg), vitamin E (300 IU/kg), calcium (2.3%), phosphorous (1.6%), and 
sodium (0.2%) (EWOS).  At the time of study, the average weight of fish used was 400 grams.   
 
3.3.2 Ex-vivo Tissue Collection 
Fish were euthanized by blunt trauma and the entire intestinal section was dissected out 
of both fish.  In Nile tilapia, the intestine was much longer than the trout, and it contained no 
pyloric caeca.  Its intestinal section was separated as proximal intestine (2 inches distal from the 
stomach), mid-intestine (5 inches distal from the stomach) and hindgut (5 to 6 inches distal from 
the stomach).  In rainbow trout, the intestine was separated according to the pyloric caeca region 
(located directly distal to the stomach), midgut (located right after the pyloric caeca, 2 inches 
from the stomach), and hindgut (5 to 6 inches from the stomach).  The pyloric caeca is visually 
distinct from the midgut section.  Similarly, the hindgut is visually distinct from the midgut and 
it was represented as a thicker, larger diameter tissue, darker in pigment, along with visual 
differences in musculature (27).   
 
3.3.3 Electrophysiology 
3.3.3.1 Ussing Chamber technique. The fish intestinal sections were examined in Ussing 
chambers using techniques adapted from this group (125, 126, 164, 182).  The Ussing chamber 
system used in this study was an EasyMount Ussing Chamber System (Physiologic Instruments 
Inc., San Diego, CA).  Sections were washed in teleost saline: 118mM NaCl, 2.9mM KCl, 
2.0mM CaCl2·2H2O, 1.0mM MgSO4·7H2O, 0.1mM NaH2.PO4·H2O, 2.5mM Na2HPO4 and 
1.9mM NaHCO3 at pH 7.9 (63).  This physiological buffer was used for both tilapia and trout.  
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No glucose was added to the buffer.  The lumen of the intestine for both fish was also washed 
with buffer using an 18gage needle, to clean the luminal membrane of any residual chyme.   
The dissected tissue sections were exposed as a flat sheet between two sliders of inserts 
(Slider Number: P2304, Physiologic Instruments Inc., San Diego, CA).  The available tissue area 
for tilapia and trout was constant and equal to 0.3 cm2.  The teleost saline buffer solutions 
bathing the apical and basal sides of the intestine had a buffer volume of 5ml, and were 
continuously gassed throughout the experiment with 1% CO2 and 99% O2 for the fish (40).   
The transepithelial voltage and passing current set across the tissue was measured via agar 
bridges and Ag/AgCl reference electrodes.  These electrodes were connected to leads that are 
connected to the voltage/current clamp.  The short-circuit current (Isc) was measured by the 
computer (in µA), and this was a result of the tissue current opposing the current induced by the 
electrodes.  The pulse was kept constant at 0.001V.  A recirculating bath capable of chilling and 
heating controlled the temperature of the jacketed chambers, with tissues examined at fish 
housing temperatures.  The temperature used for tilapia was between 25oC-26oC and for trout 
was between 11oC-12oC.  Needle valves were also present for the adjustment of gas flow into the 
chambers.   
Once mounted, the tissue was allowed to reach a steady baseline current for 30-40 minutes 
prior to adding 1mM increments of glucose to the apical side and measuring the short-circuit 
current in µA.  An equivalent amount of D-mannitol was added to the basal side in order to 
prevent the development of osmotic gradients from the addition of glucose.  Also, mannitol 
would not be transported across the epithelium, which presents no interference with the 
movement of glucose transport.  Before each addition of glucose and mannitol, a wait period of 
3-4 minutes was allowed for equilibration of the current.   
 
3.3.4 Chemicals. Dapagliflozin is a competitive inhibitor of glucose for mammalian SGLT2 
(La/Hc) transporters, with EC50 values around 1.12nM for human SGLT2 (35, 93, 116).  
Phloridzin dihydrate is a competitive inhibitor against mammalian SGLT1 (Ha/Lc) transporters, 
with a Ki around 1 µM for renal and intestinal sodium-glucose cotransporters (4, 177, 198).  For 
pharmacological characterization, 0.001µM, 0.01µM, 0.1µM, 1µM, 10µM, 100µM, 200µM, and 
300µM of dapagliflozin, and 1µM, 10µM, and 100µM of phloridzin dihydrate (AdooQ® 
Bioscience, Irvine, CA) were used in sequential order in the Ussing Chamber as final 
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concentrations.   The inhibitors were added after each tissue segment reached a final glucose and 
mannitol concentration of 50mM.  For tilapia, dose responses of dapagliflozin followed by 
phloridzin dihydrate addition were performed.  Additionally, a dose response of phloridzin 
dihydrate by itself was conducted in tilapia after final glucose and mannitol concentrations of 
50mM was reached.  In trout, dose responses of dapagliflozin followed by phloridzin dihydrate 
were used.   
 
3.3.5 RNA extraction and cDNA synthesis using RT-PCR.  Approximately 1mg samples of 
tissue were obtained from the dissection of the intestinal tract, and stored in RNAlater® RNA 
Stabilization Solution at -80oC.  RNA was isolated using the TRIzol reagent, and cDNA was 
synthesized through reverse transcription PCR using the qScript™ cDNA SuperMix (Quanta 
Biosciences, Maryland, USA).  The reaction was run as: incubation for 5 minutes at 25oC, then 
30 minutes at 42oC, and the final 5 minutes at 85oC.  The cDNA samples were stored at -80oC 
for subsequent use in quantitative PCR. 
 
3.3.6 Genomic Identification of SLC5A Genes.  A detailed BLAST+ (Basic Local Alignment 
Search Tool) application was used to identify all of the annotated SLC5A transporters in both 
tilapia and trout.  The twelve human SLC5A transporter sequences retrieved from the National 
Center for Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov/) were used 
in a “blastn” command to search for similar mRNA sequences in the tilapia and trout genome 
(204).  The expect value (e-value) was used to assess the significance of the match, where an e-
value close to zero was considered significant and an e-value higher than 10^-15 was considered 
as a non-significant match.  Once SLC5A transporters were identified from tilapia and trout, 
phylogenetic trees were generated using the alignment program CLUSTAL W and MEGA7 
(www.megasoftware.net) software. 
 
3.3.7 Gene transcript expression levels by quantitative polymerase chain reaction.  
Quantitative PCR was performed on the RT-PCR reaction using the GoTaq®qPCR Master Mix 
containing SYBR®Green1 (Promega, Madison USA).  The BioRad QPCR system was used to 
perform these reactions.  The total volume of the PCR reaction was 12.5µL.  A total of 40 cycles 
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of qPCR was performed, with each cycle consisting of GoTaq® Hot Start Polymerase activation 
at 95oC for 2 minutes, and then denaturation at 95oC for 15 seconds, followed by 
annealing/extension at the primer’s hybridization temperature (59oC) for 1 minute.  The 
dissociation step was at 60-95oC.   Serial dilutions of cDNA were also used to generate a 
standard curve for each target gene, where the efficiency of each primer was calculated.  The 
efficiencies for the tilapia primers ranged from 1.9-2.1, and similar range of efficiencies were 
determined for trout primers as well.  EFα1 (α-elongation factor 1) was the housekeeping gene 
and it was used to normalize the relative expression levels in tilapia and trout.  The method of 
analysis used to represent the relative expression levels was calculated using delta CT, where the 
amount of the gene of interest was normalized to the amount of EFα1 in that sample (173).   
The primers for tilapia and trout SLC5A genes and EFα1 were designed using the Integrated 
DNA Technologies website (https://www.idtdna.com/site), where the sequences and their 
accession numbers are presented in Tables 3.1 and 3.2, respectively.   
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Table 3.1 Tilapia Primer Sequences used for quantitative PCR 
 
Gene Forward Primer (5`-3`) Reverse Primer (5`-3`) 
Accession 
Number 
SGLT1 CCCGAGTACTTGAAGAAGAG GCAATAACAGCGAGGTAGA XM_019361130.1 
SGLT2 AGGAGGATGAGGGAGAATAA ACACTGGGTCCTCACTAA XM_013273846.2 
SMIT1 CAACGCCAAGTACAGAAAC CTCTGCGATTCTCCCTTATAG XM_019353114.1 
SGLT4 ATGGTGGTTGGAATCTGG GTCCCTGCTAGACCAATAAA XM_005475685.3 
NIS TCCATGTCCTACCTCTACTT GACCCTCCACTTTCTTCTT XM_005453978.3 
SMCT1 TCAGTGTTGAGTGAGAAGG AGAGCGAACACCACATAG XM_013271289.2 
SGLT5 CACCGTGGACTCTGATTT TACATCTGCGTGTGAAGAG XM_003455975.4 
SMIT2 GAGACGGAAGAAGGAAGATG GCCCAGTAACCAATGATAAAG XM_005461087.3 
SMIT GCTGTCTGTGGATCTCTATT GAACTGTGTCCGTGTAGAT XM_019352280.1 
SMVT CAGGAGGAATAGCAGAAGTC CTTGGTTCACACCGTACA XM_005460242.3 
EFα1 CTCTTCTACCGTCGGATTAC ATTGACTCCCTCGTAGAAAC XM_005476483.3 
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Table 3.2 Trout Primer Sequences used for quantitative PCR 
 
Gene Forward Primer (5`-3`) Reverse Primer (5`-3`) Accession Number 
SGLT1 CTAAGTGTCACGGCTCTATAC GCGTCTGGAAGTTCTCATAA XM_021591066.1 
SGLT2 ATTGGTAGTGGTCACTTTGT AAACAGCCAGCCCAATAG NM_001124432 
SGLT4 GTGCTGGTGTTTGTGTATG AGATGGTGCTCTGGAATG XM_021604024.1 
NIS GGCTTGTGTCTCGTTGTA TGTCCAGCACCAAGTATG XM_021573060.1 
SMIT2 CAAGATCCTGCCCTTCTT GTAGCTTCATGACCAGTTTG XM_021592865.1 
SMVT ATCTTACCAGCGCTTACC CCCATAGATCAAAGCCAGTA XM_021573745.1 
EFα1 AGCGAGCTCAAGAAGAAG GACCAAGAGGAGGGTATTC NM_001124339.1 
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3.3.8 Statistical Analyses.  Vmax (represented in µA/cm2) and Km (represented in mM) values 
were determined for each intestinal section in each species using GraphPad Prism 8 (GraphPad 
Software, Inc.) (100, 119, 142, 145).  Here, the Km values for both fish species represents the 
concentration at 50% maximum rate of the transporter, and the assumption is made that the rate 
of transport (catalysis) and rate of binding are similar.  Tilapia intestinal segments followed 
Sigmoidal kinetics, whereas trout pyloric caeca and midgut followed Michaelis-Menten kinetics 
and the kinetics in trout hindgut fit Sigmoidal Hill kinetics (F-test, P < 0.05).  The equation used 
for the Sigmoidal Hill kinetics and Michaelis-Menten fits were: 
Equation 3.1 
Sigmoidal Hill fit: Y=Vmax*Xh/(Kdh + Xh) 
Equation 3.2 
Michaelis-Menten fit: Y = Vmax*X/(Km + X) 
A 1-way ANOVA was performed on the three intestinal sections of each species to determine 
whether the Vmax and Km values for each gut section was significantly different (210).  All data 
met parametric assumptions, being normally distributed and exhibited homogeneity of variance 
so ANOVA analyses were used  (210).  After ANOVA, pairwise comparisons were made using 
Tukey’s posteriori tests, as appropriate.  A P < 0.05 was considered significantly different.  To 
compare the Vmax values between tilapia and trout, a student’s t-test was performed to confirm 
significance.   For the inhibitor dapagliflozin, the percent activity remaining was calculated from 
the division of the 50mM increment short-circuit current (the concentration where the transporter 
is 100% saturated and it is 100% un-inhibited) and the resultant drop in current from the addition 
of each drug concentration.  For phloridzin dihydrate, the percent activity remaining was 
calculated from the division of the 300uM concentration of dapagliflozin (concentration where 
Ha/Lc transporter is un-inhibited) and the resultant drop in current from the addition of the drug.  
Parametric 2-way ANOVAs (two factors: intestinal sections and dosage of the drug) were 
performed on the three intestinal sections of each species and the dosages of each inhibitor to 
determine significance (210).  The Ki values for the dapagliflozin response and the phloridzin 
dihydrate only responses were calculated for tilapia using the “One-Site Fit logIC50” from 
GraphPad Prism 8 (GraphPad Software, Inc.).  This fit follows the equation: Y = Bottom + (Top-
Bottom)/(1+10(X-LogIC50)).  Parametric 1-way ANOVA was performed on the three intestinal 
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sections to determine significance.  For the qPCR analyses, fold differences were determined by 
the BioRad system, where the threshold cycle was established using the housekeeping gene, 
EFα1.  A 2-way ANOVA (two factors: intestinal location and gene) was conducted on the gene 
expressions followed by Tukey’s posteriori test for pairwise comparisons.  All statistical 
analyses were performed on SigmaPlot (Systat).    
 
3.4 Results 
3.4.1 Nile Tilapia 
3.4.1.1 Ha/Hc Electrogenic Glucose Absorption kinetics  
In tilapia, glucose gradients performed in an Ussing chamber measured short-circuit 
current and demonstrated electrogenic sodium-dependent glucose absorption that followed 
Sigmoidal Hill kinetics in all intestinal segments, with Hill coefficients greater than 1 (proximal 
intestine, mid-intestine, and hindgut).  All three intestinal sections saturated around 30mM 
glucose in tilapia (Figure 3.1).  Additionally, the calculated Vmax and Km values were 
consistent with that of a Ha/Hc system in all segments (Figure 3.1 and Table 3.3).  No 
statistically significant differences in Vmax and Km values were found among the different 
intestinal segments in tilapia (Table 3.3; Vmax: P = 0.5, Km: P = 0.4), demonstrating a single 
Ha/Hc system throughout the tilapia gastrointestinal tract.  Generally, low Km values around 4-
6mM and high Vmax values around 47µA/cm2 - 60µA/cm2 were found throughout tilapia gut.  
Sodium-dependency of glucose transport was confirmed by replacement of sodium with 
potassium creating a sodium-free teleost saline Ussing chamber buffer, which eliminated the 
glucose stimulated current (Figure 3.1).  Similarly, a sodium-free teleost saline using N-Methyl-
D-glucamine as a substitute for sodium was performed, which eliminated the glucose stimulated 
current as well (data not shown). 
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Figure 3.1 Kinetics of sodium-dependent glucose transport in tilapia. 
Sigmoidal Hill kinetics for sodium-dependent and sodium-independent electrogenic glucose 
transport for tilapia in A) proximal intestine, illustrated with representative trace on the right side 
(B) (Sodium-dependent: Fish N = 26; Sodium-independent: Fish N = 7), C) mid-intestine, 
illustrated with representative trace on the right side (D) (Sodium-dependent: Fish N = 30; 
Sodium-independent: Fish N = 6), and E) hindgut, illustrated with representative trace on the 
right side (F) (Sodium-dependent: Fish N = 31; Sodium-independent: Fish N = 6).  The maximal 
velocity (Vmax) and Michaelis-Menten constant (Km) is represented in A) proximal intestine for 
illustration.  Data are represented as means ± SEM.  Isc, short-circuit current. 
 
 
 
 59 
 
Table 3.3 Vmax and Km Values for Nile Tilapia and Rainbow Trout 
 
 
Vmax (µA) and Km (mM) represented for each tissue type in Nile Tilapia and rainbow trout.  
Area of intestinal segment was 0.3cm2.  Data are presented as means ± SEM.  Different letter 
superscripts indicate significances (Tukey’s test after 1-way ANOVA, P < 0.05).  Asterisks 
represent significances for Vmax values between tilapia and trout (Student’s t-test, P < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
Nile Tilapia Rainbow Trout  
Tissue 
Vmax ± 
SEM 
(µA/cm2) 
Km ± SEM 
(mM) 
Tissue 
Vmax ± 
SEM 
(µA/cm2) 
Km ± SEM 
(mM) 
Tilapia(Vnax)  
Trout(Vmax)  
Proximal 47.0 ± 6.7 A 4.2 ± 0.7 A 
Pyloric 
Caeca 
2.3 ± 0.4 A,B 4.2 ± 1.0 A 2043%
* 
Mid-
intestine 
59.6 ± 7.0 A 6.0 ± 1.0 A Midgut 1.7 ± 0.3 A 1.8 ± 0.3 B 3506%
* 
Hindgut 56.2 ± 9.3 A 5.7 ± 1.1 A Hindgut 2.4 ± 0.2 B 12.3 ± 1.6 C 2342%* 
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3.4.1.2 Inhibition of Ha/Hc Kinetics 
Dapagliflozin, a selective inhibitor for SGLT2 (SLC5A2) or La/Hc sodium-dependent 
glucose transport, and phloridzin dihydrate, an SGLT1 (SLC5A1) or Ha/Lc system inhibitor 
were used to help decipher some of the kinetics (116, 143, 170).  Figure 3.2 illustrates the 
percent activity remaining in each intestinal tissue after the cumulative addition of increasing 
dosages of inhibitors dapagliflozin and then phloridzin, as well as phloridzin addition alone.   
The three intestinal sections in tilapia were similarly inhibited by dapagliflozin in a dose-
dependent manner (Figure 3.2Ai, P > 0.5 for tissue differences), with ~50-60 % activity 
remaining at a final 300µM dose in all intestinal segments (Figure 3.2Ai, P < 0.05 for inhibitor 
effect).  The Ki (inhibition at 50%) values for the proximal intestine was 7.7 ± 1.5 µM, mid-
intestine was 7.4 ± 1.7 µM, and the hindgut was 5.7 ± 1.6 µM.  These values were not 
significantly different from each other (P = 0.6).  No significant inhibition was found upon 
addition of phloridzin dihydrate added sequentially after dapagliflozin (Figure 3.2Aii, P > 0.5).  
However, addition of phloridzin by itself resulted in significant inhibition (Figure 3.2Aiii, P < 
0.05 for inhibitor effect) at a final concentration of 100 µM, with ~60-80% activity remaining, 
again with no significant differences found between intestinal segments (Figure 3.2Aiii, P > 0.5 
for tissue differences).  Additionally, the Ki values for the proximal intestine was 11.1 ± 0.002 
µM, the mid-intestine was 11.6 ± 0.002 µM, and the hindgut was 7.6 ± 0.002 µM.  The Ki values 
between the intestinal segments were not significantly different from each other (P = 0.4).      
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Figure 3.2 Pharmacological inhibition in tilapia. 
Percent activity remaining of short-circuit current (Isc) in Nile tilapia of A) i) dapagliflozin 
(0.001, 0.01, 0.1,10, 100, 200, and 300µM) (all tissues: N = 25), following addition of ii) 
phloridzin dihydrate (1, 10,100 µM) (all tissues: N = 25) and iii) phloridzin dihydrate (1, 10,100 
µM) without previous addition of dapagliflozin (proximal: N = 22, mid-intestine: N = 18, and 
hindgut: N = 20) on intestinal tissues.  B) Representative traces for proximal tissue of i) 
dapagliflozin addition, ii) phloridzin dihydrate addition following dapagliflozin, and iii) 
phloridzin dihydrate only addition.  Asterisks represent significance from 100% transporter 
activity before inhibition, which is presented as the dotted line (2-way ANOVA, P < 0.05). 
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3.4.1.3 SLC5A Gene Profiling Affirms Kinetics 
To identify the genes responsible for the observed current, tilapia genomic analysis was 
performed which found 10 of 12 known SLC5A family members.  The SLC5A transporters 
identified were SGLT1 (SLC5A1, sodium/glucose cotransporter 1), SGLT2 (SLC5A2, 
sodium/glucose cotransporter 2), SMIT1 (SLC5A3, sodium/myoinositol cotransporter 1), 
SGLT4 (SLC5A9, sodium/glucose cotransporter 4), NIS (SLC5A5, sodium/iodide 
cotransporter), SMCT1 (SLC5A8, sodium/monocarboxylate cotransporter), SGLT5 (SLC5A10, 
sodium/glucose cotransporter 5), SMIT2 (SLC5A11, sodium/myoinositol cotransporter 2), SMIT 
(SLC5A3, sodium/myoinositol cotransporter), and SMVT (SLC5A6, sodium/multivitamin 
cotransporter) in the genome using the BLAST+ application (Table 3.1).   The expression levels 
of each gene were then compared among the different tissues using quantitative real-time PCR. 
All intestinal tissues in tilapia had similar gene profiling with no significant differences in 
expression from each other, supporting the similarity in physiological responses of the three 
segments (Figure 3.3A, P > 0.5 for tissue differences).  Overall, SGLT1 (SLC5A1) and SMIT2 
(SLC5A11) expression were significantly higher than the expression of the other genes in all 
tissues (Figure 3.3A, P < 0.001).  The proximal intestine and hindgut had significantly higher 
SMIT2 (SLC5A11) expression than SGLT1 (SLC5A1) (Figure 3.3A, P < 0.05 for transporter 
type within each tissue location), whereas the mid-intestine had statistically similar SGLT1 
(SLC5A1) and SMIT2 (SLC5A11) expression (Figure 3.3A, P > 0.5 for transporter type in mid-
intestine).  Sequence similarities in identified tilapia SLC5A transporters were compared in a 
phylogenetic tree (Figure 3.3B).  In a CLUSTAL W analysis, the nucleotide identities of SLC5A 
family members found in the genome relative to tilapia SGLT1 (SLC5A1) were 60.6% SGLT2 
(SLC5A2), 47.9% SMIT1 (SLC5A3), 57.5% SGLT4 (SLC5A9), 35.5% NIS (SLC5A5), 33% 
SMCT1 (SLC5A8), 53.8% SGLT5 (SLC5A10), 55.3% SMIT2 (SLC5A11), 48.3% SMIT 
(SLC5A3), and 37.4% SMVT (SLC5A6).   
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Figure 3.3 Genomic and gene expression analyses in tilapia. 
A) Relative expression levels of SLC5A transporters in Nile tilapia (Proximal intestine: N = 8-
10, Mid-intestine: N = 6-10, Hindgut: N = 6-10) using quantitative PCR.  Expression levels were 
normalized against EFα1 housekeeping gene.  Asterisks represent significance between genes 
and tissues (2-way ANOVA, P < 0.05). B) Phylogenetic tree of the ten members of the SLC5A 
family of cotransporters.  The alignment program CLUSTAL W and the phylogenetic display 
program MEGA7 were used to generate the tree.  
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3.4.2 Rainbow Trout 
3.4.2.1 Electrogenic Glucose Absorption reveals a Three-Kinetic System 
A glucose gradient performed in the Ussing chamber using the pyloric caeca, midgut, and 
hindgut intestinal segments of trout resulted in short-circuit current.  The pyloric caeca and 
midgut both followed Michaelis-Menten kinetics whereas the hindgut followed Sigmoidal Hill 
kinetics (Figure 3.4).  The pyloric caeca and midgut both saturated around 5mM glucose, with a 
significantly higher Km value in the pyloric caeca (4.2 mM) compared to the midgut (1.8 mM) 
(Table 3.3, P < 0.05), but not significantly different Vmax values between the two trout tissues 
(2.3 µA/cm2 versus 1.7 µA/cm2) (Table 3.3, P > 0.5). These values characterize a Ha/Lc system 
in the pyloric caeca and a super-high-affinity (sHa)/Lc system in the midgut of trout (Figure 3.4 
and Table 3.3).  The trout hindgut saturated around 50mM glucose, but with a significantly 
higher Km value than the midgut and pyloric caeca (Figure 3.4 and Table 3.3, P < 0.05).  The hill 
coefficient was greater than 1 for the hindgut.  The Vmax value in the trout hindgut was slightly 
higher than midgut, but was similar to the pyloric caeca and not significantly different from each 
other (Figure 3.4 and Table 3.3, P > 0.5).  The observed Vmax (2.4 µA/cm2) and higher Km 
(12.3 mM) values in the hindgut in comparison to the proximal sections of the trout intestine 
support a low-affinity, low-capacity (La/Lc) system.  Thus, trout presents with three different 
kinetic systems along their gastrointestinal tract, with large differences in affinity for glucose and 
an overall low-capacity for glucose transport compared to tilapia. Specifically, tilapia Vmax 
values were significantly (2043-3506% or approximately 20 -35 times, P < 0.05 in Student’s t-
test) higher compared to trout (Table 3.3).   Finally, sodium dependency of glucose transport was 
demonstrated in a sodium free buffer (Figure 3.4).  Additionally, a sodium-free teleost saline 
using N-Methyl-D-glucamine as a substitute for sodium was performed, which eliminated the 
glucose stimulated current as well (data not shown).  Interestingly, in trout, there was no 
significant inhibition in any of the kinetic systems in response to both dapagliflozin and 
phloridzin dihydrate (Figure 3.5Ai and ii, P > 0.5 for inhibitor effect in 2-way ANOVA).   
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Figure 3.4 Kinetics of sodium-dependent glucose transport in trout. 
Michaelis-Menten and Sigmoidal Hill kinetics for sodium-dependent and sodium-independent 
electrogenic glucose transport for trout in A) pyloric caeca, illustrated with representative trace 
on the right side (B) (Sodium-dependent: Fish N = 12; Sodium-independent: Fish N = 5), C) 
midgut, illustrated with representative trace on the right side (D) (Sodium-dependent: Fish N = 
18; Sodium-independent: Fish N = 4), and E) hindgut, illustrated with representative trace on the 
right side (F) (Sodium-dependent: Fish N = 24; Sodium-independent: Fish N = 4).  The Vmax 
and Km is represented in A) pyloric caeca for illustration.  Data are represented as means ± 
SEM. 
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Figure 3.5 Lack of pharmacological inhibition in trout. 
A) Percent activity remaining in rainbow trout of i) dapagliflozin (0.001, 0.01, 0.1,10, 100, 200, 
and 300µM) (all tissues: N = 12), following addition of ii) phloridzin dihydrate (1, 10,100 µM) 
(all tissues: N = 12) and iii) representative trace for pyloric caeca of dapagliflozin and phloridzin 
dihydrate additions.  Data are represented as means ± SEM.  Dashed line represents 100% 
transporter activity before inhibition. 
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3.4.2.2 SLC5A Gene Profiling Affirms Kinetics 
To identify the genes responsible for the observed kinetics, trout genomic analysis was 
performed and identified 5 of 12 known SLC5A family members.  Trout SGLT1 (SLC5A1, 
sodium/glucose cotransporter 1), SGLT2 (SLC5A2, sodium/glucose cotransporter 2), SGLT4 
(SLC5A9, sodium/glucose cotransporter 4), NIS (SLC5A5, sodium/iodide cotransporter), SMIT2 
(SLC5A11, sodium/myoinositol cotransporter 2), and SMVT (SLC5A6, sodium/multivitamin 
cotransporter) were identified in the trout genome after using the BLAST+ application (Table 
3.2).  The expression levels of each gene were compared among the different tissues using 
quantitative real-time PCR.  
In trout, SGLT1 (SLC5A1) expression in the pyloric caeca and midgut were significantly 
higher than the expression levels of the other genes, supporting the higher affinity and low-
capacity kinetics in both tissue segments (Figure 3.6A, P < 0.001).  In addition, SGLT2 
(SLC5A2) and SMIT2 (SLC5A11), two low-affinity transporters had significantly higher 
expression in the trout pyloric caeca than the midgut, supporting the high-affinity (Ha) to super-
high-affinity (sHa) paradigm between pyloric caeca and midgut (Figure 3.6A, P < 0.05).  A 
significant drop in SGLT1 (SLC5A1) was found in the trout hindgut, potentially explaining the 
reduced affinity in this segment (Figure 3.6A, P < 0.05). However, significant drops in SGLT2 
(SLC5A2) and SMIT2 (SLC5A11) were also noted, leaving the observed glucose absorbing 
capacity unexplained (Figure 3.6A, P < 0.05).  The phylogenetic tree identifying sequence 
similarities between trout SLC5A transporters are illustrated in figure 3.6B.  In a CLUSTAL W 
analysis, the nucleotide identities relative to trout SGLT1 (SLC5A1) were 62.3% SGLT2 
(SLC5A2), 56.5% SGLT4 (SLC5A9), 38.3% NIS (SLC5A5), 59.4% SMIT2 (SLC5A11), and 
40.5% SMVT (SLC5A6).   
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Figure 3.6 Genomic and gene expression analyses in trout. 
A) Relative expression levels of SLC5A transporters in rainbow trout (Pyloric Caeca: N = 6-10, 
Midgut: N = 10, Hindgut: N = 8-10) using quantitative PCR.  Expression levels were normalized 
against EFα1 housekeeping gene.  Letters represent significance between genes and tissues (2-
way ANOVA, P < 0.05). B) Phylogenetic tree of the six members of the SLC5A family of 
cotransporters.  The alignment program CLUSTAL W and the phylogenetic display program 
MEGA7 were used to generate the tree.  
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3.5 Discussion 
This study demonstrated that tilapia intestine possesses higher electrogenic glucose 
absorption and greater expression of glucose transporter orthologs than trout intestine.  
Differences between the two fish species portray tilapia as a homogeneous, one-kinetic glucose 
absorption system (Ha/Hc) throughout the gastrointestinal tract.  In contrast, trout have 
heterogeneous, three-kinetic glucose absorption systems (Ha/Lc, sHa/Lc, and La/Lc) 
corresponding to the three different intestinal segments.  Comparative studies between omnivore 
and carnivore sodium-dependent glucose absorption has been minimally explored in mammals 
and birds, with studies lacking in fish (5, 51, 99).  Additionally, the existence of two different 
segment-specific sodium-dependent glucose transport systems along the small intestine 
associated with SLC5A transporters have been shown in mammals, but has not been described in 
fish (112, 130, 201).  In the current study, we present fundamental differences that exist between 
the omnivorous tilapia and carnivorous trout in terms of sodium-dependent glucose transport 
along the gastrointestinal tract.  Additionally, both fish species have hindgut sodium-dependent 
glucose absorption suggesting a divergent adaptation from mammals, where colonic glucose 
absorption is lacking.   
 
3.5.1 One-Kinetic SLC5A-associated Homogeneous Glucose Absorption in Tilapia 
Tilapia, an omnivorous fish, would generally consume a higher carbohydrate diet in their 
natural environment, and has been shown to better tolerate a higher glucose load than trout in 
terms of its clearance from the plasma (176).  In captivity, tilapia are generally fed a higher 
carbohydrate-inclusion diet (up to 50% dietary carbohydrate), which is correlated with good 
growth (118, 142, 159, 176, 199).  In contrast, trout can tolerate up to 20% carbohydrate in their 
diet, before exhibiting poor growth (60, 199).  Both dietary carbohydrate levels in fish are 
generally lower than mammalian diets, which are up to 60% inclusion (32).  Our study adds to 
these known nutritional physiological differences by demonstrating that tilapia have 
approximately 20 – 35 times (around 2000-3500%, Table 3.3) higher capacity for sodium 
dependent glucose transport than corresponding segments in trout.  The higher absorption in 
tilapia is driven by a single unique Ha/Hc kinetic system, which is demonstrated by low Km and 
high Vmax values along the entirety of the intestinal tract, which would enhance their ability to 
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absorb more glucose, a characteristic of omnivores  (Table 3.3) (199). Similarly, a study carried 
out in the omnivorous freshwater fish black bullhead (Ictalurus melas) using isolated enterocytes 
found brush-border transport of 3-O-methylD-glucose (3-OMG, non-metabolizable form of D-
glucose) to saturate around 40mM (177). 
Further characterization with pharmacological inhibitors supported the homogenous 
Ha/Hc kinetic system in tilapia.  In mammals, these inhibitors have been used to differentiate the 
kinetic systems (Ha/Lc and La/Hc) of SGLTs  (64, 84, 89, 116, 198).  Specifically,  the recently 
developed dapagliflozin and the traditionally used phloridzin dihydrate, have been used to inhibit 
SGLT2 (SLC5A2), a La/Hc transporter and SGLT1 (SLC5A1), a Ha/Lc transporter, 
respectively, in the kidney of rats, pigs, and humans (64, 96, 116, 191).  Additionally, phloridzin 
dihydrate has been used with studies in fish using techniques like brush-border membrane 
vesicles (BBMVs) exhibiting inhibition of sodium-dependent glucose transport (4, 130, 177, 
184, 200).  Here, dapagliflozin was first applied, to selectively inhibit La/Hc transporter kinetics, 
followed by phloridzin dihydrate to inhibit any further Ha/Lc kinetics.   
Dapagliflozin resulted in inhibition with all intestinal segments responding similarly, 
with sequential addition of phloridzin dihydrate not resulting in any further inhibition. In 
contrast, phloridzin addition by itself resulted in similar significant inhibition in all segments. All 
segments reacting the same to all inhibitors with similar Ki values exhibited throughout the 
intestine support a one-kinetic, homogeneous system throughout tilapia gut.   The lack of 
sequential inhibition of phloridzin after dapagliflozin suggest that a) dapagliflozin can inhibit 
Ha/Lc transporters (SGLT1-like) in tilapia or b) the unique Ha/Hc system is created by a single 
SGLT which is sensitive to both drugs.  Arguing against the latter possibility is the fact that 
genomic and gene expression analysis suggested the former.        
Bioinformatic analysis identifying 10 SLC5A transporters exhibited similar gene 
expressions across all three intestinal segments in tilapia. Such similar expression would explain 
homogenous segmental sodium-dependent glucose kinetics and inhibition.  More specifically, 
the similar, but significantly higher levels of SGLT1 (SLC5A1) and SMIT2 (SLC5A11) 
expression in all three segments compared to all the other SLC5A genes, support two different 
transporters contributing to the Ha/Hc system.  The elevated expression of SGLT1 (SLC5A1), a 
well characterized Ha/Lc transporter supports the high affinity kinetics and phloridzin inhibition 
(16).  Interestingly, although SMIT2 (SLC5A11) had the highest expression compared to all the 
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other genes, it is known to primarily transport inositols (204).  However, it is previously known 
as SGLT6, and was characterized as a very low-affinity glucose transporter in mammals (11, 14, 
42). The high capacity of glucose transport was demonstrated with rabbit SMIT2 (SLC5A11) 
cRNA injected into Xenopus oocytes, and detected glucose transport around 50mM (124).  In the 
phylogenetic tree (Figure 3.3B), SMIT2 (SLC5A11) is divergent from SGLT1 (SLC5A1) with 
only 55.3% homology, suggesting differences in function. Nonetheless, the putative high 
capacity glucose transporter could explain Hc kinetics found in each of the tilapia intestinal 
segments.  Altogether, the combined dominant expression and function of these two transporters 
are further supported by a Sigmoidal Hill fit.  Together, this suggests that the heterogeneous 
expression in tilapia of ten different SLC5A transporters along all areas of gastrointestinal tract, 
with a dominance of SGLT1 (SLC5A1) and SMIT2 (SLC5A11) expression produces the Ha/Hc 
kinetics and the pharmacological inhibition observed. Such a Ha/Hc system would be 
advantageous for an omnivorous fish to absorb high levels of glucose presented to the gut from 
the diet (199). 
    
3.5.2 Three-Kinetic SLC5A-associated Glucose Absorption in Trout 
The segregation of three kinetic sodium-dependent glucose transport systems were found 
along the gastrointestinal tract of trout.  In all the trout gut segments, the capacity for glucose 
transport was low in comparison to tilapia.  However, the overall affinity was higher in the 
proximal segments of trout pyloric caeca and midgut, but drastically decreased as it reached the 
distal hindgut.  The low capacity in all three segments of trout would protect the fish from rapid 
glucose absorption. Exogenous glucose ingestion in carnivorous fish has shown to induce the 
process of gluconeogenesis, further increasing the plasma glucose levels (121, 151).  This can 
lead to persistent hyperglycemia (high plasma glucose levels) and high levels of plasma insulin 
which can hinder growth and increase liver size (110, 163).  The differences in affinity explain 
how the proximal sections are sensitive to glucose transport when luminal glucose concentrations 
are low, around 1mM - 5mM, but the hindgut is sensitive to glucose transport only when the 
intestinal luminal glucose concentration is much higher, above 5mM.  
The differences in affinity for glucose between the trout pyloric caeca and midgut may 
assist glucose absorption as the concentration of glucose decreases in the chyme as it moves 
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through the intestine (4).  The Ha/Lc transport system characterized in the current study in the 
pyloric caeca would be efficient at absorbing most of the available glucose in the trout chyme.  
However, as the chyme moves to the midgut with decreasing glucose concentrations, the sHa/Lc 
transport system would become advantageous.  A related study examining proximal intestinal 
glucose absorption in the carnivorous, seawater, pacific copper rockfish demonstrate similar 
kinetic segmental differences. (4).  The uptake of 3H-D-glucose in BBMVs (brush-border 
membrane vesicles) of pyloric caeca and upper intestine (anatomically similar to midgut) 
exhibited Michaelis-Menten kinetics of sodium-dependent glucose absorption (4). The Jms 
(Vmax) was similar between both organs (pyloric caeca and upper intestine), but the Km values 
were different (high Km for pyloric caeca and low Km for upper intestine) (4).  The differences 
in the Km values indicate that pyloric caeca has lower affinity for glucose concentration than the 
upper intestine (midgut) (4).  Similarly, we found differences in Km values between pyloric 
caeca and midgut, where the midgut demonstrated a super- high-affinity (sHa) for glucose 
compared to the pyloric caeca, with no differences in the Vmax.  Ahearn et al. (1992) suggested 
that since the pyloric caeca has first access to the food, it absorbs more of the nutrients at higher 
concentrations (4).  In contrast, the chyme that is released to the subsequent midgut section has 
lower nutrient content, thus needs a higher affinity transport system (4).  Here we took trout 
intestinal segmental contributions further by characterizing glucose uptake in the hindgut as well. 
Interestingly, the above assertion does not hold for the trout hindgut with its Sigmoidal/Hill fit 
and lower affinity (La) and higher capacity than the midgut, suggesting physiological roles for 
this system other than nutrient absorption.  Finally, the use of known mammalian SGLT 
inhibitors suggest a lack of contribution from trout SGLT1 (SLC5A1) and SGLT2 (SLC5A2) to 
the kinetic systems. However, given that the sequence similarity of trout SGLT1 (SLC5A1) and 
SGLT2 (SLC5A2) to human is only 58% and 66% respectively, this finding was not too 
surprising. Alternatively, the lack of inhibition may be attributed to the lower temperature used 
for trout kinetic measurements.  Such temperature sensitivity of glucose transport inhibitors has 
previously been described (65).  Thus, the three kinetic trout system was further characterized by 
genomic and gene expression analysis.  
In trout, 5 of the known 12 SLC5A transporters where found and exhibited high SGLT1 
(SLC5A1, Ha/Lc) expression in the pyloric caeca and midgut compared to the other SLC5A 
transporters.  This data is correlated with the Michaelis-Menten Vmax values for the trout 
 73 
 
pyloric caeca and midgut segments that exhibit Lc transport.  However, the trout pyloric caeca 
SGLT2 (SLC5A2) and SMIT2 (SLC5A11) which are low-affinity transporters were more 
prominently expressed than in the midgut, possibly explaining the comparatively lower affinity 
detected in the pyloric caeca segment (11, 14, 42).  Therefore, the kinetics of Ha/Lc in the trout 
pyloric caeca is likely due to the combined expression of SGLT1 (SLC5A1), SGLT2 (SLC5A2), 
and SMIT2 (SLC5A11), whereas the sHa/Lc kinetics in the midgut is due to a decrease in 
SGLT2 (SLC5A2) and SMIT2 (SLC5A11).  In comparison, the decrease in trout hindgut SGLT1 
(SLC5A1) expression was associated with a drastic reduction in affinity to glucose in this 
segment, again suggesting that the high- and super-high-affinity of the pyloric caeca and midgut 
is driven by SGLT1 (SLC5A1). The expression of the other SLC5A genes in the trout hindgut, 
which do not significantly differ from the midgut then may account for the low-capacity kinetics.   
Although our analysis of SLC5A gene expression does account for the kinetics defined in this 
study, there is still the possibility of another unidentified SGLT–like transporter that may explain 
the Lc paradigm in trout hindgut.  Overall, our results confirm that the carnivorous trout has 
SGLT1 (SLC5A1), SGLT2 (SLC5A2), and SMIT2 (SLC5A11) transporters in the pyloric caeca 
likely driving an observed Ha/Lc system, and an increase in proportional SGLT1 (SLC5A1) 
expression to SGLT2 (SLC5A2) and SMIT2 (SLC5A11) driving a sHa/Lc system in the midgut.  
A La/Lc kinetic system in the trout hindgut is supported by low expression of all trout SLC5A 
genes and a significant drop in SGLT1 (SLC5A1).   
 
3.5.3 Fish Hindgut Glucose Absorption- Different from Mammals  
The presence of sodium-dependent glucose absorption in the hindgut of tilapia and trout 
was surprising in comparison to the mammalian models, where it is non-existent in this location 
(75, 84, 86, 112).    However, for aquatic animals, the regulation of ionic and osmotic balances 
are extremely important, utilizing ionic and substrate transporters in their gills, kidneys and 
intestines to maintain this balance (10, 92, 190).  The gut plays a role in osmoregulation by 
controlling the intake of dietary ions, using glucose transporters along with dietary substrates to 
passively contribute to ionic and osmotic balances (108, 190).  Interestingly, the presence of 
active D-glucose uptake in the rectum was found in frugivorous avian species and was 
considered important to offset the fast digesta transit through their short gut (122, 123).  
However, the omnivorous chicken with its longer gut demonstrated high hindgut glucose uptake 
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(68).  This suggest functions of this glucose absorption other than nutrient uptake.  One 
possibility would be osmoregulation, especially given the proximity of the rectum and cloaca (8, 
71).  Together, our characterization of sodium-dependent glucose transport and associated 
SGLTs in the hindguts of these fish may be an unexplored mechanism that may contribute to 
ionic and osmotic regulation in tilapia and trout.   
 
3.5.4 Omnivorous and Carnivorous Comparisons between Fish and Mammals  
The homogenous Ha/Hc kinetic system  of sodium-dependent glucose absorption that 
exists throughout the omnivorous tilapia differs from previously characterized omnivorous 
systems such as the dog, cattle, human, rat, and pig (64, 75, 84, 86, 101, 165).  Generally, two 
types of intestinal segmental differences in sodium-dependent glucose absorption kinetic systems 
were identified, with Ha/Lc kinetics in the jejunum, La/Hc in the ileum, and the colon being void 
of transport (64, 75, 84, 86, 101, 165).  Thus, tilapia have evolved to use their entire intestinal 
tract for Ha/Hc sodium-dependent glucose absorption, whereas omnivorous mammals only 
utilized their small intestinal sections (jejunum and ileum) for  either Ha/Lc or La/Hc, but never 
show Ha/Hc sodium-dependent glucose absorption (12, 21, 75, 112). This fundamental 
difference suggests that tilapia may be more efficient than these other omnivorous mammals at 
absorbing glucose. Comparatively, trout differ from the carnivorous cat, with the cat having 
similar intestinal kinetic segmental segregation to omnivorous animals with Ha/Lc and La/Hc 
kinetics (201). The trout differs with three-kinetic, sodium-dependent glucose transport systems 
(Ha/Lc, sHa/Lc, La/Lc), that is overall low-capacity. This suggests trout to have a very limited 
capacity to absorb glucose compared to other omnivorous and carnivorous mammals.    
 
3.6 Conclusion 
In tilapia, electrogenic sodium-dependent glucose absorption was characterized as a 
segmentally homogenous Ha/Hc kinetic system. These finding were supported by the high 
expression of SGLT1 (SLC5A1) and SMIT2 (SLC5A11), and similar sensitivities to 
dapagliflozin and phloridzin dihydrate throughout the GI.  In trout, a Ha/Lc system in the pyloric 
caeca was supported by the expression of SGLT1 (SLC5A1), SGLT2 (SLC5A2), and SMIT2 
(SLC5A11), whereas the midgut demonstrated an sHa/Lc kinetic system, supported by the 
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SGLT1 (SLC5A1) expression and a decrease in SGLT2 (SLC5A2) and SMIT2 (SLC5A11) 
expression compared to pyloric caeca.  Finally, the hindgut demonstrated a La/Lc kinetic system 
supported by a decrease in SGLT1 (SLC5A1) expression and a general expression of SLC5A 
genes. Overall, tilapia and trout demonstrate differences in transport kinetics and intestinal 
segmental contribution associated with SLC5A family members.  Additionally, these findings 
highlight segmental kinetic differences between the gastrointestinal tract of fish and mammals.   
 
3.7 Perspectives and Significance 
Here, we present the first report comparing the kinetic characterization of electrogenic 
sodium-dependent glucose transport in the omnivorous Nile tilapia and the carnivorous rainbow 
trout gastrointestinal tract.  The differences found suggest that omnivorous and carnivorous fish 
may have unique transport systems for glucose.  This may have evolved to allow each species to 
maximize its glucose uptake from its natural diet.  However, this omnivore-carnivore paradigm 
needs to be further tested in other mammalian and aquatic systems.  Finally, in comparison to 
mammals, the discovery here of hindgut sodium-dependent glucose absorption in fish suggests 
that this process may play a greater role in osmoregulation, a homeostatic mechanism vital to 
aquatic species.   
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4.1 Abstract 
Kinetic characterization of electrogenic sodium-dependent transport in Ussing chambers of D-
glucose and D-galactose demonstrated sigmoidal/Hill kinetics in porcine jejunum and ileum, 
with the absence of transport in the distal colon.  In the jejunum, a high-affinity, super-low-
capacity (Ha/sLc) kinetic system accounted for glucose transport, and a low-affinity, low-
capacity (La/Lc) kinetic system accounted for galactose transport.  In contrast, the ileum 
demonstrated a high-affinity, super-high-capacity (Ha/sHc) glucose transport, and a low-affinity, 
high-capacity (La/Hc) galactose transport systems.  Jejunal glucose transport was not inhibited 
by dapagliflozin, but galactose transport was inhibited. Comparatively, ileal glucose and 
galactose transport were both sensitive to dapagliflozin.  Genomic and gene expression analysis 
identified 10 of the 12 known SLC5A family members in the porcine jejunum, ileum, and distal 
colon. Dominant SGLT1 (SLC5A1) and SGLT3 (SLC5A4) expression was associated with the 
sigmoidal Ha/sLc glucose and La/Lc galactose transport systems in the jejunum. Comparatively, 
dominant expression of SGLT1 (SLC5A1) in the ileum was only associated with Ha glucose and 
La galactose kinetic systems. However, the sigmoidal kinetics and overall high capacity (Hc) of 
transport is unlikely accounted for by SGLT1 (SLC5A1) alone.  Finally, the absence of transport 
and lack of pharmacological inhibition in the colon was associated with poor expression of 
SLC5A genes.  Altogether, the results demonstrated intestinal segregation of monosaccharide 
transport fit different sigmoidal kinetic systems.  This reveals multiple transporter populations in 
each system, supported by gene expression profiles and pharmacological inhibition.  Overall, this 
work demonstrates a complexity to transporter involvement in intestinal electrogenic 
monosaccharide absorption systems not previously defined.   
 
4.2 New and Noteworthy 
Here, our work presents the first sigmoidal/Hill kinetic characterization of sodium-
dependent glucose and galactose transport in the porcine jejunum and ileum.  More importantly, 
this characterization strongly indicates the presence of multiple transporter populations in each 
segment.  This notion of multiple transporter populations contributing to the observed kinetic 
transport systems has not been previously reported. Thus, this work presents a new perspective 
on the mechanism of electrogenic monosaccharide transport along the gastrointestinal tract.   
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4.3 Introduction 
 Sodium-dependent glucose absorption along the small intestine (jejunum and ileum) of 
mammals (rats, pigs, rabbits, and humans) represent a heterogeneous transport system (21, 115, 
132).  In particular, this has been studied extensively in porcine models that have diets similar to 
humans and a comparable gastrointestinal tract anatomy and physiology (13, 75).  This 
heterogeneous system is defined by the presence of two types of sodium-dependent glucose 
transport kinetics in the jejunum and ileum (179, 205, 206). Specifically, the transport kinetics of 
glucose in the jejunum have been identified as a high-affinity, low-capacity (Ha/Lc) transport 
system, while the ileum demonstrates a low-affinity, high-capacity (La/Hc) glucose transport 
system (12, 13, 22, 53, 64, 75, 84, 112, 202-204). These systems were characterized with 
Michaelis-Menten kinetics (hyperbolic saturation), suggesting only one transporter involvement 
in each segment. (21, 75, 101, 112, 202). However, the small number of incremental increases in 
the glucose gradient used may have limited generating precise kinetic fits (84, 112).   
Thus far, these heterogenous Michaelis-Menten systems were thought to be the product 
of the Ha/Lc sodium-dependent glucose transporter 1 (SGLT1), a member of the SLC5A (solute 
carrier family member 5A) transporter family (77, 165, 203, 204, 206). The SLC5A family is 
responsible for the co-transport of glucose and sodium, resulting in a measurable current (77, 
165, 203, 204, 206).  Recently, porcine jejunal and ileal sodium-dependent glucose transport 
kinetics revealed Ha kinetics in both segments, suggesting SGLT1 (SLC5A1) may be 
responsible in both segments (84, 112).  However, it was concluded that the Hc kinetics observed 
in the ileum cannot be explained by SGLT1 (SLC5A1) (84, 112).    
The possibility of a modified SGLT1 (SLC5A1) transporter responsible for the 
segregation of sodium-dependent glucose transport in the jejunum and ileum has been studied by 
Herrmann et al., as well as Klinger et al. (84, 112). It was concluded that the possibility of 
glycosylation- or phosphorylation-mediated changes to the SGLT1 (SLC5A1) transporter may 
compensate in situations where glucose transport is decreased, but it was not the reason for the 
heterogeneity of transport between the jejunum and ileum (112).  Additionally, kinetic analysis 
only demonstrated Michaelis-Menten kinetics, suggesting only one transporter involvement (84, 
112).  However, the presence of a modified SGLT1 should have likely created sigmoidal 
kinetics.   
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Here, we report the first detailed kinetic description of both sodium-dependent glucose 
and galactose transport systems along the porcine gastrointestinal tract, with use of the 
dapagliflozin inhibitor and an extensive gene expression analysis of all known pig SLC5A 
orthologs. Overall, this description best fit sigmoidal/Hill kinetics, indicating the involvement of 
multiple populations of transporters in each segment.  Additionally, different functional 
populations of transporters are present between the jejunum and ileum.  
 
4.4 Materials and Methods  
4.4.1 Animals 
Twenty-two 7-9-week-old purebred Yorkshire barrows were housed in pairs and 
provided with a commercial, non-medicated diet and water ad libitum.  The contents of the feed 
contained: crude protein (16%), crude fat (2.4%), crude fibre (5%), vitamin A (6000 IU/kg), 
vitamin D3 (900 IU/kg), vitamin E (25 IU/kg), calcium (0.62%), phosphorous (0.55%), sodium 
(0.2%), lysine (0.83%), methionine (0.27%), and threonine (0.58%) (Whole Earth Pig Grower, 
Co-op Feed).  Pigs were housed in the Animal Care Unit at the University of Saskatchewan, and 
maintained in accordance with the guidelines of the Canadian Council on Animal Care (CCAC, 
2005) (33).  All animal protocols were approved by the Animal Care Committee at the 
University of Saskatchewan (AUP#: 20130034). 
 
4.4.2 Ex-vivo Tissue Collection 
Pigs were euthanized and the gastrointestinal tract was removed. The gastrointestinal 
tract was separated to obtain sections of the jejunum, ileum, and distal colon. The jejunum was 
obtained 18 inches distal from the stomach, the ileum was sampled 2 inches proximal of the 
ileal-caecal junction, and the distal colon was sampled 4 inches proximal of the rectum.     
 
4.4.3 Electrophysiology  
4.4.3.1 Ussing Chamber technique.  Porcine intestinal samples were examined in Ussing 
chambers using techniques adapted from our group (125, 126, 182). The Ussing chamber system 
used in this study was an EasyMount Ussing Chamber System (Physiologic Instruments Inc., 
 80 
 
San Diego, CA).  Each segment was placed in a modified Krebs buffer containing: 114mM 
NaCl, 5mM KCl, 2.15mM CaCl2·2H2O, 1.1mM MgCl2·6H2O, 0.3mM NaH2.PO4·H2O, 1.65mM 
Na2HPO4 and 25mM NaHCO3 at pH 7.4, and devoid of glucose. The lumen of the intestine was 
washed with buffer using a syringe and 18-gauge needle to clean the luminal membrane of any 
residual chyme. The serosa and longitudinal muscle layers were removed from the intestinal 
samples with forceps prior to mounting on 1cm2 Ussing chamber inserts (Slider Number: P2314, 
Physiologic Instruments Inc., San Diego, CA). Once mounted, tissues were inserted into the 
Ussing chamber, and both apical and basolateral surfaces were bathed with 5mL of Krebs buffer 
solution. The chambers were continuously gassed for the duration of the experiment with  5% 
CO2 and 95% O2 (40). Needle valves were also present for the adjustment of gas flow into the 
chambers.   
The transepithelial voltage and passing current set across the tissue was measured via 3M 
KCl agar bridges and Ag/AgCl reference electrodes. These electrodes were connected to leads 
that lead to the voltage/current clamp. The short-circuit current (Isc) was measured by the 
software program LabChart (ADInstruments Pty Ltd.) in µA, and this was a result of the tissue 
current opposing the current induced by the electrodes. The tissues were pulsed every 30 seconds 
at 0.001V to determine tissue resistances from the resulting current. A recirculating water bath 
capable of chilling and heating was responsible for maintaining the buffer in the Ussing 
chambers at 36-37oC.   
The glucose gradient used was: 1-25mM, 30mM, 40mM, and 50mM in sequential order. The 
gradient from 1-25mM was added to the chamber in increasing 1mM increments, followed by 
increments of 30mM, 40mM, and 50mM. The tissues were allowed to reach a steady baseline 
current for 20 minutes prior to the addition of D-glucose to the apical side of the chamber. An 
equivalent amount of D-mannitol was added to the basal side to prevent the development of an 
osmotic gradient from the addition of glucose.  Prior to the addition of each increment of glucose 
and mannitol, a wait period of 3-4 minutes was allowed between each increment for the current 
to reach a steady state. The experiment with D-galactose was conducted in a similar manner.   
 
4.4.4 Chemicals.  For pharmacological characterization, 0.001µM, 0.01µM, 0.1µM, 1µM, 
10µM, 100µM, 200µM, and 300µM of dapagliflozin (AdooQ® Bioscience, Irvine, CA) was 
used in sequential order in the Ussing Chamber as final concentrations. The drug was added to 
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the apical side, after the jejunum, ileum, and distal colon were at final glucose/galactose and 
mannitol concentrations of 50mM. A wait period of 5-7 minutes was allowed between each 
increment for the current to reach steady state.  
 
4.4.5 RNA extraction and cDNA synthesis using RT-PCR.  Approximately 1mg samples of 
tissue were obtained from the dissection of the intestinal tract and stored in RNAlater® RNA 
Stabilization Solution (Thermo Fisher Scientific, Baltics) at -80oC.  RNA was isolated using the 
TRIzol reagent (Ambion Life Technologies, Van Allen Way, CA), and cDNA was synthesized 
through reverse transcription PCR using the qScript™ cDNA SuperMix (Quanta Biosciences, 
Maryland, USA) according to the manufacturer’s protocol. The cDNA samples were stored at -
80oC for subsequent use in quantitative PCR. 
 
4.4.6 Genomic Identification of SLC5A Genes.  A detailed BLAST+ (Basic Local Alignment 
Search Tool) application was used to identify all of the annotated porcine SLC5A transporters.  
The twelve human SLC5A transporter sequences retrieved from the National Center for 
Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov/) were used in a 
“blastn” command to search for similar mRNA sequences in the porcine genome (204).  The 
expect value (e-value) was used to assess the significance of the match, where an e-value close to 
zero was considered significant and an e-value higher than 10^-15 was considered as a non-
significant match.  Once SLC5A transporters were identified, phylogenic trees were generated 
using the alignment program CLUSTAL W and MEGA7 (www.megasoftware.net) software. 
 
4.4.7 Gene transcript expression levels by quantitative polymerase chain reaction.   
Quantitative PCR was performed by RT-qPCR reaction using the GoTaq®qPCR Master Mix 
containing SYBR®Green1 (Promega, Madison USA).  The Bio-Rad QPCR system (CFX96TM 
Bio-Rad Laboratories, Inc) was used to perform these reactions.  The total volume of the PCR 
reaction was 12.5µL.  A total of 40 cycles of qPCR was performed, with each cycle consisting of 
GoTaq® Hot Start Polymerase activation at 95oC for 2 minutes, and then denaturation at 95oC 
for 15 seconds, followed by annealing/extension at the primer’s hybridization temperature for 1 
minute.  The dissociation step was at 60-95oC.   Serial dilutions of cDNA were also used to 
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generate a standard curve for each target gene, where the efficiency of each primer was 
calculated.  The efficiencies for the primers ranged from 1.8-2.0.  Porcine β-actin (Beta-actin) 
was used as the housekeeping gene and was used to normalize the relative mRNA expression 
levels of SGLTs in the pig.  The method of analysis used to represent the relative expression 
levels was calculated using delta CT, where the amount of gene of interest was normalized to the 
amount of β-actin in that sample (173).      
The primers for the porcine SLC5A genes and housekeeping gene were designed through the 
Integrated DNA Technologies website (https://www.idtdna.com/site), where the sequences and 
their accession numbers are presented in Table 4.1.  
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Table 4.1 Pig Primer Sequences used for quantitative PCR 
 
Gene Forward Primer (5`-3`) Reverse Primer (5`-3`) 
Accession 
Number 
SGLT1 CTGTGGTGTGCACTACTT GGTCAATACGCTCCTCTTT NM_001164021.1 
SGLT2 CTGGGCTGGAACATCTAC CGTAACCCATGAGGATGAA XM_021086375.1 
SMIT1 TCTGAGATGCAGTGAGAATAG CTGAATGACCCAAGGAAGA XM_005657149.3 
SGLT3 ATTGTGTGGGTCCCATTAG GAAGGCTCCCTGTTCATT NM_214182.1 
NIS GTTAGATCCTCTCTGGACAAC CCACCTGTAAAGTGGGTATAG NM_214410.1 
SMVT CAGCAATCAGCATCTTTGG GGCCATGTTGGTCACTAT XM_013996254.2 
CHT AGCAGTTGCAGGTGTAATA GTAGACACACTCAGAGGAAC XM_021087111.1 
SMCT1 CCTCACTGCCAGCTTTAT TCGTAGGTGCTGGTAAATC NM_001291414.1 
SGLT4 GGAACCTTTACCTCTCCAC CTCCTGAAAGCCCAGAAA XM_021096677.1 
SGLT5 TCCAGATCGAGAACCTCA AGAAGAGGTTGACACACAC NM_001012297.1 
SMIT2 CCCTCACCTCCATCTTTAAC TGGAGACCAGCACTAGAA NM_001110422.1 
SMCT2 CACTGGGTAAGGAGGAAAG CAGGTGTGAGCTGAATGA XM_003122908.4 
β-ACTIN CACCACTGGCATTGTCAT GTGGTGGTGAAGCTGTAG XM_021086047 
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4.4.8 Designating Affinities (Ha or La) and Capacities (sHc, Hc, sLc, or Lc).  After the Km 
and Vmax values were calculated from Hill/sigmoidal fits (preferred model) using GraphPad 
Prism 8 (GraphPad Software, Inc.), the affinities, high-affinity (Ha) or low-affinity (La), and the 
capacities, super-high-capacity (sHc), high-capacity (Hc), super-low-capacity (sLc), and low 
capacity (Lc) were designated to the transport systems. To denote whether a system was Ha or 
La, the Km values were statistically compared between jejunum and ileal glucose and galactose 
transport. If Km values were low and non-significant from each other, they were characterized as 
high-affinity, Ha.  In Tables 4.2 and 4.3, the Km values for the jejunum and ileum glucose 
transport were low and non-significant from each other, which designated as Ha. If Km values 
were higher and significantly different from the low Km values, then those were designated as 
low-affinity, La. In Tables 4.2 and 4.3, the Km values for the jejunum and ileum galactose 
transport were non-significant from each other and higher than the corresponding glucose 
transport, thus they were designated as La.  Similarly, if the Vmax values were low and 
significantly different from the high Vmax values, then those were denoted as low-capacity, Lc 
(Tables 4.2 and 4.3).  Additionally, if the low Vmax values were significantly different from 
each other, then it was further designated as Lc and sLc (Tables 4.2 and 4.3).  If the Vmax values 
were high, and significantly different from the low Vmax values, then those would be designated 
as high-capacity, Hc (Table 4.2).  Additionally, if the high Vmax values were significantly 
different from each other, then they were further designated as Ha and sHc (Tables 4.2 and 4.3).  
Altogether in this study, the characterization of Ha/sLc, La/Lc, Ha/sHc, and La/Hc were 
determined by statistically comparing Km and Vmax values between monosaccharide transport 
and segments.    
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Table 4.2 Vmax and Km Values for D-Glucose and D-Galactose Electrogenic Absorption 
 
 
Vmax (µA) and Km (mM) represented for sodium-dependent electrogenic D-glucose and D-
galactose absorption for each tissue type in pig. ND represents non-detectable transport of those 
substrates.  Area of intestinal segment was 1cm2.  Data are presented as means ± SEM.  Different 
letter superscripts represent significance between each intestinal segment for Vmax and Km 
within each substrate (Student’s t-test, P < 0.05).  Asterisks represent significances for Vmax and 
Km between substrates for the same intestinal segment (Student’s t-test, P < 0.05).   
 
 
 
 
 
 
 
 
 
 
 
D-Glucose D-Galactose 
Glucose Vs. 
Galactose 
Tissue 
Km ± SEM 
(mM) 
Vmax ± 
SEM 
(µA/cm2) 
Tissue 
Km ± SEM 
(mM) 
Vmax ± 
SEM 
(µA/cm2) 
Km Vmax 
Jejunum 4.6 ± 0.4 A 11.1 ± 2.3 A Jejunum 19.1 ± 1.2 A 30.0 ± 5.0 A * * 
Ileum 6.3 ± 0.9 A 100.7 ± 9.3B Ileum 17.4 ± 2.1 A 60.3 ± 7.1 B * * 
Distal 
Colon 
nd nd 
Distal 
colon 
nd nd nd nd 
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Table 4.3 Final Designations of Transport Systems for each Segment 
 
Tissue D-Glucose D-Galactose 
Jejunum 
High-affinity, super-low-
capacity (Ha/sLc) 
Low-affinity, low-capacity 
(La/Lc) 
Ileum 
High-affinity, super-high-
capacity (Ha/sHc) 
Low-affinity, high-capacity 
(La/Hc) 
Distal Colon ND ND 
 
Kinetic transport systems defined for each porcine intestinal segment for D-glucose and D-
galactose sodium-dependent transport.  These designations are further defined in the Material 
and Methods Section.  ND represents non-detectable kinetic characterization of sodium-
dependent transport.  
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4.4.9 Statistical Analyses.  D-glucose and D-galactose gradients in the jejunum and ileum 
demonstrated sigmoidal saturation kinetics, with hill coefficients greater than 1. This was 
determined from conducting an F-test between the traditionally used Michaelis-Menten fit and a 
sigmoidal/Hill fit to confirm the preferred model using GraphPad Prism 8 (GraphPad Software, 
Inc.) (119, 145). The sigmoidal/Hill fit was determined as the preferred model, with a P < 0.001. 
Generally, sigmoidal/Hill fits indicate the presence of more than one binding site/transporter, 
with hill coefficients usually greater than 1 (104, 135).  The Vmax (represented in µA/cm2) and 
Km (represented in mM) values for glucose and galactose transport were calculated using the 
equation for “One Site-Specific Binding with Hill slope” for jejunum and ileum using GraphPad 
Prism 8. The equation used for the Sigmoidal Hill kinetics was: 
Equation 4.1 
Sigmoidal Hill fit: Y=Vmax*Xh/(Kdh + Xh) 
All data met parametric assumptions, being normally distributed and exhibited homogeneity of 
variance. A student’s t-test was performed between jejunum and ileum Vmax and Km values for 
glucose and galactose to determine significance (210). Similarly, a student’s t-test was performed 
between jejunal glucose and galactose transport for Vmax and Km, as well as ileal glucose and 
galactose transport for Vmax and Km to determine significance. A P < 0.05 was considered to be 
significantly different.  
For the inhibitor dapagliflozin, the percent activity remaining was calculated from the 
division of the 50mM increment short-circuit current (the concentration where the transporter is 
100% saturated and it is 100% un-inhibited) and the resulting drop in current from the addition 
of each drug concentration. These calculations were performed for both glucose and galactose 
inhibitor data. The Ki values for the dapagliflozin response were calculated for jejunum and 
ileum using the “One-Site Fit logIC50” from GraphPad Prism 8 (GraphPad Software, Inc.).  This 
fit follows the equation: Y = Bottom + (Top-Bottom)/(1+10(X-LogIC50)).  Parametric 1-way 
ANOVA’s were performed on the three intestinal sections to determine significance for 
inhibition. After ANOVA, pairwise comparisons were made using Tukey’s posteriori tests, as 
appropriate. A Student’s t-test was performed between Ki values to determine significance.  For 
the qPCR analyses, relative expressions were determined by the BioRad system, where the 
threshold cycle was established using the housekeeping gene, β-actin. A 2-way ANOVA (two 
factors: intestinal segment and gene) was conducted on the gene expressions. After ANOVA, 
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pairwise comparisons were made using Tukey’s posteriori tests, as appropriate. All statistical 
analyses were performed on SigmaPlot (Systat Software Inc., San Jose, CA).   
 
4.5 Results 
4.5.1 Jejunum 
4.5.1.1 Ha/sLc Glucose and La/Lc Galactose Kinetic Transport Systems 
The electrogenic sodium-dependent glucose and galactose transport followed 
sigmoidal/Hill kinetics in the porcine jejunum, with Hill coefficients greater than 1 (Figures 4.1A 
and 4.2A). An F-test was conducted to confirm that the sigmoidal/Hill fit was preferred over a 
Michaelis-Menten, hyperbolic fit (P< 0.001). Jejunal glucose transport became saturated around 
14 – 15mM glucose and resulted in very low Vmax and Km values (Table 4.2 and Figure 4.1A). 
In contrast, jejunal glucose transport revealed a significantly lower Vmax compared to the 
galactose transport system (Table 4.2, P < 0.001). The Km values between jejunal glucose and 
galactose transport revealed significantly higher Km in jejunal galactose transport (Table 4.2, P < 
0.001).  Thus, these findings support a Ha/sLc (low Km, very low Vmax) glucose transport 
system and a La/Lc (high Km, low Vmax) galactose transport system in the porcine jejunum 
(Tables 4.2 and 4.3).  Additionally, the sigmoidal kinetics observed suggests the involvement of 
more than one transporter population in the jejunal monosaccharide transport.  Sodium-
dependency of glucose transport in the jejunum was demonstrated by replacement of sodium 
with choline creating a sodium-free Krebs buffer, which eliminated the glucose-mediated current 
(Figures 4.1A and 4.1B) (147).    
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Figure 4.1 Kinetics of sodium-dependent glucose transport in pig. 
Sigmoidal kinetics for sodium-dependent electrogenic glucose transport in A) jejunum, 
illustrated with representative traces on the right side (B) (Sodium-dependent: Pig N = 11; 
Sodium-independent: Pig N = 3), C) ileum, illustrated with representative traces on the right side 
(D) (Sodium-dependent: Pig N = 13; Sodium-independent: Pig N = 3), and E) no kinetics 
observed in distal colon, illustrated with representative traces on the right side (F) (Sodium-
dependent: Pig N = 13; Sodium-independent: Pig N = 3).  The Vmax and Km is represented in 
A) jejunum for illustration purposes.  Data are represented as means ± SEM. 
 
 
 
 
 90 
 
 
 
 
 
 
 
 
Figure 4.2 Kinetics of sodium-dependent galactose transport in pig. 
Sigmoidal kinetics for sodium-dependent electrogenic galactose transport in A) jejunum, ileum 
and colon, illustrated with representative traces on the right side (B) (Pig: Jejunum: N = 5, Ileum: 
N = 6, Distal Colon: N = 6).  Data are represented as means ± SEM.  
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4.5.1.2 Inhibition of Ha/sLc Glucose and La/Lc Galactose Systems 
Dapagliflozin, a selective inhibitor for SGLT2 (sodium/glucose cotransporter 2) was 
used, and did not inhibit glucose-induced electrogenic current in the porcine jejunum (Figures 
4.3A and B) (116, 170). Interestingly, dapagliflozin did cause significant inhibition (about 20-
25%) of the galactose-induced electrogenic current at the higher concentrations (100-300µM) 
(Figures 4.4A and B, P < 0.001).  The Ki value for inhibition of jejunal galactose transport by 
dapagliflozin is presented in Table 4.4.   
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Figure 4.3 Pharmacological inhibition of glucose transport. 
Percent activity remaining of short-circuit current (Isc) in response to D-glucose transport by A) 
dapagliflozin (0.001, 0.01, 0.1,10, 100, 200, and 300µM) in pig intestinal tissues (Jejunum: 
N=12, Ileum: N=12, Distal Colon: N=11).  B) Representative traces for all intestinal tissues are 
presented for illustration purposes.  Data are represented as means ± SEM.  Asterisks represent 
significance from 100% transporter activity before inhibition, which is presented as the dotted 
line (1-way ANOVA, P < 0.05).  
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Figure 4.4 Pharmacological inhibition of galactose transport. 
Percent activity remaining of short-circuit current (Isc) in response to D-galactose transport by 
A) dapagliflozin (0.001, 0.01, 0.1,10, 100, 200, and 300µM) in pig intestinal tissues (All tissues: 
N = 6).  B) Representative traces for all intestinal tissues are presented for illustration purposes.  
Data are represented as means ± SEM.  Asterisks represent significance from 100% transporter 
activity before inhibition, which is presented as the dotted line (1-way ANOVA, P < 0.05).  
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Table 4.4 Ki Values for D-Glucose and D-Galactose Electrogenic Absorption 
 
 
Ki (µM) values represented for dapagliflozin inhibition of sodium-dependent electrogenic D-
glucose (Jejunum: N=12, Ileum: N=12, Distal Colon: N=11) and D-galactose (All tissues: N = 6) 
absorption for each tissue type in pig. ND represents non-detectable inhibition.  Data are 
presented as means ± SEM.  Different letter superscripts represent significance between each 
intestinal segment (Student’s t-test, P < 0.05).   
 
 
 
 
 
 
 
 
 
 
 
D-Glucose D-Galactose 
Tissue Ki ± SEM (µM) Tissue Ki ± SEM (µM) 
Jejunum nd Jejunum 4.6 ± 0.9 A 
Ileum 6.0 ± 1.0 Ileum 1.8 ± 0.6 B 
Distal Colon nd Distal colon nd 
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4.5.1.3 SLC5A Gene Identification Affirms Kinetics in Jejunum 
To identify gene product candidates that could contribute to the observed kinetics in the 
porcine jejunum, BLAST+ was utilized to probe the known SLC5A gene family.  Our findings 
revealed 12 porcine SLC5A members in the genome (Table 4.1).  However, quantitative real-
time PCR only identified 10 porcine SLC5A members in the intestine.  The SLC5A transporters 
identified with qPCR were SGLT1 (SLC5A1, sodium/glucose cotransporter 1), SGLT2 
(SLC5A2, sodium/glucose cotransporter 2), SMIT1 (SLC5A3, sodium/myoinositol cotransporter 
1), SGLT3 (SLC5A4, sodium/glucose cotransporter 3), SMVT (SLC5A6, sodium/multivitamin 
cotransporter), CHT (SLC5A7, sodium/choline cotransporter), SMCT1 (SLC5A8, 
sodium/monocarboxylate cotransporter 1), SGLT5 (SLC5A10, sodium/glucose cotransporter 5), 
SMIT2 (SLC5A11, sodium/myoinositol cotransporter 2), and SMCT2 (SLC5A12, 
sodium/monocarboxylate cotransporter 2). The genes NIS (SLC5A5, sodium/iodide 
cotransporter) and SGLT4 (SLC5A9, sodium/mannose cotransporter) were not detected by 
qPCR in the pig jejunum. 
More specifically, porcine SGLT1 (SLC5A1) expression was significantly greater than 
the other 9 identified SLC5A isoforms in the jejunum, supporting the Ha/sLc glucose and La/Lc 
galactose transport systems (Figure 4.5A, P < 0.001 for transporter type).  In addition, SGLT3 
(SLC5A4) expression in the jejunum was significantly greater than the expression in the ileum 
and distal colon (Figure 4.5A, P < 0.05 for transporter type). Both gene candidates support the 
observed kinetics and inhibitor data found in the porcine jejunum. Sequence similarities between 
pig SLC5A transporters were compared in a phylogenic tree (Figure 4.5B). In a CLUSTAL W 
analysis, the nucleotide identities relative to pig SGLT1 (SLC5A1) were 57.5% SGLT2 
(SLC5A2), 48.1% SMIT1 (SLC5A3), 72.8% SGLT3 (SLC5A4), 40.3% NIS (SLC5A5), 39.8% 
SMVT (SLC5A6), no sequence similarity with CHT (SLC5A7), 37.3% SMCT1 (SLC5A8), 
51.7% SGLT4 (SLC5A9), 56.6% SGLT5 (SLC5A10), 56.1% SMIT2 (SLC5A11), and 35.3% 
SMCT2 (SLC5A12), revealing highest nucleotide sequence similarity between SGLT1 
(SLC5A1) and SGLT3 (SLC5A4).   
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Figure 4.5 Genomic and gene expression analyses in pig. 
A) Relative expression levels of SLC5A transporters (Jejunum: N = 8-10, Ileum: N = 7-10, 
Distal Colon: N = 7-10) using quantitative PCR.  Expression levels were normalized against β-
actin housekeeping gene.  Letters represent significance between genes and tissues (2-way 
ANOVA, P < 0.05). ND represents non-detectable expression of those genes.  B) Phylogenic tree 
of the 12 members of the SLC5A family of cotransporters in pig.  The alignment program 
CLUSTAL W and the phylogenic display program MEGA7 were used to generate the tree.  
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4.5.2 Ileum 
4.5.2.1 Ha/sHc Glucose and La/Hc Galactose Kinetic Transport Systems  
In the porcine ileum, glucose and galactose gradients followed sigmoidal/Hill kinetics for 
both substrates, with hill coefficients greater than 1 (Figures 4.1C and 4.2A). An F-test was 
conducted to confirm that the sigmoidal/Hill fit was preferred over a Michaelis-Menten, 
hyperbolic fit (P < 0.001).  A Ha/sHc glucose transport system was demonstrated, which 
saturated around 30-40 mM glucose and resulted in a similarly low Km and a significantly 
higher Vmax compared to the glucose transport system in the jejunum (Km: P = 0.1, Vmax: P < 
0.001; Table 4.2 and Figure 4.1C). Specifically, ileal glucose transport kinetics had 9 times 
higher capacity than jejunal glucose transport kinetics (Table 4.2; Compare ileum: 100.7 ± 9.3 
µA/cm2 versus jejunum: 11.1 ± 2.3 µA/cm2, P < 0.001).   
The galactose-induced gradient in the ileum resulted in a La/Hc transport kinetic system, 
becoming saturated around 40-50 mM, with a significantly higher Km and a lower Vmax 
compared to glucose transport (Tables 4.2 and 4.3, and Figure 4.2A, Vmax: P = 0.02 for both 
substrates, Km: P < 0.001 for both substrates). Ileal glucose transport had a significantly higher 
Vmax than ileal galactose transport, resulting in sHc and Hc kinetics, respectively (Tables 4.2 
and 4.3).  Similarly, to the jejunum, the sigmoidal kinetics observed in the ileum suggests the 
involvement of more than one transporter.  Sodium-dependency of glucose transport in the ileum 
was demonstrated by replacement of sodium with choline creating a sodium-free Krebs buffer, 
which eliminated the glucose stimulated current (Figures 4.1C and D).    
 
4.5.2.2 Inhibition of Ha/sHc Glucose and La/Hc Galactose Transport Systems 
In the ileum, dapagliflozin significantly inhibited glucose sodium-dependent electrogenic 
current from 1-300µM dosages, resulting in 20-90% inhibition (Figures 4.3A and B, P < 0.05). 
Similarly, in the galactose-induced electrogenic current, dapagliflozin significantly inhibited 
from 1-300µM dosages, resulting in approximately 40-80% inhibition (Figures 4.4A and B, P < 
0.001). The Ki values for inhibition of ileal glucose and galactose transport are presented in 
Table 4.4.  Finally, the significant difference in Ki values observed between jejunal and ileal 
galactose inhibition, as well as the absence of inhibition in jejunal glucose transport, suggest 
different multiple transporter populations between segments (Table 4.4).   
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4.5.2.3 SLC5A Gene Profiling in Ileum 
To identify gene product candidates that could contribute to the observed kinetics in the 
porcine ileum, BLAST+ was utilized to probe the known SLC5A gene family.  Similar to the 
findings in the jejunum, only 10 SLC5A members were identified by qPCR in the ileum, with no 
detection of NIS (SLC5A5) and SGLT4 (SLC5A9).  
Gene expression in the ileum revealed significantly greater expression of SGLT1 
(SLC5A1) when compared to the other 9 SLC5A isoforms (Figure 4.5A, P < 0.001).  In contrast 
to the jejunum, SGLT3 (SLC5A4) expression was not significantly different between the ileum 
and distal colon (Figure 4.5A).  Sequence similarities between pig SLC5A transporters were 
compared in a phylogenic tree (Figure 4.5B). Overall, sigmoidal kinetics of monosaccharide 
transport demonstrated in the ileum raises the possibility of another transporter in addition to 
SGLT1 (SLC5A1), which is either a modified SGLT1 (SLC5A1) different than the jejunum, or 
another transporter. 
 
4.5.3 Distal Colon 
4.5.3.1 Lack of Electrogenic Monosaccharide Transport in Distal Colon 
 The addition of glucose and galactose in the colon did not generate any observable 
sodium-dependent saturation kinetics, preventing the calculation of Vmax or Km values (Tables 
4.2 and 4.3, Figures 4.1E and 4.2A).  A lack of inhibition with dapagliflozin for glucose- and 
galactose-induced electrogenic currents confirmed the non-detectable kinetic transport system 
(Figures 4.3A and 4.4A).  Identification of 10 SLC5A transporters in the distal colon by qPCR 
resulted in low expression of all genes in comparison to the jejunum and ileum, supporting the 
absence of electrogenic monosaccharide transport in this segment (Figure 4.5A).     
 
4.6 Discussion 
In terms of porcine sodium-dependent glucose transport, our results mirror studies 
presented previously that represent an overall low-capacity of transport in the jejunum and an 
overall high-capacity of transport in the ileum (75, 84, 112).  In addition to these studies, we 
have presented sodium-dependent galactose transport following a similar pattern of low-capacity 
 99 
 
jejunal transport and high-capacity ileal transport, which has not been characterized before.  
However, in contrast to previous studies, this study presents both glucose and galactose sodium-
dependent transport following sigmoidal/Hill kinetic systems, instead of previously characterized 
Michaelis-Menten systems (75, 84, 112).  This kinetic characterization of glucose and galactose 
transport was demonstrated by both the jejunum and ileum.  Therefore, this strongly suggests the 
involvement of multiple transporter populations contributing to the kinetic systems observed in 
each segment, which is contrary to previous studies (75, 84, 112).  Finally, pharmacological 
inhibition and gene expression analysis support the presence of different multiple transporter 
populations in each segment.      
 
4.6.1 Jejunum 
4.6.1.1 Sigmoidal Kinetics Support Multiple Transporter Involvement in the Jejunum 
In this study, the porcine jejunum electrogenic glucose absorption is defined as a Ha/sLc 
system following sigmoidal/Hill kinetics, which becomes saturated at 14-15mM glucose (Figure 
4.1A, and Tables 4.2 and 4.3). Comparatively, jejunal galactose transport revealed a La/Lc 
system, with 4 times lower affinity than glucose transport (Tables 4.2 and 4.3).  Previous studies 
that have characterized glucose transport systems revealed a Ha/Lc transport system following a 
Michaelis-Menten model (21, 75, 80, 97, 112, 203, 206, 207). The use of Michaelis-Menten fits 
in these studies may be due to a smaller number of glucose increments used (21, 75, 80, 97, 112, 
203, 206, 207).  However, the results in this study reveal both glucose and galactose transport 
following a sigmoidal/Hill fit. This may be due to the techniques used, the increased number of 
glucose increments, as well as a larger glucose/galactose range (Figures 4.1 and 4.2).  
Nonetheless, with both jejunal glucose and galactose transport following sigmoidal/Hill fits, it 
strongly suggests the possibility of multiple transporter populations contributing to these kinetic 
transport systems.     
Pharmacological inhibition with dapagliflozin lacked effect on jejunal sodium-dependent 
glucose transport, but inhibited jejunal galactose transport at concentrations greater than 100µM 
(Figures 4.3A and 4.4A, respectively).  The lack of inhibition on glucose transport is not 
surprising given the low expression of SGLT2 (SLC5A2) in the jejunum, since dapagliflozin is a 
specific, competitive inhibitor for SGLT2 (SLC5A2) (Figure 4.5A) (93, 116, 143).  In contrast, 
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the inhibition of galactose-induced transport by dapagliflozin may be explained by the lower 
affinity for galactose by a transporter such as SGLT1 (SLC5A1), thus allowing for competitive 
inhibition by dapagliflozin.  Alternatively, it may also suggest the presence of another transporter 
such as SGLT3 (SLC5A4) that may be sensitive to dapagliflozin inhibition with galactose 
transport.   
Following inhibitor characterization, a genomic and gene expression analysis of all 
porcine SLC5A genes revealed that SGLT1 (SLC5A1) and SGLT3 (SLC5A4) had the greatest 
expression in the porcine jejunum (Figure 4.5A).  The high SGLT1 (SLC5A1) expression mirror 
those from previous studies that found SGLT1 (SLC5A1) as the dominant ortholog in guinea pig 
and porcine jejunal BBMVs, supporting a Ha/Lc system in this segment (21, 75, 80, 97, 112, 
203, 206, 207). Additionally, studies in rats, mice, horses, rabbits, and beef steers found that 
SGLT1 (SLC5A1) expression was greater in the jejunum than ileum, which affirmed SGLT1 
(SLC5A1) as a contributor to the Ha/Lc system (21, 75, 80, 84, 97, 112, 203, 206, 207). SGLT1 
(SLC5A1) is known to absorb both glucose and galactose, but with a lower affinity for galactose 
(204).   
However, the sigmoidal kinetic systems for jejunal glucose and galactose transport, 
strongly suggest the presence of multiple transporter populations in this segment.  Therefore, the 
high expression of SGLT3 (SLC5A4) may be the other transporter involved in the jejunum 
(Figure 4.5A).  In pigs, SGLT3 (SLC5A4) was first identified as SAAT1 (low-affinity sodium-
dependent amino acid transporter) in the porcine kidney, which was mistakenly identified as 
SGLT2 in the porcine intestine, and finally confirmed as SGLT3 (SLC5A4) as a low-affinity 
glucose transporter (53, 203, 204). It has a lower affinity for glucose and galactose compared to 
SGLT1 (SLC5A1) (53). Overall, SGLT1 (SLC5A1) and SGLT3 (SLC5A4), or secondary 
modifications of these transporters, may contribute to the sigmoidal Ha/sLc and La/Lc glucose 
and galactose transport systems respectively, further supporting the notion of multiple transporter 
populations in the porcine jejunum.   
 
4.6.2 Ileum 
4.6.2.1 Multiple Transporter Populations involved in Ileal Monosaccharide Transport 
which Differ from Jejunum 
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A Ha/sHc glucose transport system following sigmoidal/Hill kinetics was characterized 
in the porcine ileum with significant differences in kinetics and pharmacological inhibition 
compared to the jejunum. The kinetics revealed a similar affinity, but a 9 times higher capacity in 
the ileum compared to jejunal glucose transport (Tables 4.2 and 4.3). Previous studies comparing 
glucose transport between porcine jejunal and ileal BBMVs found that the ileum had a higher 
Vmax than the jejunum, but similar Km values, supporting findings in the current study (75, 84, 
112). For the first time, our study also revealed sodium-dependent galactose transport had a 
La/Hc kinetic system following sigmoidal/Hill kinetics in the ileum, but at a higher capacity than 
the jejunum (Tables 4.2 and 4.3). Finally, similarly to the jejunum, the sigmoidal/Hill kinetics for 
glucose and galactose transport in the ileum strongly suggest the presence of multiple transporter 
populations contributing to these kinetic systems.  Additionally, pharmacological inhibition and 
gene expression analysis further support these results.   
Dapagliflozin inhibited both glucose and galactose transport at concentrations 1-300µM 
in the ileum (Figures 4.3A and 4.4A).  These results are different from the jejunum, where 
dapagliflozin inhibition was only observed with jejunal galactose transport. Additionally, the Ki 
value between jejunal and ileal galactose transport were significantly different, suggesting 
different multiple transporter populations (Table 4.4).  Therefore, this strongly suggests the 
presence of another transporter in the ileum that is not similar to either SGLT1 (SLC5A1) or 
SGLT3 (SLC5A4) identified in the jejunum due to different patterns of inhibition.   
Gene expression analysis determined that SGLT1 (SLC5A1) was the dominant SLC5A 
ortholog expressed in the porcine ileum. This is similarly described in other mammalian species 
such as rabbits, mice, and rats, where high expression of SGLT1 (SLC5A1) was found in the 
ileum (75, 83, 84, 112, 115, 191).  These findings suggest that SGLT1 (SLC5A1) may contribute 
to the Ha glucose transport system and the La galactose transport system in the porcine ileum. 
This is supported by previous studies indicating SGLT1 (SLC5A1) has a higher affinity for 
glucose than galactose (204).  However, SGLT1 (SLC5A1) alone does not explain the sHc and 
Hc kinetics observed with glucose and galactose transport, as well as the dapagliflozin inhibition 
to the glucose- and galactose-induced currents. Additionally, it has been concluded previously 
that SGLT1 (SLC5A1), although having dominant expression in the ileum, was not wholly 
responsible for the overall high-capacity glucose transport in the ileum (112). Thus, suggesting 
more than one transport involved in ileal glucose transport, although only Michaelis-Menten 
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kinetics were found (84, 112). Here, more importantly, the sigmoidal/Hill fits observed with ileal 
monosaccharide transport strongly suggest the involvement of another transporter.   
 
4.6.3 Distal Colon 
4.6.3.1 Lack of Electrogenic Monosaccharide Transport 
The distal colon demonstrated a lack of glucose and galactose sodium-dependent 
transport.  Our findings are supported by previous studies that have suggested that the colon 
lacks glucose transport (150, 203). During neonatal development in pigs, mice, and rats, the 
colon possess villus-like structures that assist in carbohydrate absorption, but this property 
disappears soon after birth (150). The pigs used in the current study were weaned and 7-9 weeks 
of age, thus having a mature colon lacking monosaccharide absorptive properties, producing the 
observed results (Figures 4.1E and 4.2A).  Additionally, the lack of dapagliflozin inhibition and 
the poor expression of all SLC5A genes further support the absence of sodium-dependent 
glucose and galactose transport in the colon.   
 
4.7 Conclusion  
Electrogenic sodium-dependent glucose and galactose absorption in the jejunum and 
ileum followed sigmoidal/Hill kinetics, suggesting the presence of multiple transporter 
populations in each segment.  In support of this, the jejunum had dominant expression of SGLT1 
(SLC5A1) and SGLT3 (SLC5A4), possibly contributing to the Ha/sLc glucose and the La/Lc 
galactose transport systems.  In contrast, the ileum presents itself with Ha/sHc glucose and La/Hc 
galactose transport systems, with dominant expression of SGLT1 (SLC5A1).  However, the 
sigmoidal kinetics in the ileum likely suggests the involvement of another transporter along with 
SGLT1 (SLC5A1).  Additionally, pharmacological inhibition demonstrates differences in 
inhibition patterns between jejunum and ileum supporting different multiple transporter 
populations in each segment. Finally, this detailed kinetic analysis provides a substantial burden 
of proof for not one but multiple transporter populations that differ between jejunum and ileum 
in the electrogenic absorption of glucose and galactose not previously reported.  
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5.1 Abstract 
The mucosal to serosal flux of 14C 3-O-Methyl D-glucose across the proximal small intestine 
was compared between Nile tilapia (Oreochromis niloticus), rainbow trout (Oncorhynchus 
mykiss), and the pig (Sus scrofa) in Ussing chambers.  A 1mM to 8000mM D-glucose gradient 
revealed a high-affinity, high-capacity (Ha/Hc) total glucose transport system in tilapia, a high-
affinity, low-capacity (Ha/Lc) total glucose transport system in trout, and a low-affinity, low-
capacity (La/Lc) total glucose transport system in pig.  The overall La glucose transport in the 
pig suggested a different mechanism of total glucose absorption compared to tilapia and trout.  
This was supported by responses to inhibitors of sodium-dependent glucose transporters 
(SGLTs), glucose transporter type 2 (GLUT2), and aquaporins (AQPs) on the apical side 
demonstrating major differences between the three species.  In tilapia, glucose flux was inhibited 
by SGLT and AQP inhibitors, but not with the GLUT2 inhibitor.  In trout, none of the inhibitors 
caused inhibition of total glucose transport.  However, the pig responded to inhibition by both 
SGLT and AQP inhibitors, as well as the GLUT2 inhibitor.  Genomic and gene expression 
analysis of GLUT2 supported this finding with the highest expression in the pig jejunum 
compared to tilapia and trout.  Altogether, the Ha/Hc total tissue glucose absorption in tilapia is 
associated with a combination of SGLT and AQP transporters.  In contrast, the La/Lc total tissue 
glucose transport system in the pig seems to be associated with a combination of SGLTs, AQPs, 
and apical GLUT2 contributing to continuing absorption at higher concentration.   
 
5.2 Introduction 
In the 1960s, the mechanism of glucose transport across the brush-border membrane 
(BBM) of mammalian enterocytes was first proposed (106, 107).  Since then, this model 
developed to include both the entry of glucose through the sodium-dependent glucose transporter 
type 1 (SGLT1) by secondary active transport, followed by exit across the basolateral membrane 
via the facilitative glucose transporter type 2 (GLUT2) (44, 106, 107, 110).  However, 11 more 
sodium-dependent glucose transporters have been identified and characterized that may also 
contribute to glucose movement across the intestinal BBM in addition to SGLT1 (13, 17, 18, 53, 
112, 124).  (13, 17, 18, 53, 112, 124, 204).   
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Generally, it is thought that SGLTs saturated around 30-50mM glucose, reaching their 
maximum transport capacity (105-107, 120, 213).  However, luminal glucose concentrations in 
mammals are often in excess of 50mM (thought to be around 300 – 400mM), especially after a 
meal (105, 120).  Therefore, the luminal glucose concentration will exceed the maximum 
saturation capacity of SGLTs (105, 120, 213).  Thus, this leads to the question of whether SGLT 
transporters are the only ports of glucose entry present along the apical membrane of enterocytes, 
especially when luminal glucose concentrations exceed 30 – 50mM.  
Therefore, the proposed theory of apical glucose absorption was modified to suggest the 
involvement of two components (105, 107, 213). This includes the SGLTs and a diffusive 
component that saturates at higher concentrations than SGLTs (105-107).  This diffusive 
component has been argued to follow different pathways, including a “paracellular solvent drag” 
pathway, and a “GLUT2 translocation” pathway (106, 107, 213).  However, evidence gathered 
was in stronger support of the “GLUT2 translocation” pathway, that suggested GLUT2 was 
responsible for the majority of glucose absorption once luminal glucose concentrations exceeded 
the capacities of SGLTs (107, 213).  This pathway was initiated after SGLT1 reached maximum 
saturation capacity, which then activates protein kinase C βII (PKC βII) that activates 
downstream pathways leading to GLUT2 translocation to the BBM of enterocytes (107, 213).  
Once situated on the apical side, GLUT2 assists in glucose absorption at high luminal glucose 
concentrations (107). However, this has not been confirmed outside of the mouse.  
Aside from GLUT2 possibly being the diffusive component of total glucose absorption, 
other types of transporters may contribute to glucose absorption as well.  These include 
aquaporins (AQPs), which have about 13 members and have recently been suggested to transport 
other types of solutes apart from water (186).  More specifically, aquaporin 9 (AQP 9) in humans 
have been found to transport non-charged solutes like carbamides, polyols, purines, and 
pyrimidines, in addition to their well known ability to transport urea and water (186).  Therefore, 
AQPs may have the ability to transport solutes like glucose, especially when luminal glucose 
concentrations drastically increase.  
Here, we present the mucosal to serosal flux (Jms) of 14C 3-O-Methyl D-glucose (non-
metabolizable form of D-glucose) across the proximal intestinal segments of Nile tilapia, 
rainbow trout, and pig in Ussing chambers. Overall, our data suggest that all species use SGLTs 
and AQPs in the total absorption of glucose, supported by inhibitor and gene expression data. In 
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trout, the data suggests most of the glucose transport occurs through SGLTs.  However, it would 
appear that the pig differs with its low-affinity (La) total glucose absorption system, suggesting 
apical GLUT2 transporter involvement, supported by inhibitor and gene expression analysis. 
Together, there are similarities of total glucose absorption between the aquatic and mammalian 
species, but also drastic differences.     
 
5.3 Materials and Methods  
5.3.1 Maintenance of Animals 
All fish and pigs were maintained in accordance with the guidelines of the Canadian 
Council on Animal Care (CCAC, 2005) (33). All animal protocols were approved by the Animal 
Care Committee at the University of Saskatchewan (AUP#: 19980142 – Fish, 20130034 - Pig).    
 
5.3.1.1 Pigs. Eight 7-9-week-old purebred Yorkshire barrows were obtained from a finishing 
farm. They were housed in pairs in the Animal Care Unit at the University of Saskatchewan, and 
provided with a commercially prepared, non-medicated, pellet starter diet ad libitum.  The 
contents of the feed contained: crude protein (16%), crude fat (2.4%), crude fibre (5%), vitamin 
A (6000 IU/kg), vitamin D3 (900 IU/kg), vitamin E (25 IU/kg), calcium (0.62%), phosphorous 
(0.55%), sodium (0.2%), lysine (0.83%), methionine (0.27%), and threonine (0.58%) (Whole 
Earth Pig Grower, Co-op Feed).     
 
5.3.1.2 Nile Tilapia.  Nile tilapia were obtained from AmeriCulture Inc. (New Mexico, USA) as 
fingerlings.  They were housed in 360L tanks filtered via a biological filtration system.  
Photoperiod was kept constant at 14h light/10h dark, and the water temperature maintained at 27 
± 2oC.  Fish were fed a standard ration of commercial feed by hand twice per day to visual 
satiety.  The contents of the feed contained: crude protein (54%), crude fat (16%), crude fibre 
(1%), vitamin A (15000 IU/kg), vitamin D3 (5000 IU/kg), vitamin E (400 IU/kg), calcium 
(2.3%), phosphorous (1.5%), and sodium (0.2%) (EWOS).  The average weight of fish at the 
time of study was 700 grams.   
 
 107 
 
5.3.1.3 Rainbow Trout.  Triploid female rainbow trout were obtained from Wild West 
Steelhead (Lucky Lake, Saskatchewan, CA).  The fish were housed in standard 1000-4000L 
density tanks, provided with biologically-filtered recirculation systems. They were housed in 
municipal, dechlorinated water at temperatures between 11 ± 2oC, with a photoperiod at 12h 
light/12h dark.  They were fed a standard ration of commercial feed at 2-5% of their body 
weight.  The contents of the feed contained: crude protein (53%), crude fat (20%), crude fibre 
(1%), vitamin A (15000 IU/kg), vitamin D3 (5000 IU/kg), vitamin E (300 IU/kg), calcium 
(2.3%), phosphorous (1.6%), and sodium (0.2%) (EWOS).  At the time of study, the average 
weight of fish used was 300 grams.   
 
5.3.2 Ex-vivo Tissue Collection 
5.3.2.1 Tilapia and Trout.  Fish were euthanized by blunt trauma to the head and the entire 
intestinal section was dissected out of both fish.  In Nile tilapia, its intestinal section was 
separated to obtain proximal intestinal tissue (2 inches distal from the stomach).  In rainbow 
trout, the intestine was separated to obtain the midgut section (located right after the pyloric 
caeca, 2 inches from the stomach).   
5.3.2.2 Pig.  Pigs were euthanized and the entire gastrointestinal section was removed for further 
dissections.  The intestine was separated to obtain sections of the jejunum, which was obtained 
18 inches distal from the stomach.     
 
5.3.3 Electrophysiology  
5.3.3.1 Ussing Chamber technique.  The fish intestinal sections (tilapia proximal intestinal and 
trout midgut) were examined in Ussing chambers using techniques adapted from this group (125, 
126, 164, 182).  The Ussing chamber system used in this study was an EasyMount Ussing 
Chamber System (Physiologic Instruments Inc., San Diego, CA).  Sections were washed in 
teleost saline: 118mM NaCl, 2.9mM KCl, 2.0mM CaCl2·2H2O, 1.0mM MgSO4·7H2O, 0.1mM 
NaH2.PO4·H2O, 2.5mM Na2HPO4 and 1.9mM NaHCO3 at pH 7.9 (63).  This physiological buffer 
was used for both tilapia proximal intestine and trout midgut.  No glucose was added to the 
buffer.  The lumen of the intestine for both fish was also washed with buffer using an 18gage 
needle, to clean the luminal membrane of any residual chyme.   
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The pig intestinal section (jejunum) was examined in Ussing chambers similarly as described 
for the fish.  The jejunal segment was placed in Krebs buffer containing: 114mM NaCl, 5mM 
KCl, 2.15mM CaCl2·2H2O, 1.1mM MgCl2·6H2O, 0.3mM NaH2.PO4·H2O, 1.65mM Na2HPO4 
and 25mM NaHCO3 at pH 7.4, similar to the buffer used in a mice study done by Clarke (40).  
No glucose was added to the buffer.  The lumen of the intestine was washed with buffer using an 
18gage needle to clean the luminal membrane of any residual chyme.  The muscularis mucosal 
layer was also stripped from the intestine prior to mounting.   
The dissected tissue sections were exposed as a flat sheet between two sliders of inserts.  The 
available tissue area for tilapia and trout was constant and equal to 0.3 cm2 (Slider Number: 
P2304, Physiologic Instruments Inc., San Diego, CA).  The available tissue area for pig intestinal 
tissue was 1cm2 (Slider Number: P2314, Physiologic Instruments Inc., San Diego, CA).  For 
trout and tilapia, the teleost saline buffer solutions bathing the apical and basal sides of the 
intestine had a buffer volume of 5ml, and were continuously gassed throughout the experiment 
with 1% CO2 and 99% O2 for the fish (40).  For the pig jejunum sections, the Krebs buffer 
solution bathing the apical and basal sides of the intestine had a buffer volume of 5ml, and were 
continuously gassed throughout the experiment with  5% CO2 and 95% O2 (40).   
The transepithelial voltage and passing current set across the tissue was measured via agar 
bridges and Ag/AgCl reference electrodes.  These electrodes were connected to leads that lead to 
the voltage/current clamp.  The pulse was kept constant at 0.001V.  A recirculating bath capable 
of chilling and heating controlled the temperature of the jacketed chambers, with tissues 
examined at fish housing temperatures.  The temperature used was matched to housing 
temperature for fish and body temperature for pigs; tilapia was 25oC-26oC, trout was 11oC-12oC, 
and pigs was 36-37oC.  Needle valves were also present for the adjustment of gas flow into the 
chambers.   
Once mounted, the intestinal sections were allowed to reach a steady baseline current for 30-
40 minutes, followed by addition of 1µCi of 14C-3-O-Methyl D-glucose and 1µCi 3H-inulin to 
the apical side of the intestinal tissues.  An initial 100uL “hot” sample was taken from the apical 
(“hot”) side for 14C-3-O-Methyl D-glucose and 3H-inulin.  An isotope equilibration period was 
performed after, with a 70 minute time period for tilapia and trout, and a 60 minute time period 
for pig.  Following the isotope equilibration period, a non-labeled D-glucose gradient from 1mM 
to 8000mM was used to assess saturation of transport, with equivalent amounts of non-labeled 
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D-mannitol additions to the basal side to control for osmotic drift.   3H-inulin was used as a 
control to measure tissue integrity through the duration of the experiment.  After every increment 
of D-glucose, there was a wait period of 10 minutes after which a 500µL sample was taken from 
the basolateral/ “cold” side.  The radioactive samples were placed into 6mL liquid scintillation 
vials (LSVs) that contained 4.3mL of UltimaGold cocktail solution (PerkinElmer®, Waltham, 
MA).  The radioactive samples were counted in a Beckman scintillation β-counter for 14C and 3H 
emission (PerkinElmer®, Waltham, MA).   
 
5.3.4 Chemicals.  For pharmacological characterization, 0.000001mM, 0.00001mM, 0.0001mM, 
0.001mM, 0.01mM, 0.1mM, 0.2mM, and 0.3mM of dapagliflozin (AdooQ® Bioscience, Irvine, 
CA), followed by 0.001mM, 0.01mM, 0.1mM, 1mM, and 2mM of phloridzin dihydrate 
(AdooQ® Bioscience, Irvine, CA), followed by  1mM, 2mM, 3mM, 4mM, and 5mM of 
phloretin (AdooQ® Bioscience, Irvine, CA), followed by 1mM, 2mM, 3mM, 4mM, and 5mM 
tetraethyl ammonium (TEA) (Sigma-Aldrich Co., St. Louis, MO), and finally with 1mM, 2mM, 
3mM, 4mM, and 5mM nickel chloride (NiCl2) (FisherScientific Ottawa, Ontario) were used in 
sequential order in the Ussing Chamber as final concentrations.  The inhibitors were added to the 
apical side once D-glucose and D-mannitol concentrations in the chambers reached 8000mM.   
 
5.3.5 Radioisotopes.  1µCi of 14C-3-O-Methyl D-glucose (non-metabolizable analogue of 
glucose) and 1µCi of 3H-inulin, obtained from PerkinElmer® (Waltham, MA) were used. 
 
5.3.6 RNA extraction and cDNA synthesis using RT-PCR.  Approximately 1mg samples of 
tissue were obtained from the dissection of the intestinal tract, and stored in RNAlater® RNA 
Stabilization Solution at -80oC.  RNA was isolated using the TRIzol reagent, and cDNA was 
synthesized through reverse transcription PCR using the qScript™ cDNA SuperMix (Quanta 
Biosciences, Maryland, USA).  The reaction was run as: incubation for 5 minutes at 25oC, then 
30 minutes at 42oC, and the final 5 minutes at 85oC.  The cDNA samples were stored at -80oC 
for subsequent use in quantitative PCR. 
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5.3.7 Genomic Identification of SLC5A Genes.  A detailed BLAST+ (Basic Local Alignment 
Search Tool) application was used to identify all of the annotated GLUT2 transporters in both 
tilapia, trout, and pig.  The human GLUT2 transporter sequence retrieved from the National 
Center for Biotechnology Information (NCBI) website (http://www.ncbi.nlm.nih.gov/) were used 
in a “blastn” command to search for similar mRNA sequences in the tilapia, trout, and pig 
genome (204).  The expect value (e-value) was used to assess the significance of the match, 
where an e-value close to zero was considered significant and an e-value higher than 10^-15 was 
considered as a non-significant match.  Once GLUT2 transporters were identified from tilapia, 
trout, and pig, phylogenetic trees were generated using the alignment program CLUSTAL W and 
MEGA7 (www.megasoftware.net) software. 
 
5.3.8 Gene transcript expression levels by quantitative polymerase chain reaction.   
Quantitative PCR was performed on the RT-PCR reaction using the GoTaq®qPCR 
Master Mix containing SYBR®Green1 (Promega, Madison USA).  The BioRad QPCR system 
was used to perform these reactions.  The total volume of the PCR reaction was 12.5µL.  A total 
of 40 cycles of qPCR was performed, with each cycle consisting of GoTaq® Hot Start 
Polymerase activation at 95oC for 2 minutes, and then denaturation at 95oC for 15 seconds, 
followed by annealing/extension at the primer’s hybridization temperature (59oC) for 1 minute.  
The dissociation step was at 60-95oC.   Serial dilutions of cDNA were also used to generate a 
standard curve for each target gene, where the efficiency of each primer was calculated.  The 
efficiencies for the tilapia, trout, and pig primers ranged from 1.9-2.1.  Tilapia, trout, and pig 
EFα1 (α-elongation factor 1) was used as the house-keeping gene, and was used to normalize the 
relative mRNA expression levels of GLUT2 for each species.  The method of analysis used to 
represent the relative expression levels was calculated using delta CT, where the amount of the 
gene of interest was normalized to the amount of EFα1 in that sample (173). 
 The primers for pig, trout, and tilapia were designed using the Integrated DNA Technologies 
website (https://www.idtdna.com/site), where the sequences and their accession numbers are 
presented in Table 5.1.   
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Table 5.1 Nile Tilapia, Rainbow Trout, and Pig Primer Sequences used for quantitative 
PCR 
 
 
 
 
 
 
 
 
 
 
 
 
Species Gene Forward Primer (5`-3`) Reverse Primer (5`-3`) 
Accession 
Number 
 
Nile 
Tilapia 
GLUT2 CCTCCTTCTTGGTTGGATTT CAGACGTCAGACCACAATAG XM_003442884.5 
 EFα1 CTCTTCTACCGTCGGATTAC ATTGACTCCCTCGTAGAAAC XM_005476483.3 
     
 
Rainbow 
Trout 
GLUT2 CAACCATTGGAGTAGGAGTTC ACATAGGACATCCAGGAGTAG XM_021610908.1 
 EFα1 AGCGAGCTCAAGAAGAAG GACCAAGAGGAGGGTATTC NM_001124339.1 
     
 
Pig 
 
GLUT2 GGACTTGTGCTACTGGATAA CGTGGTCCTTGACTGAAA NM_001097417.1 
 EFα1 GCGAGTGGGATTCTGTTA GGTGCCTGTCATCTTCTT XM_013987376.1 
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5.3.9 Statistical Analyses.  The mucosal to serosal flux (Jms) of 3-O-Methyl-D-Glucose was 
calculated from the protocol adapted from Schultz et al. (174).  The 14C and 3H emissions from 
the 500µL cold samples taken after each concentration increment and inhibitor concentration 
were recorded as counts per minute (cpm).  The Jms was calculated as follows: 
Equation 5.1 
ΦmsC (Jms) = νs(ps2 – cps1)/(Δtpm*A) 
ps = cpm/cm
3 in the serosal reservoir 
νs = volume of buffer in the serosal side in cm3 
A = area of tissue exposed 
Δt = time interval between samples in hours 
pm* = specific activity of 
14C-3-O-methylD-glucose in the mucosal solution in cpm/µmol 
ΦmsC = unidirectional 14C flux from mucosa to serosa in µmol/cm2/hour  
Vmax (represented in µmol/cm2/hr) and Km (represented in mM) values were determined 
for each species’ intestinal sections using GraphPad Prism 8 (GraphPad Software, Inc.).  All 
three sections followed Michaelis-Menten kinetics (F-test with Sigmoidal/Hill fit, P < 0.05 for 
Michaelis-Menten fit), where the equation for Michaelis-Menten is: 
Equation 5.2 
Michaelis-Menten fit: Y = Vmax*X/(Km + X) 
A 1-way ANOVA was performed between each species to determine significant 
differences between Vmax and Km values.  All data met parametric assumptions, being normally 
distributed and exhibited homogeneity of variance so ANOVA analyses were used.  After 
ANOVA, pairwise comparisons were made using Tukey’s posteriori tests, as appropriate.  A P < 
0.05 was considered significantly different.  The percentage increase of Jms from the 50mM 
increment to the 5-8M increments were calculated for each species, and a 1-way ANOVA was 
performed to determine significance between the compared increments.  After ANOVA, 
pairwise comparisons were made using Tukey’s posteriori tests, as appropriate.  A P < 0.05 was 
considered significantly different.   
For the inhibitors, the percent activity remaining was calculated from the division of the 
last previous drug increment (the concentration where the transporter is 100% un-inhibited by 
that specific inhibitor) and the resultant drop in mucosal to serosal flux (Jms) from the addition 
of each drug concentration.  Parametric 1-way ANOVA’s were performed between the 100% 
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and each drug response to determine significance.  After ANOVA, pairwise comparisons were 
made using Tukey’s posteriori tests, as appropriate.  Again, P < 0.05 was considered significant.  
The Ki values for the inhibitor responses were calculated using the “One-Site Fit long IC50” 
from GraphPad Prism 8 (GraphPad Software, Inc.).  This fit follows the equation: Y = Bottom + 
(Top-Bottom)/(1+10(X-LogIC50)).  Student’s t-test were performed to determine significance 
between Ki values for that inhibitor between species.   
For the qPCR analyses, relative expressions were determined by the BioRad system, 
where the threshold cycle was established using the housekeeping gene, EFα1.  A 1-way 
ANOVA (one factor: species) was conducted on the gene expressions.  After ANOVA, pairwise 
comparisons were made using Tukey’s posteriori tests, as appropriate.  A P < 0.05 was 
considered significant.  All statistical analyses were performed on SigmaPlot (Systat Software 
Inc., San Jose, CA).  
 
5.4 Results 
5.4.1 Kinetic Characterization of 14C 3-O-Methyl D-glucose in Nile Tilapia, Rainbow Trout, 
and Pig 
In tilapia, trout, and pig, the mucosal to serosal flux (Jms) of 14C 3-O-Methyl D-glucose 
was measured in Ussing chambers, and followed Michaelis-Menten kinetics in all three species.  
Tilapia demonstrated a significantly higher capacity (higher Vmax) of glucose flux compared to 
trout and pig (Table 5.2 and Figure 5.1; P < 0.001).  There were no significant differences in 
Vmax values between trout and pig, indicating similar capacities in overall whole tissue glucose 
absorption.  However, the Km value in pig was significantly higher (over 400 fold) compared to 
tilapia and trout, with no significant differences between tilapia and trout Km values (Table 5.2 
and Figure 5.1; P < 0.001).  The higher Km value in pig suggests an overall dominating low-
affinity glucose transport system.  Altogether, the kinetic values present a Ha/Hc total glucose 
transport system in tilapia, a Ha/Lc total glucose transport system in trout, and a La/Lc total 
glucose transport system in the pig (Table 5.2).   
Finally, the percentage increase of Jms in response to glucose increments was assessed in 
each species (Figure 5.1D).  No significant differences in Jms increase occurred for tilapia and 
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trout, but significant increases from 50mM to 5000, 6000, 7000, and 8000mM were observed for 
pig (above 300%; Figure 5.1D, P < 0.001).   
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Table 5.2 Vmax and Km Values for Nile Tilapia, Rainbow Trout, and Pig 
 
Vmax (µA) and Km (mM) values represented for Nile Tilapia, rainbow Trout, and pig.  Area of 
intestinal segment was 0.3cm2 for both fish and 1cm2 for pig.  Data are presented as means ± 
SEM.  Significant differences for Vmax values found between species: A, Nile Tilapia vs. B, 
rainbow Trout, and A, Nile Tilapia vs. B, Pig, with no significant differences between rainbow 
Trout and pig (Tukey’s test after 1-way ANOVA, P < 0.05).  Significant differences for Km 
values found between species: A, Nile Tilapia vs. B, Pig, and A, rainbow Trout vs. B, Pig, with 
no significant differences between Nile Tilapia and rainbow Trout (Tukey’s test after 1-way 
ANOVA, P < 0.05).   
 
 
 
 
 
 
 
 
 
 
 
 
Species Intestinal Section 
Vmax ± SEM 
(µmol/cm2/hr) 
Km ± SEM 
(mM) 
Nile Tilapia Proximal Intestine 0.009 ± 0.001A 1.6 ± 0.4A 
Rainbow Trout Midgut 0.002 ± 0.0003B 3.3 ± 0.7A 
Pig Jejunum 0.004 ± 0.0005B 1561.4 ± 185.6B 
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Figure 5.1 Kinetics of total tissue glucose absorption in tilapia, trout, and pig. 
Michaelis-Menten kinetics for mucosal to serosal (Jms) 3-O-Methyl D-glucose flux for A) tilapia 
proximal intestine (Fish N = 15) with Vmax and Km represented for illustration, B) trout midgut 
intestinal section (Fish N = 17) with Vmax and Km represented for illustration, and C) pig 
jejunum (Pig N = 6) with Vmax and Km represented for illustration.  D) The percentage increase 
of Jms for the represented concentration comparisons between species.  Single asterisk 
represents significant differences for those concentration comparisons within pig (1-Way 
ANOVA, P < 0.05).  Data are represented as means ± SEM. 
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5.4.2 Inhibition of Whole Intestinal Tissue Glucose Flux 
 A series of inhibitors for sodium-dependent glucose transporters (SGLTs), glucose 
transporter type 2 (GLUT2), and aquaporins (AQPs) were used in succession to inhibit total 
glucose flux across the intestinal segments of tilapia, trout, and pig.  Dapagliflozin, specific for 
sodium-dependent glucose transporter type 2 (SGLT2), and phloridzin dihydrate, specific for 
sodium-dependent glucose transporter type 1 (SGLT1) were both used cumulatively to inhibit 
SGLTs (116, 143, 170).  Phloretin is an inhibitor specifically for the GLUT2 transporter, and 
tetraethylammonium (TEA) and nickel (II) chloride (NiCl2) inhibit aquaporins (50, 107, 211).  
The cumulative addition of each inhibitor was in the order of dapagliflozin, phloridzin dihydrate, 
phloretin, TEA, and NiCl2 after glucose flux reached 8000mM in all three species.  A dose 
response was performed for each inhibitor.  Figures 5.2, 5.3, and 5.4 illustrate the percent 
activity remaining after successive addition of each inhibitor in each species.   
 
5.4.2.1 Nile tilapia Flux inhibition 
 Tilapia had significant inhibition with dapagliflozin from 0.001 to 0.3mM, with about 
60% activity remaining by 0.3mM dapagliflozin (Figure 5.2A, P < 0.05).  Similarly, significant 
inhibition was observed with phloridzin dihydrate, with about 70% activity remaining by the 
2mM concentration (Figure 5.2B, P < 0.05).  Following phloridzin dihydrate, phloretin did not 
reveal significant inhibition with any of its concentrations (Figure 5.2C).  However, TEA did 
reveal significant inhibition at 3mM and 5mM concentrations (Figure 5.2D, P < 0.05).  At the 
3mM and 5mM TEA inhibitor concentrations, about 70% activity remained (Figure 5.2D).  
Finally, NiCl2 did not reveal significant inhibition at any concentrations (Figure 5.2E).  A 
significant difference between the Ki value of NiCl2 was observed between tilapia and pig (Table 
5.3, P < 0.05).  
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Figure 5.2 Pharmacological inhibition in tilapia. 
Percent activity remaining of Jms in Nile tilapia by A) dapagliflozin (0.000001, 0.00001, 0.0001, 
0.001, 0.01, 0.1, 0.2, and 0.3mM) (Fish N = 11), followed by addition of B) phloridzin dihydrate 
(0.001, 0.01, 0.1, 1, and 2mM) (Fish N = 14), followed by C) phloretin (1, 2, 3, 4, and 5mM) 
(Fish N = 8), followed by D) tetraethylammonium (1, 2, 3, 4, and 5mM) (Fish N = 9), and finally 
by E) NiCl2 (1, 2, 3, 4, and 5mM) (Fish N = 6).  Single asterisks represent significance from 
100% (where 100% represents transport is 100% un-inhibited by that inhibitor), which is 
presented as the dotted line (1-way ANOVA, P < 0.05). 
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Table 5.3 Ki Values for Nile Tilapia, Rainbow Trout, and Pig 
 
Ki (mM) values represented for Nile Tilapia, rainbow Trout, and pig.  Data are presented as 
means ± SEM.  Different letter superscripts indicate significances for NiCl2: A, Nile tilapia vs. 
B, pig (Student’s t-test, P < 0.05).  ND represents non-detectable data. 
 
 
Species Inhibitor Ki ± SEM (mM) 
Nile Tilapia Dapagliflozin 0.007 ± 0.002 
 Phloridzin Dihydrate 1.2 ± 0.7 
 Phloretin 4.7 ± 1.0 
 Tetraethylammonium (TEA) 4.5 ± 1.5 
 Nickel Chloride (NiCl2) 4.7 ± 1.1
A 
Rainbow Trout Dapagliflozin nd 
 Phloridzin Dihydrate nd 
 Phloretin nd 
 Tetraethylammonium (TEA) nd 
 Nickel Chloride (NiCl2) nd
 
Pig Dapagliflozin 0.004 ± 0.001 
 Phloridzin Dihydrate 0.5 ± 0.3 
 Phloretin 3.6 ± 1.6 
 Tetraethylammonium (TEA) 6.1 ± 2.0 
 Nickel Chloride (NiCl2) 1.6 ± 0.7
B 
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5.4.2.2 Rainbow Trout Flux inhibition  
 No significant inhibition was observed for dapagliflozin, phloridzin dihydrate, phloretin, 
TEA, and NiCl2 (Figure 5.3A, B, C, D, and E).  Additionally, no Ki values were detected for any 
of the inhibitors (Table 5.3). 
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Figure 5.3 Lack of pharmacological inhibition in trout. 
Percent activity remaining of Jms in rainbow trout by A) dapagliflozin (0.000001, 0.00001, 
0.0001, 0.001, 0.01, 0.1, 0.2, and 0.3mM) (Fish N = 12), followed by addition of B) phloridzin 
dihydrate (0.001, 0.01, 0.1, 1, and 2mM) (Fish N = 9), followed by  C) phloretin (1, 2, 3, 4, and 
5mM) (Fish N = 15), followed by D) tetraethylammonium (1, 2, 3, 4, and 5mM) (Fish N = 13), 
and finally by E) NiCl2 (1, 2, 3, 4, and 5mM) (Fish N = 5).  The 100% represents transporter is 
100% not inhibited by that inhibitor, which is presented as the dotted line. 
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5.4.2.3 Pig Flux inhibition 
 Dapagliflozin revealed significant inhibition from 0.0001mM to 0.3mM concentrations, 
with about 50% activity remaining at 0.3mM (Figure 5.4A, P < 0.05).  Similarly, phloridzin 
dihydrate revealed significant inhibition from 0.01mM to 2mM concentrations, demonstrating 
about 60% activity remaining at 2mM phloridzin dihydrate (Figure 5.4B, P < 0.05).  In contrast 
to tilapia, pig revealed significant inhibition with phloretin, from 3 to 5mM (Figure 5.4C, P < 
0.05).  Additionally, about 70% activity remained with phloretin at 5mM (Figure 5.4C).  Both 
TEA and NiCl2 revealed significant inhibition, with TEA demonstrating inhibition at 
concentrations from 3mM to 5mM, leaving about 50-60% activity remaining (Figure 5.4D, P < 
0.05).  The inhibitor NiCl2 revealed significant responses at 1mM and 5mM, yielding about 70-
75% activity remaining (Figure 5.4E, P < 0.05).  A significant difference between the Ki value of 
NiCl2 was observed with tilapia (Table 5.3, P < 0.05).  
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Figure 5.4 Pharmacological inhibition in pig. 
Percent activity remaining of Jms in pig by A) dapagliflozin (0.000001, 0.00001, 0.0001, 0.001, 
0.01, 0.1, 0.2, and 0.3mM) (Pig N = 6), followed by addition of B) phloridzin dihydrate (0.001, 
0.01, 0.1, 1, and 2mM) (Pig N = 5), followed by C) phloretin (1, 2, 3, 4, and 5mM) (Pig N = 4), 
followed by D) tetraethylammonium (1, 2, 3, 4, and 5mM) (Pig N = 4), and finally by E) NiCl2 
(1, 2, 3, 4, and 5mM) (Pig N = 4).  Single asterisks represent significance from 100% (where 
100% represents transport is 100% un-inhibited by that inhibitor), which is presented as the 
dotted line (1-way ANOVA, P < 0.05). 
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5.4.3 Genomic and Gene Expression Analysis 
The GLUT2 (SLC2A2) transporter was identified for tilapia, trout and pig genome using 
the BLAST+ application (Table 5.1).  The expression levels of GLUT2 were compared among 
the different species using quantitative real-time PCR. 
 Pig revealed significantly higher GLUT2 expression (over 100 fold higher) compared to 
tilapia and trout (Figure 5.5A, P < 0.05).  The significantly higher GLUT2 expression in pig 
jejunum is supported by its kinetic characterization and the inhibitor response of phloretin.  Both 
tilapia and trout had similar expression of GLUT2 (Figure 5.5A).  The low expression of GLUT2 
in tilapia was supported by the kinetic characterization and the lack of inhibition by phloretin 
(Figure 5.2C).  Sequence similarities of GLUT2 between tilapia, trout, and pig were compared in 
a phylogenetic tree (Figure 5.5B).  In a CLUSTAL W analysis, the nucleotide identity of GLUT2 
was compared between the three species, and relative to tilapia GLUT2 (SLC2A2) were 70% 
GLUT2 (SLC2A2) in trout, and 62% GLUT2 (SLC2A2) in pig.  Sequence similarities of AQPS 
in tilapia, trout, and pig were compared in a phylogenetic tree as well (Figures 5.6A, B, and C).  
It revealed the number of AQPs present in each species, possibly suggesting contribution of 
these transporters to total glucose flux.   
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Figure 5.5 Genomic and gene expression analyses in tilapia, trout, and pig. 
A) Relative expression levels of GLUT2 transporters in Nile tilapia proximal intestine (N = 10), 
rainbow trout midgut intestinal section (N = 10), and pig jejunum (N = 10) using quantitative 
PCR.  Expression levels were normalized against EFα1 housekeeping gene.  Asterisk represents 
significance between species (1-way ANOVA, P < 0.05).  B) Phylogenetic tree of GLUT2 in 
each species.  The alignment program CLUSTAL W and the phylogenetic display program 
MEGA7 were used to generate the tree.   
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Figure 5.6 Genomic analyses of AQPs in tilapia, trout, and pig. 
A) Phylogenetic tree of AQPs in tilapia.  B) Phylogenetic tree of AQPs in trout.  C) Phylogenetic 
tree of AQPs in pig.  The alignment program CLUSTAL W and the phylogenetic display 
program MEGA7 were used to generate the tree.   
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5.5 Discussion 
For the first time, we characterized the total tissue glucose transport systems in tilapia, 
trout, and pig, using a D-glucose gradient ranging from 1mM to 8000mM.  Along with inhibitor 
and genomic analyses, we demonstrate SGLT involvement and the potential involvement of 
AQPs that may contribute to glucose absorption in all species.  Additionally, important species 
differences between the mammalian pig and the aquatic species here suggest apical GLUT2 
transporter involvement in the pig, but not in tilapia and trout.  It would appear apical GLUT2 
transporter involvement likely contributes to continued glucose absorption above the capacity of 
SGLTs. 
 
5.5.1 Ha/Hc Tilapia, Ha/Lc Trout and La/Lc Pig total glucose transport systems 
Kinetic characterization of total intestinal glucose absorption between tilapia, trout, and 
pig revealed an overall Ha/Hc transport system in tilapia, a Ha/Lc transport system in trout, and a 
La/Lc transport system in pig (Table 5.2).  The Hc transport in tilapia is similar to the Hc 
sodium-dependent glucose transport system (~47µA/cm2; data presented in Chapter 1), which 
has a higher Vmax value compared to sodium-dependent glucose transport in trout (~1.7µA/cm2; 
data presented in Chapter 1).  This suggests the majority of glucose transport in tilapia is 
predominantly through sodium-dependent glucose transporters.  However, the affinity for total 
glucose absorption is similar between both aquatic species presented here, suggesting similar 
transporters may be responsible in both species. The high Km values for tilapia and trout in the 
millimolar range indicate that transporters involved in total glucose absorption are generally high 
affinity. Even though tilapia exhibits a higher Vmax value for glucose flux, both tilapia and trout 
demonstrate saturation of glucose transport around 50mM glucose (Figures 5.1A and B, and 
Table 5.2).  This is further emphasized as a lack of percentage increase in Jms after 50mM 
glucose for both aquatic species (Figure 5.1D).   
The low saturation of the transporters in both fish species could have evolved due to the 
lower use of glucose by fish species, previously described (82, 151).  This is particularly true for 
carnivorous fish like rainbow trout, where glucose use is not the primary energy source 
compared to omnivorous fish and mammals (121, 161).  This is reflected by the lower Vmax in 
total glucose absorption in trout compared to tilapia.  It has also been demonstrated in 
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omnivorous fish like the black bullhead catfish that glucose usage is lower than mammals, which 
may also be true for the omnivorous tilapia (110, 161).   Therefore, the possibility of apical 
GLUT2 absorption for tilapia and trout may not exist or is not needed.  The low saturation of the 
transporters in both aquatic species, as well as the very low Km values in comparison to the pig, 
support this notion.  
 In contrast, the pig total glucose transport is a La/Lc total glucose absorption system, with 
a Km in the molar range that is over 400 fold higher than both tilapia and trout (Table 5.2).  This 
very low-affinity for total glucose transport has been similarly described in other mammals, such 
as mice and rats (107).  This system was attributed to apical GLUT2 insertion that allowed for 
higher glucose absorption, thus increasing the overall Km value of total glucose transport (106, 
107, 192).   However, the Km values for GLUT2 reported in these studies ranged from 17mM to 
56mM, and were dependent on the glucose range and techniques used (44, 107).  These Km 
values are over 20 fold lower than the Km value presented in this study, possibly due to 
differences in techniques such as glucose range, type of assay, and species used (rodents versus 
pig) (107).  The total glucose transport in the pig which continued after 50mM glucose, in 
comparison to tilapia and trout, exhibited a significant percentage increase of Jms at the higher 
concentrations (Figure 5.1D).  Therefore, the presence of apical GLUT2 transporters may 
explain the higher saturation of total glucose transport present in the pig, shifting the Km value 
away from SGLTs. The presence of GLUT2 was supported by pharmacological inhibition.   
 
5.5.2 Inhibition of Glucose Flux defines Different Transport Mechanism between Species 
Inhibitor responses from dapagliflozin, phloridzin dihydrate, phloretin, TEA, and NiCl2 
demonstrated differences between the aquatic species here and the mammalian pig (Figures 5.2, 
5.3, and 5.4).  Dapagliflozin and phloridzin dihydrate in tilapia defined the involvement of 
SGLTs for total tissue glucose absorption (Figures 5.2A and B).  This has been similarly 
demonstrated in a previous study that focused on sodium-dependent glucose transport in tilapia 
and found inhibition with both dapagliflozin and phloridzin (180).  Since most of inhibition was 
achieved by SGLT inhibitors, it suggests that majority of transport in tilapia is through SGLTs.  
Additionally, the lack of phloretin response in tilapia suggests a lack of GLUT2 involvement 
with total glucose absorption (Figure 5.2C).  However, significant inhibition with TEA, but less 
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than the SGLT inhibitors in tilapia suggests the possible involvement of AQPs. Transport 
through AQPs may explain the Michaelis-Menten kinetics observed in this study, where the Km 
of AQPs for glucose may sit between the two previously described SGLTs associated with the 
electrogenic transport in tilapia (see Chapter 1).  In contrast, trout did not exhibit any significant 
responses to any of the inhibitors (Figure 5.3).  The lack of significant inhibition to total tissue 
glucose absorption in trout may be due to the low temperature used to conduct the flux 
experiments (~11-12oC), some of which have been previously described (180).  These low 
temperatures may have hindered the effects of the inhibitors that have previously been used on 
mammalian systems (temperatures ~ 37oC), thus producing no measurable effect on trout total 
glucose absorption (Figure 5.3).   
Similarly to tilapia, the pig responded to inhibition by dapagliflozin and phloridzin 
dihydrate, indicating the involvement of SGLTs in total tissue glucose absorption (Figures 5.4A 
and B).  However, in contrast to tilapia and trout, significant inhibition with phloretin was 
observed. GLUT2 phloretin sensitivity has been shown in rat jejunum and Xenopus laevis oocyte 
expression systems (81, 106, 189, 213).  This supports GLUT2 involvement in the pig, giving 
insight into the large shifted Km in comparison to the aquatic species here.  Additionally, it was 
found that SGLT1 was not sensitive to phloretin, further supporting the fact that GLUT2 
transporters may be present in pig jejunum (107, 120).  Finally, the AQP inhibitors, TEA and 
NiCl2, were found to produce significant inhibition, suggesting that AQPs are involved in total 
tissue glucose absorption in the pig (Figures 5.4D and E) (50, 211).  Similar to tilapia, the lack of 
sigmoidal kinetic fit in the pig may be attributed to AQP transport with a Km that is between 
previously described SGLT transporters (see Chapter 2).   
 The involvement of AQPs in both tilapia and pig to total tissue glucose absorption is 
plausible as AQPs are known to have substrate transport promiscuity of AQPs (50, 186).  It was 
demonstrated in human AQP isoform 9 (AQP9) that in addition to transporting water and urea, it 
could also transport non-charged solutes such as carbamides and polyols (186).  Other 
researchers have defined AQPs as aqua-glycerol-porins, that allow passive diffusion of other 
solutes in addition to water (50).  Therefore, given the response to TEA and NiCl2, AQPs 
contributing to total tissue glucose absorption in tilapia and pig is plausible.  
 
5.5.3 Gene Expression support a dominant GLUT2-transporter involvement in Pig 
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Genomic and gene expression analysis of GLUT2 in all three species revealed 
significantly higher GLUT2 expression in the pig, compared to tilapia and trout (Figure 5.5A).  
This result supports the kinetic and inhibitor analyses in the pig, suggesting a large contribution 
of GLUT2 to total glucose absorption.  This plausible GLUT2 contribution to total glucose 
absorption may indicate that the pig also has a GLUT2 apical translocation mechanism, which 
has been shown previously to assist with high glucose absorption in mice and rats (106, 107).  In 
addition to GLUT2 transporters, the pig jejunum also involves SGLT and AQP transporters, 
based on the responses to the inhibitors.  In the pig jejunum, SGLT1 (SLC5A1) and SGLT3 
(SLC5A4) may contribute to the La/Lc total tissue glucose transport system (Chapter 2).  
Additionally, 12 AQPs members have been identified in the pig genome, some possibly 
contributing to overall glucose flux in the pig (Figure 5.6C).     
In contrast, the low expression of GLUT2 in both fish species is supported by the kinetic 
and inhibitor analyses (in tilapia), suggesting a lack of apical GLUT2 contribution to total 
glucose absorption.   Thus, the SGLTs are likely responsible for the majority of transport, which 
have been identified in Chapter 1.  Therefore, for tilapia, possible SGLT1 (SLC5A1) and SMIT2 
(SLC5A11) transporters may contribute to the overall Ha/Hc total tissue glucose transport 
system, and SGLT1 (SLC5A1) in trout may contribute to the overall Ha/Lc total tissue glucose 
transport system (Chapter 1) (180).  Interestingly in tilapia, responses to the AQP inhibitors 
suggest the possible involvement of AQPs contributing to total tissue glucose absorption, 
possibly shifting the kinetic fit from a sigmoidal/Hill to Michaelis-Menten.   With a phylogenetic 
analysis, AQPs were identified in both tilapia and trout, with 9 members identified in tilapia and 
10 members identified in trout, possibly suggesting AQPs may contribute to overall glucose flux 
(Figures 5.6A and B).    
 
5.6 Conclusion 
Total tissue glucose flux presents a Ha/Hc total glucose transport system in tilapia, a 
Ha/Lc total glucose transport system in trout, and a La/Lc total glucose transport system in pig.  
The Ha/Hc total glucose transport system in tilapia is most likely attributed to SGLTs, with some 
AQP contribution, and lack of apical GLUT2 involvement. The Ha/Lc total glucose transport 
system in trout is most likely attributed to SGLTs, given similarities to the electrogenic kinetics 
(Chapter 1).  In contrast, the pig jejunum is a La/Lc total glucose transport system, which may be 
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attributed to SGLTs, GLUT2, and AQP transporters.  Given these differences in transporter 
involvement, this study demonstrates continued glucose absorption at higher concentrations in 
the mammalian pig, whereas this is not observed in the aquatic tilapia and trout species. These 
transport mechanisms observed in the mammalian pig may be an evolutionary adaptation 
different from fish, which may not be exposed to a diet high enough in free glucose to allow non-
facilitative glucose absorption.   
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Chapter 6 – General Discussion 
 
6.1 Implications  
Overall, we characterized sodium-dependent and total tissue glucose transport kinetic 
systems in the mammalian pig (omnivore), the omnivorous tilapia, and the carnivorous trout. We 
found that the transport mechanism for glucose is different between species.  We assume that 
these differences exist to meet the specific needs of that species, depending on many factors such 
as environmental influences and their natural diets.  
 Specifically, in chapter 3, we discovered different kinetic sodium-dependent glucose 
transport systems between tilapia and trout, which has not been previously characterized or 
compared.  Overall, we demonstrated that electrogenic sodium-dependent glucose transport was 
much higher in tilapia than trout, which was not surprising as tilapia is an omnivorous fish with 
higher amounts of carbohydrates in its natural diet.  However, we also demonstrated that trout 
can absorb high concentrations of glucose, especially in its hindgut intestinal section, which is 
interesting as they are known to be poorly tolerant of high carbohydrate levels in their diet (69).  
Finally, the hindgut glucose absorption that exists in both fish species is different from 
mammals, where colonic glucose absorption is little to none.  This presents a divergent 
adaptation from mammals, where both tilapia and trout have evolved to absorb glucose along 
their hindgut, implicating this segment and the glucose transporters in other physiological roles.  
We speculated it may have to do with osmoregulation, which has been studied in avian species 
(68).  Interestingly, even though sodium-dependent glucose absorption has been extensively 
studied in mammalian species in comparison to their aquatic counterparts, there are still 
undefined mechanisms, especially in the pig.  Therefore, our next chapter focuses on sodium-
dependent glucose absorption in the pig, revealing interesting insights into its glucose transport 
mechanisms. 
Thus, in chapter 4, the kinetic characterization of sodium-dependent glucose absorption 
was investigated along the porcine jejunum, ileum, and distal colon.  Here, for the first time, we 
demonstrated that the jejunum and ileum follow sigmoidal/Hill kinetics, instead of the previously 
characterised Michaelis-Menten kinetics.  This result changes the perspective of porcine sodium-
dependent glucose transport, since this kinetic fit strongly suggests that multiple transporters are 
involved in each segment.  Previous studies have characterized sodium-dependent glucose 
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transport in both segments following Michaelis-Menten models, suggesting only one-transporter 
involvement (75).  However, our characterization reveals that this is not the case.  Therefore, our 
kinetic work strongly supports the involvement of multiple transporters in each segment 
contributing to overall glucose absorption in the porcine jejunum and ileum.  This is supported 
by the expression of multiple SLC5A isoforms identified here and previously described 
secondary modifications of SGLT1 along the GI tract.   
Finally, in chapter 5, we studied total tissue glucose absorption, to include sodium-
dependent and sodium-independent absorption.  Our results described surprising differences 
between the mammalian pig and the aquatic species tilapia and trout.  The sodium-independent 
component of total tissue glucose absorption along the BBM is generally assumed to be 
associated with the GLUT2 transporter, at least in rodents (213).  Interestingly, this was not 
found in tilapia and trout.  In fact, the majority of transport in these fish species seemed to occur 
predominantly through SGLTs, saturating at around 50mM glucose.  However, the pig 
demonstrated continued glucose absorption past 50mM glucose, with a strong GLUT2 presence 
based on pharmacological inhibition, as well as gene expression analyses.  Therefore, the pig 
demonstrated glucose absorption through SGLTs, as well as through GLUT2 transporters.  This 
is interesting, suggesting that mammals adapted to increase the efficiency of their glucose 
absorption, seeing as they have much higher carbohydrates in their natural diets compared to 
both omnivorous and carnivorous fish species (1).  Finally, this chapter revealed the possible 
contribution of AQPs to total glucose absorption in tilapia and pig.  With pharmacological 
inhibition of AQP transporters in both species, we revealed that AQPs may contribute to total 
glucose transport, an area not yet investigated in these species. 
Glucose absorption, whether it is sodium-dependent or a combination of sodium-
dependent and sodium-independent, revealed different kinetic glucose transport systems in the 
species presented in the above chapters.  We demonstrated and provided reasons as to why 
different kinetic glucose transport systems may exist along the GI tract of these species.  
However, there is still no concrete answer as to why these systems are needed.     
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6.2 Limitations 
Each chapter contains limitations, as with all studies based on techniques and assays 
used.  These limitations are presented below.  
In chapter 3, there are a few limitations in this study based on the techniques used.  The 
assumption of mRNA expression of the SLC5A transporters directly correlating with protein 
function does not always hold.  However, identifying these fish SLC5A proteins using Western 
blots is not currently possible as there are no available fish SLC5A antibodies.  Another technical 
limitation in this study involves the possibility of contamination of other tissues when collecting 
whole intestinal segments for RT-qPCR.  Avoiding contamination by scraping cells off the 
epithelial lumen was not possible, given the very thin intestinal tissue which would tear upon 
scraping, thus not completely eliminating contamination.  Another limitation addresses the 
higher absorptive capacity seen in tilapia, which could be due to other structural and functional 
adaptations.  The current study expressed absorptive capacity in terms of intestinal segment area 
exposed by the insert in the Ussing chamber (0.3 cm2).  However, while the tissue area was 
constant, the epithelial surface area may have differed between the two species, depending on the 
size of villi and microvilli structures.  Additionally, the higher SGLT1 expression in tilapia 
compared to trout may contribute to the higher Vmax values as the coupling ratio of sodium to 
glucose for SGLT1 is known to be 2:1 (13, 16, 53, 58, 75, 83, 84, 90, 112).  Finally, the 
definition of Km in this study is collectively termed as affinity, where the assumption is made 
that the rate of transport and binding is similar.  This assumption is supported by the fact that our 
technique requires the simultaneous binding and transport of glucose to generate a current.   
 In chapter 4, there are limitations as well.  As said previously in chapter 3, we 
acknowledge that mRNA and protein expression are not directly correlative, therefore the gene 
expression results presented in this chapter only suggest the possible involvement of these 
transporters.  Additionally, we have assumed that the SLC5A family, secondary modifications of 
family members, or another family of sodium-dependent glucose transporters may be responsible 
for the observed glucose transport kinetic differences between the jejunum and ileum.  
Investigating these different mechanisms would be beyond the scope of the study presented in 
this chapter.   
 In Chapter 5, as mentioned previously in Chapter 3, one of the limitations addresses the 
fact that the results obtained from the gene expression analyses represents assumptions, since 
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mRNA and protein expression are not always correlated.  However, performing Western blots 
using fish and pig antibodies for SGLTs, GLUT2, and AQPs is not possible, as fish and pig 
antibodies are not available.  Additionally, GLUT2 expression was conducted using whole 
intestinal tissues, rather than scraping the apical portion of the intestine.  Therefore, possible 
GLUT2 expression from the basolateral membrane may also contribute to the overall expression.  
However, our conclusions of GLUT2 presence on the apical side of the pig jejunum is based on 
the support of using inhibitors only on the apical side of the intestine and observing significant 
inhibition.   
 
6.3 Future Research 
In our first study, we have shown that the omnivorous tilapia absorbs higher amounts of 
glucose than the carnivorous trout.  Additionally, the aquatic species here demonstrated major 
differences in sodium-dependent glucose transport systems, with different patterns of intestinal 
segregation.  Therefore, we speculate whether these results may mirror other omnivorous and 
carnivorous fish species, such as the carnivorous salmon, or the omnivorous black bullhead 
catfish.  Studying sodium-dependent glucose absorption in other types of fish can allow for 
broader conclusions to be made between omnivorous and carnivorous fish species.  We have also 
demonstrated that both tilapia and trout absorb glucose across the entirety of their GI tract, 
especially in their hindgut segments.  This finding has also been demonstrated in avian and other 
fish species (Tambaqui, black Piranha, and Pacu), which may all suggest a unique evolutionary 
adaptation to glucose absorption, similar to tilapia and trout (68, 99, 156).  Therefore, 
specifically exploring the absorption of glucose in the hindgut of these species can reveal 
important evolutionary adaptational mechanisms in these species.  Finally, the sodium-dependent 
glucose transporters responsible for hindgut glucose absorption in trout were not identified.  
Thus, future studies can focus on identifying potential sodium-dependent glucose transporters 
from other solute carrier families that may contribute to the observed kinetics in the trout 
hindgut.   
In the pig, the heterogeneous system of sodium-dependent glucose absorption in the 
jejunum and ileum has been demonstrated in other mammalian species, but has yet to be fully 
characterized.  More specifically, the second transporter involved in ileal sodium-dependent 
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glucose absorption has not been identified.  Investigating the identity of this transporter from 
other solute carrier families, or producing knockdowns of existing transporters may provide 
answers.  Additionally, heterogeneous systems of glucose transport have been discovered in 
other species like bovine, equine, and rodents, where characterization is incomplete.  Therefore, 
further investigating these systems can possibly introduce similar or different mechanisms of 
glucose transport in these species.   
Finally, total tissue glucose absorption can be expanded to study other mammalian 
species, to see similar transport mechanisms to the pig.  Additionally, the other intestinal sections 
in both the pig and the aquatic species can be used to study total tissue glucose absorption as 
well.  The GLUT2 presence in the pig and its lack thereof in tilapia and trout is very interesting 
as this difference has not been presented before.  Therefore, studying total tissue glucose 
absorption in other aquatic species is important to see if similar results are observed in 
comparison to tilapia and trout.  Additionally, studying the importance of GLUT2 in pig or other 
mammalian models by running different assays (sodium-independent Ussing chamber 
experiments, knockdowns, etc.) can allow us to better understand the difference in glucose 
transport mechanisms between mammalian species.   
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